<html xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns="http://www.w3.org/TR/REC-html40"><meta http-equiv="content-type" content="application/vnd.ms-excel; charset=UTF-8"><head><!--[if gte mso 9]><xml><x:ExcelWorkbook><x:ExcelWorksheets><x:ExcelWorksheet><x:Name>Sheet0</x:Name><x:WorksheetOptions><x:DisplayGridlines/></x:WorksheetOptions></x:ExcelWorksheet></x:ExcelWorksheets></x:ExcelWorkbook></xml><![endif]--></head><body><table><tr style=''><td>Gene</td><td>SNP Identifiers</td><td>SNP location</td><td>Genomic loci</td><td>Disease or Protective allele</td><td>Allele Frequency (GnomAD)</td><td>Literatures</td></tr><tr style=''><td>ABCB1</td><td>rs1045642</td><td>Exon</td><td>7q21.12</td><td>Disease</td><td>&gt; 0.01</td><td>Association between ABCB1, ABCG2 carrier protein and COX-2 enzyme gene polymorphisms and breast cancer risk in a Turkish population</td></tr><tr style=''><td>ABCG2</td><td>rs2231142</td><td>Exon</td><td>4q22.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association between ABCB1, ABCG2 carrier protein and COX-2 enzyme gene polymorphisms and breast cancer risk in a Turkish population</td></tr><tr style=''><td>ABHD8</td><td>rs10424198</td><td>Intron</td><td>19p13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus</td></tr><tr style=''><td>ABHD8</td><td>rs4808616</td><td>3 Prime UTR Variant</td><td>19p13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus</td></tr><tr style=''><td>ABR</td><td>-</td><td>CNV</td><td>17p13.3&nbsp;</td><td>Protective</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>ABRAXAS1</td><td>-</td><td>-</td><td>4q21.23</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>ABRAXAS1</td><td>rs11099601</td><td>3 Prime UTR Variant</td><td>4q21.23</td><td>Disease</td><td>&gt; 0.01</td><td>Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21</td></tr><tr style=''><td>ABRAXAS1</td><td>rs201627097</td><td>Exon</td><td>4q21.23</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer-Associated Abraxas Mutation Disrupts Nuclear Localization and DNA Damage Response Functions</td></tr><tr style=''><td>AC008132.1</td><td>-</td><td>CNV</td><td>22q11.21</td><td>Protective</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>AC058822.1</td><td>-</td><td>-</td><td>4q12&nbsp;</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>ACE</td><td>rs1799752</td><td>Intron</td><td>17q23.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association of AGTR1 (A1166C) and ACE (I/D) Polymorphisms with Breast Cancer Risk in North Indian Population</td></tr><tr style=''><td>ACE</td><td>rs1799752</td><td>Intron</td><td>17q23.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort</td></tr><tr style=''><td>ACE</td><td>rs1799752</td><td>Intron</td><td>17q23.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women</td></tr><tr style=''><td>ACOXL-AS1</td><td>rs73954922</td><td>Intron&nbsp;</td><td>2q13&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ACOXL&nbsp;</td><td>rs73954922</td><td>Intron&nbsp;</td><td>2q13&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ACTA2</td><td>rs1800682</td><td>Intron</td><td>10q23.31</td><td>Disease</td><td>&gt; 0.01</td><td>Functional Polymorphisms of FAS and FASL Gene and Risk of Breast Cancer – Pilot Study of 134 Cases</td></tr><tr style=''><td>ACTA2</td><td>rs2234767</td><td>Intron</td><td>10q23.31</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms of the FAS and FASL genes and risk of breast cancer</td></tr><tr style=''><td>ACYP2</td><td>rs12621038</td><td>Intron</td><td>2p16.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic variants in the acylphosphatase 2 gene and the risk of breast cancer in a Han Chinese population</td></tr><tr style=''><td>ACYP2</td><td>rs1682111</td><td>Intron</td><td>2p16.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variants in the acylphosphatase 2 gene and the risk of breast cancer in a Han Chinese population</td></tr><tr style=''><td>ACYP2</td><td>rs17045754</td><td>Intron</td><td>2p16.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic variants in the acylphosphatase 2 gene and the risk of breast cancer in a Han Chinese population</td></tr><tr style=''><td>ACYP2</td><td>rs843706</td><td>Intron</td><td>2p16.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association between single nucleotide polymorphisms in the TSPYL6 gene and breast cancer susceptibility in the Han Chinese population</td></tr><tr style=''><td>ADAM29</td><td>rs6828523</td><td>Intron</td><td>4q34.1</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>ADAM29</td><td>rs6828523</td><td>Intron</td><td>4q34.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>ADARB2&nbsp;</td><td>rs74122632</td><td>Intron</td><td>10p15.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>ADCY3</td><td>rs6725517</td><td>Intron</td><td>2p23.3</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>ADCY9</td><td>rs11076805</td><td>Intron</td><td>16p13.3</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>ADCY9&nbsp;</td><td>rs2601774</td><td>Intron&nbsp;</td><td>16p13.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ADSS1</td><td>rs10623258</td><td>Intron</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>AFDN&nbsp;</td><td>rs3778663</td><td>Intron&nbsp;</td><td>6q27&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>AGTR1</td><td>rs5186</td><td>3 Prime UTR Variant</td><td>3q24</td><td>Disease</td><td>&gt; 0.01</td><td>Association of AGTR1 (A1166C) and ACE (I/D) Polymorphisms with Breast Cancer Risk in North Indian Population</td></tr><tr style=''><td>AHR</td><td>rs2066853</td><td>Exon</td><td>7p21.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women</td></tr><tr style=''><td>AHRR</td><td>rs62641919</td><td>Intron</td><td>5p15.33</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>AHRR&nbsp;</td><td>rs62641919</td><td>Intron&nbsp;</td><td>5p15.33&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>AIRE</td><td>rs2075876</td><td>Intron</td><td>21q22.3</td><td>Protective</td><td>&gt; 0.01</td><td>Analysis of the autoimmune regulator (AIRE) gene variant rs2075876 (G/A) association with breast cancer susceptibility</td></tr><tr style=''><td>AKAP6</td><td>rs3784179</td><td>Intron</td><td>14q13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>AKAP9</td><td>rs6960867</td><td>Exon</td><td>7q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association of a Common AKAP9 Variant With Breast Cancer Risk: A Collaborative Analysis</td></tr><tr style=''><td>AKAP9</td><td>rs6964587</td><td>Exon</td><td>7q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association of a Common AKAP9 Variant With Breast Cancer Risk: A Collaborative Analysis</td></tr><tr style=''><td>AKAP9</td><td>rs6964587</td><td>Exon</td><td>7q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium</td></tr><tr style=''><td>AKAP9&nbsp;</td><td>rs141039834</td><td>Exon</td><td>7q21.2</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>AKAP9&nbsp;</td><td>rs2075881</td><td>Intron&nbsp;</td><td>7q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>AKR1A1</td><td>rs35349030</td><td>Intron&nbsp;</td><td>1p34.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>AKR1A1</td><td>rs3790585</td><td>Intron</td><td>1p34.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>AKT1&nbsp;</td><td>rs1130233&nbsp;</td><td>Exon </td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients</td></tr><tr style=''><td>ALDH2</td><td>rs671</td><td>Exon</td><td>12q24.12</td><td>Disease</td><td>&gt; 0.01</td><td>The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium</td></tr><tr style=''><td>ALG9&nbsp;</td><td>rs11354045</td><td>Intron&nbsp;</td><td>11q23.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ALOX12</td><td>rs1126667</td><td>Exon</td><td>17p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer</td></tr><tr style=''><td>ALOX12</td><td>rs434473</td><td>Exon</td><td>17p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non‐Hispanic white women: The breast cancer health disparities study</td></tr><tr style=''><td>ALOX12</td><td>rs9904779</td><td>5 Prime UTR Variant</td><td>17p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non‐Hispanic white women: The breast cancer health disparities study</td></tr><tr style=''><td>ALOX12-AS1</td><td>rs1126667</td><td>Intron</td><td>17p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer</td></tr><tr style=''><td>ALOX12-AS1</td><td>rs434473</td><td>Intron</td><td>17p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non‐Hispanic white women: The breast cancer health disparities study</td></tr><tr style=''><td>ALOX12-AS1</td><td>rs9904779</td><td>Intron</td><td>17p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non‐Hispanic white women: The breast cancer health disparities study</td></tr><tr style=''><td>AMFR</td><td>rs2432539</td><td>Intron</td><td>16q13</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>AMFR&nbsp;</td><td>rs2432539</td><td>Intron&nbsp;</td><td>16q13&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ANGPT2&nbsp;</td><td>rs1823375</td><td>Intron&nbsp;</td><td>8p23.1</td><td>Protective</td><td>&gt; 0.01</td><td>The impact of Angiopoietin-2 genetic polymorphisms on susceptibility for malignant breast neoplasms</td></tr><tr style=''><td>ANKLE1</td><td>rs56069439</td><td>Intron</td><td>19p13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>ANTXR1</td><td>rs4602255</td><td>Intron</td><td>2p13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>ANTXR1&nbsp;</td><td>rs62134416</td><td>Intron&nbsp;</td><td>2p13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>AP4B1-AS1</td><td>rs11102694</td><td>Intron&nbsp;</td><td>1p13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>APC</td><td>rs1801155</td><td>Exon</td><td>5q22.2</td><td>Disease</td><td>&lt; 0.01</td><td>The APC I1307K allele conveys a significant increased risk for cancer</td></tr><tr style=''><td>APC</td><td>rs454886</td><td>Intron</td><td>5q22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association of Genetic Variation in Genes Implicated in the β-Catenin Destruction Complex with Risk of Breast Cancer</td></tr><tr style=''><td>APEX1</td><td>rs1130409</td><td>Exon</td><td>14q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association of Polymorphisms in Base Excision Repair Genes With the Risk of Breast Cancer: A Case-Control Study in North Indian Women</td></tr><tr style=''><td>APEX1</td><td>rs1130409</td><td>Exon</td><td>14q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association of DNA Repair Gene APE1 Asp148Glu Polymorphism With Breast Cancer Risk</td></tr><tr style=''><td>APEX1</td><td>rs1130409</td><td>Exon</td><td>14q11.2</td><td>Protective</td><td>&gt; 0.01</td><td>Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk</td></tr><tr style=''><td>APOBEC3A</td><td>rs12628403</td><td>Intron</td><td>22q13.1 </td><td>Disease</td><td>&gt; 0.01</td><td>A Common Deletion in the APOBEC3 Genes and Breast Cancer Risk</td></tr><tr style=''><td>APOBEC3A_B</td><td>rs12628403</td><td>Intron</td><td>22q13.1 </td><td>Disease</td><td>&gt; 0.01</td><td>A Common Deletion in the APOBEC3 Genes and Breast Cancer Risk</td></tr><tr style=''><td>APOBEC3A_B</td><td>rs12628403</td><td>Intron&nbsp;</td><td>22q13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>APOBEC3A&nbsp;</td><td>rs12628403</td><td>Intron&nbsp;</td><td>22q13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>AQP4-AS1</td><td>rs745983748</td><td>Intron&nbsp;</td><td>18q11.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ARHGAP26</td><td>rs13172733</td><td>Intron</td><td>5q31.3</td><td>Disease</td><td>&gt; 0.01</td><td>A genome-wide association study of breast cancer in women of African ancestry</td></tr><tr style=''><td>ARHGAP26</td><td>rs153170</td><td>Intron</td><td>5q31.3</td><td>Disease</td><td>&gt; 0.01</td><td>A genome-wide association study of breast cancer in women of African ancestry</td></tr><tr style=''><td>ARHGEF5</td><td>rs720475</td><td>Intron</td><td>7q35</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>ARL11</td><td>rs3803185</td><td>Exon</td><td>13q14.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk</td></tr><tr style=''><td>ARLNC1</td><td>rs1981867</td><td>Intron</td><td>19q13.41</td><td>Disease</td><td>&gt; 0.01</td><td>Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility</td></tr><tr style=''><td>ASPH</td><td>rs2350923</td><td>Intron</td><td>8q12.3</td><td>Disease</td><td>&gt; 0.01</td><td>BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts</td></tr><tr style=''><td>ASPRV1&nbsp;</td><td>rs6756513</td><td>Intron&nbsp;</td><td>2p13.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ASTN2</td><td>rs1895062</td><td>Intron</td><td>9q33.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>ASTN2-AS1</td><td>rs1407243</td><td>Intron&nbsp;</td><td>9q33.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ASTN2-AS1</td><td>rs1895062</td><td>Intron</td><td>9q33.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>ASTN2&nbsp;</td><td>rs1407243</td><td>Intron&nbsp;</td><td>9q33.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ATAD5&nbsp;</td><td>rs7223535</td><td>Intron&nbsp;</td><td>17q11.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ATE1</td><td>rs10510102</td><td>Intron</td><td>10q26.13</td><td>Disease</td><td>&gt; 0.01</td><td>Novel Breast Cancer Susceptibility Locus at 9q31.2: Results of a Genome-Wide Association Study</td></tr><tr style=''><td>ATG10</td><td>rs10514231</td><td>Intron</td><td>5q14.2 </td><td>Protective</td><td>&gt; 0.01</td><td>Potentially functional polymorphisms in ATG10 are associated with risk of breast cancer in a Chinese population</td></tr><tr style=''><td>ATG10</td><td>rs1864182</td><td>Exon</td><td>5q14.2 </td><td>Protective</td><td>&gt; 0.01</td><td>Potentially functional polymorphisms in ATG10 are associated with risk of breast cancer in a Chinese population</td></tr><tr style=''><td>ATG10</td><td>rs7707921</td><td>Intron</td><td>5q14.2 </td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>ATG10&nbsp;</td><td>rs4081859</td><td>Intron&nbsp;</td><td>5q14.1&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ATM</td><td>-</td><td>CNV</td><td>11q22.3&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>ATM</td><td>-</td><td>Exon</td><td>11q22.3</td><td>Disease</td><td>&lt; 0.01</td><td>Evaluation of the Role of Finnish Ataxia-Telangiectasia Mutations in Hereditary Predisposition to Breast Cancer</td></tr><tr style=''><td>ATM</td><td>-</td><td>Exon</td><td>11q22.3</td><td>Disease</td><td>&lt; 0.01</td><td>ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles</td></tr><tr style=''><td>ATM</td><td>-</td><td>Exon</td><td>11q22.3</td><td>Disease</td><td>&lt; 0.01</td><td>Cancer risks and mortality in heterozygous ATM mutation carriers</td></tr><tr style=''><td>ATM</td><td>-</td><td>Exon</td><td>11q22.3</td><td>Disease</td><td>&lt; 0.01</td><td>Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families</td></tr><tr style=''><td>ATM</td><td>-</td><td>Exon</td><td>11q22.3</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>ATM</td><td>-</td><td>Exon</td><td>11q22.3</td><td>Disease</td><td>&lt; 0.01</td><td>Male breast cancer risk associated with pathogenic variants in genes other than&nbsp;BRCA1/2: an Italian case-control study</td></tr><tr style=''><td>ATM</td><td>-</td><td>Exon</td><td>11q22.3</td><td>Disease</td><td>-</td><td>Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry</td></tr><tr style=''><td>ATM</td><td>-</td><td>Exon</td><td>11q22.3</td><td>Disease</td><td>-</td><td>Evaluating breast cancer predisposition genes in women of African ancestry</td></tr><tr style=''><td>ATM</td><td>rs609429</td><td>Intron</td><td>11q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>ATM Haplotypes and Cellular Response to DNA Damage: Association with Breast Cancer Risk and Clinical Radiosensitivity</td></tr><tr style=''><td>ATM</td><td>rs664677</td><td>Intron</td><td>11q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>ATM Haplotypes and Cellular Response to DNA Damage: Association with Breast Cancer Risk and Clinical Radiosensitivity</td></tr><tr style=''><td>ATM&nbsp;</td><td>rs228590</td><td>Intron&nbsp;</td><td>11q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>SDC4-rs1981429 and ATM-rs228590 may provide early biomarkers of breast cancer risk</td></tr><tr style=''><td>ATM&nbsp;</td><td>rs769142993</td><td>Exon</td><td>11q22.3</td><td>Disease</td><td>&lt; 0.01</td><td>ATM c.7570G&gt;C is a high-risk allele for breast cancer</td></tr><tr style=''><td>ATP12A</td><td>-</td><td>CNV</td><td>13q12.12&nbsp;</td><td>Protective</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>ATR</td><td>rs2227931</td><td>Exon</td><td>3q23</td><td>Protective</td><td>&gt; 0.01</td><td>Mutation analysis of the ATR gene in breast and ovarian cancer families</td></tr><tr style=''><td>ATR</td><td>rs6805118</td><td>Intron</td><td>3q23</td><td>Protective</td><td>&gt; 0.01</td><td>Associations of ATR and CHEK1 Single Nucleotide Polymorphisms with Breast Cancer</td></tr><tr style=''><td>ATR</td><td>rs768843213</td><td>Intron</td><td>3q23</td><td> Disease</td><td>&lt; 0.01</td><td>Mutation analysis of the ATR gene in breast and ovarian cancer families</td></tr><tr style=''><td>ATRIP&nbsp;</td><td>rs753154444</td><td>Exon </td><td>3p21.31</td><td>Disease</td><td>&lt; 0.01</td><td>Variants in ATRIP are associated with breast cancer susceptibility in the Polish population and UK Biobank</td></tr><tr style=''><td>ATXN1</td><td>rs3819405</td><td>Intron</td><td>6p22.3</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>ATXN1&nbsp;</td><td>rs3819405</td><td>Intron&nbsp;</td><td>6p22.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ATXN7</td><td>rs1053338</td><td>Exon</td><td>3p14.1</td><td>Disease</td><td>&gt; 0.01</td><td>Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium</td></tr><tr style=''><td>ATXN7&nbsp;</td><td>rs73117066</td><td>Intron&nbsp;</td><td>3p14.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>AURKA&nbsp;</td><td>rs1047972&nbsp;</td><td>Exon</td><td>20q13.2&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>AURKA&nbsp;Gene Variants rs1047972, and rs8173 Are Associated With Breast Cancer</td></tr><tr style=''><td>AURKA&nbsp;</td><td>rs8173&nbsp;</td><td>3 Prime UTR Variant</td><td>20q13.2&nbsp;</td><td>Protective/Disease</td><td>&gt; 0.01</td><td>AURKA&nbsp;Gene Variants rs1047972, and rs8173 Are Associated With Breast Cancer</td></tr><tr style=''><td>AXIN2</td><td>rs11079571</td><td>Intron</td><td>17q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of Genetic Variation in Genes Implicated in the β-Catenin Destruction Complex with Risk of Breast Cancer</td></tr><tr style=''><td>AXIN2</td><td>rs11079571</td><td>Intron</td><td>17q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>The Association Between AXIN2 Gene Polymorphisms and the Risk of Breast Cancer in Chinese Women</td></tr><tr style=''><td>AXIN2</td><td>rs2240308</td><td>Exon</td><td>17q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>AXIN2 Polymorphisms, the β-Catenin Destruction Complex Expression Profile and Breast Cancer Susceptibility</td></tr><tr style=''><td>AXIN2</td><td>rs2240308</td><td>Exon</td><td>17q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genotypes and Haplotypes in the&nbsp;AXIN2&nbsp;and&nbsp;TCF7L2&nbsp;Genes are Associated With Susceptibility and With Clinicopathological Characteristics in Breast Cancer Patients</td></tr><tr style=''><td>AXIN2</td><td>rs3923086</td><td>Intron</td><td>17q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of Genetic Variation in Genes Implicated in the β-Catenin Destruction Complex with Risk of Breast Cancer</td></tr><tr style=''><td>AXIN2</td><td>rs3923086</td><td>Intron</td><td>17q24.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association of Single Nucleotide Polymorphisms in Wnt Signaling Pathway Genes With Breast Cancer in Saudi Patients</td></tr><tr style=''><td>AXIN2</td><td>rs3923087</td><td>Intron</td><td>17q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of Genetic Variation in Genes Implicated in the β-Catenin Destruction Complex with Risk of Breast Cancer</td></tr><tr style=''><td>AXIN2</td><td>rs3923087</td><td>Intron</td><td>17q24.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association of Single Nucleotide Polymorphisms in Wnt Signaling Pathway Genes With Breast Cancer in Saudi Patients</td></tr><tr style=''><td>AXIN2</td><td>rs3923087</td><td>Intron</td><td>17q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>The Association Between AXIN2 Gene Polymorphisms and the Risk of Breast Cancer in Chinese Women</td></tr><tr style=''><td>AXIN2</td><td>rs4791171</td><td>Intron</td><td>17q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of Genetic Variation in Genes Implicated in the β-Catenin Destruction Complex with Risk of Breast Cancer</td></tr><tr style=''><td>AXIN2</td><td>rs7210356</td><td>Intron</td><td>17q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of Genetic Variation in Genes Implicated in the β-Catenin Destruction Complex with Risk of Breast Cancer</td></tr><tr style=''><td>BABAM1</td><td>rs8170</td><td>Exon</td><td>19p13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Susceptibility Loci for Subtypes of Breast Cancer in an African American Population</td></tr><tr style=''><td>BABAM1</td><td>rs8170</td><td>Exon</td><td>19p13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>BAIAP2L1</td><td>rs4439053</td><td>Intron&nbsp;</td><td>7q22.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>BAIAP2L1</td><td>rs79518236</td><td>Intron</td><td>7q21.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>BARD1</td><td>-</td><td>Exon</td><td>2q35</td><td>Disease</td><td>&lt; 0.01</td><td>Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer</td></tr><tr style=''><td>BARD1</td><td>-</td><td>Exon</td><td>2q35</td><td>Disease</td><td>&lt; 0.01</td><td>Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer</td></tr><tr style=''><td>BARD1</td><td>-</td><td>Exon</td><td>2q35</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>BARD1</td><td>-</td><td>Exon</td><td>2q35&nbsp;</td><td>Disease</td><td>-</td><td>Evaluating breast cancer predisposition genes in women of African ancestry</td></tr><tr style=''><td>BARD1</td><td>rs28997576</td><td>Exon</td><td>2q35</td><td>Disease</td><td>&gt; 0.01</td><td>The BARD1 Cys557Ser Variant and Risk of Familial Breast Cancer in a South-American Population</td></tr><tr style=''><td>BARD1</td><td>rs28997576</td><td>Exon</td><td>2q35</td><td>Disease</td><td>&gt; 0.01</td><td>Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer</td></tr><tr style=''><td>BARD1</td><td>rs28997576</td><td>Exon</td><td>2q35</td><td>Disease</td><td>&gt; 0.01</td><td>Nordic Collaborative Study of the BARD1 Cys557Ser Allele in 3956 Patients With Cancer: Enrichment in Familial BRCA1/BRCA2 Mutation-Negative Breast Cancer but Not in Other Malignancies</td></tr><tr style=''><td>BARD1</td><td>rs587780021</td><td>Exon</td><td>2q35</td><td>Disease</td><td>&lt; 0.01</td><td>BARD1 is a Low/Moderate Breast Cancer Risk Gene: Evidence Based on an Association Study of the Central European p.Q564X Recurrent Mutation</td></tr><tr style=''><td>BARD1&nbsp;</td><td>rs2229571</td><td>Exon</td><td>2q35&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Mutations in exon region of BRCA1-related RING domain 1 gene and risk of breast cancer</td></tr><tr style=''><td>BARD1&nbsp;</td><td>rs28997575</td><td>Exon</td><td>2q35&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Mutations in exon region of BRCA1-related RING domain 1 gene and risk of breast cancer</td></tr><tr style=''><td>BCKDHB</td><td>rs12207986</td><td>Intron</td><td>6q14.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>BCKDHB&nbsp;</td><td>rs1836962</td><td>Intron&nbsp;</td><td>6q14.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>BCL2L11</td><td>rs3833441</td><td>Non Coding Transcript Variant</td><td>2q13</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>BCL2L15&nbsp;</td><td>rs11102694</td><td>Intron&nbsp;</td><td>1p13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>BET1</td><td>rs10953105</td><td>Intron</td><td>7q21.3</td><td>Disease</td><td>&gt; 0.01</td><td>BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts</td></tr><tr style=''><td>BIVM-ERCC5</td><td>rs17655</td><td>Exon</td><td>13q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>Synergistic Effects of Polymorphisms in DNA Repair Genes and Endogenous Estrogen Exposure on Female Breast Cancer Risk</td></tr><tr style=''><td>BIVM-ERCC5</td><td>rs17655</td><td>Exon</td><td>13q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis</td></tr><tr style=''><td>BLM</td><td>rs200389141</td><td>Exon</td><td>15q26.1</td><td>Disease</td><td>&lt; 0.01</td><td>High prevalence and breast cancer predisposing role of the BLM c.1642 C&gt;T (Q548X) mutation in Russia</td></tr><tr style=''><td>BLM</td><td>rs200389141</td><td>Exon</td><td>15q26.1</td><td>Disease</td><td>&lt; 0.01</td><td>Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations</td></tr><tr style=''><td>BLM</td><td>rs2380165</td><td>Intron</td><td>15q26.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility</td></tr><tr style=''><td>BRCA1</td><td>-</td><td>CNV</td><td>17q21.31&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>BRCA1</td><td>-</td><td>Exon</td><td>17q21.31</td><td>Disease</td><td>&lt; 0.01</td><td>Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2</td></tr><tr style=''><td>BRCA1</td><td>-</td><td>Exon</td><td>17q21.31</td><td>Disease</td><td>&lt; 0.01</td><td>Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families</td></tr><tr style=''><td>BRCA1</td><td>-</td><td>Exon</td><td>17q21.31</td><td>Disease</td><td>&lt; 0.01</td><td>Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer</td></tr><tr style=''><td>BRCA1</td><td>-</td><td>Exon</td><td>17q21.31</td><td>Disease</td><td>&lt; 0.01</td><td>Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases</td></tr><tr style=''><td>BRCA1</td><td>-</td><td>Exon</td><td>17q21.31</td><td>Disease</td><td>&lt; 0.01</td><td>The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews</td></tr><tr style=''><td>BRCA1</td><td>-</td><td>Exon</td><td>17q21.31</td><td>Disease</td><td>&lt; 0.01</td><td>Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies</td></tr><tr style=''><td>BRCA1</td><td>-</td><td>Exon</td><td>17q21.31</td><td>Disease</td><td>&lt; 0.01</td><td>The Lifetime Risks of Breast Cancer in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations</td></tr><tr style=''><td>BRCA1</td><td>-</td><td>Exon</td><td>17q21.31</td><td>Disease</td><td>&lt; 0.01</td><td>Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies</td></tr><tr style=''><td>BRCA1</td><td>-</td><td>Exon</td><td>17q21.31</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>BRCA1</td><td>-</td><td>Exon</td><td>17q21.31</td><td>Disease</td><td>-</td><td>Evaluating breast cancer predisposition genes in women of African ancestry</td></tr><tr style=''><td>BRCA1</td><td>-</td><td>Exon</td><td>17q21.31</td><td>Disease</td><td>-</td><td>Association between germline pathogenic variants and breast cancer risk in Japanese women: The HERPACC study</td></tr><tr style=''><td>BRCA1</td><td>rs1799950</td><td>Exon</td><td>17q21.31</td><td>Disease</td><td>&gt; 0.01</td><td>Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan</td></tr><tr style=''><td>BRCA2</td><td>-</td><td>CNV</td><td>13q13.1&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>BRCA2</td><td>-</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2</td></tr><tr style=''><td>BRCA2</td><td>-</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families</td></tr><tr style=''><td>BRCA2</td><td>-</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Population-based study of risk of breast cancer in carriers of BRCA2 mutation</td></tr><tr style=''><td>BRCA2</td><td>-</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer</td></tr><tr style=''><td>BRCA2</td><td>-</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>&lt; 0.01</td><td>The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews</td></tr><tr style=''><td>BRCA2</td><td>-</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies</td></tr><tr style=''><td>BRCA2</td><td>-</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>&lt; 0.01</td><td>The Lifetime Risks of Breast Cancer in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations</td></tr><tr style=''><td>BRCA2</td><td>-</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies</td></tr><tr style=''><td>BRCA2</td><td>-</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>BRCA2</td><td>-</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>-</td><td>Evaluating breast cancer predisposition genes in women of African ancestry</td></tr><tr style=''><td>BRCA2</td><td>-</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>-</td><td>Association between germline pathogenic variants and breast cancer risk in Japanese women: The HERPACC study</td></tr><tr style=''><td>BRCA2</td><td>rs11571833</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>BRCA2</td><td>rs144848</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan</td></tr><tr style=''><td>BRCA2&nbsp;</td><td>rs11571833</td><td>Exon</td><td>13q13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>BRD7</td><td>-</td><td>Exon</td><td>16q12.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>BRIP1</td><td>rs137852986</td><td>Exon</td><td>17q23.2</td><td>Disease</td><td>&lt; 0.01</td><td>Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles</td></tr><tr style=''><td>BTN2A1</td><td>-</td><td>-</td><td>6p22.2</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>C11orf65</td><td>rs609429</td><td>Intron</td><td>11q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>ATM Haplotypes and Cellular Response to DNA Damage</td></tr><tr style=''><td>C11orf65&nbsp;</td><td>rs199504893</td><td>Intron&nbsp;</td><td>11q22.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>C11orf65&nbsp;</td><td>rs769142993</td><td>Non Coding Transcript Variant</td><td>11q22.3</td><td>Disease</td><td>&lt; 0.01</td><td>ATM c.7570G&gt;C is a high-risk allele for breast cancer</td></tr><tr style=''><td>C2CD6</td><td>rs59278883</td><td>Intron</td><td>2q33.1</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>CABLES1</td><td>rs11082321</td><td>Intron</td><td>18q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3, and 15q26.1</td></tr><tr style=''><td>CASC15</td><td>rs7760611</td><td>Intron</td><td>6p22.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>CASC15</td><td>rs7765429</td><td>Intron</td><td>6p22.3</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>CASC15&nbsp;</td><td>rs7765429</td><td>Intron&nbsp;</td><td>6p22.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CASC16</td><td>rs12922061</td><td>Intron</td><td>16q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>The association of CASC16 variants with breast Cancer risk in a northwest Chinese female population</td></tr><tr style=''><td>CASC16</td><td>rs3803662</td><td>Non Coding Transcript Variant</td><td>16q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>CASC16</td><td>rs3803662</td><td>Non Coding Transcript Variant</td><td>16q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>CASC16</td><td>rs3803662</td><td>Non Coding Transcript Variant</td><td>16q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer</td></tr><tr style=''><td>CASC16</td><td>rs3803662</td><td>Non Coding Transcript Variant</td><td>16q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>CASC16</td><td>rs4784227</td><td>Intron</td><td>16q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of rs4784227-CASC16 (LOC643714 locus) and rs4782447-ACSF3 polymorphisms and their association with breast cancer risk among Iranian population</td></tr><tr style=''><td>CASC16</td><td>rs4784227</td><td>Intron</td><td>16q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>The association of CASC16 variants with breast Cancer risk in a northwest Chinese female population</td></tr><tr style=''><td>CASC16</td><td>rs4784227</td><td>Intron</td><td>16q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Fine scale mapping of the breast cancer 16q12 locus</td></tr><tr style=''><td>CASC16</td><td>rs4784227</td><td>Intron</td><td>16q12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>CASC16 </td><td>rs4784227</td><td>Intron&nbsp;</td><td>16q12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association between the CASC16 rs4784227 polymorphism and breast cancer risk and prognosis in a northeast Chinese Han population</td></tr><tr style=''><td>CASC16 </td><td>rs4784227</td><td>Intron&nbsp;</td><td>16q12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association between the rs4784227-CASC16 polymorphism and the risk of breast cancer: A meta-analysis</td></tr><tr style=''><td>CASC16&nbsp;</td><td>rs3803662</td><td>Non Coding Transcript Variant</td><td>16q12.2</td><td>Protective</td><td>&gt; 0.01</td><td>Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population</td></tr><tr style=''><td>CASC16&nbsp;</td><td>rs4784227</td><td>Intron&nbsp;</td><td>16q12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CASC16&nbsp;</td><td>rs4784227</td><td>Intron&nbsp;</td><td>16q12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population</td></tr><tr style=''><td>CASC21</td><td>rs13281615</td><td>Intron</td><td>8q24.21</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>CASC21</td><td>rs13281615</td><td>Intron</td><td>8q24.21</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>CASC21</td><td>rs1562430</td><td>Intron</td><td>8q24.21</td><td>Protective</td><td>&gt; 0.01</td><td>A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)</td></tr><tr style=''><td>CASC21</td><td>rs1562430</td><td>Intron</td><td>8q24.21</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>CASC21&nbsp;</td><td>rs10096351</td><td>Intron&nbsp;</td><td>8q24.21</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CASC8</td><td>rs13281615</td><td>Intron</td><td>8q24.21</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>CASC8</td><td>rs13281615</td><td>Intron</td><td>8q24.21</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>CASC8</td><td>rs1562430</td><td>Intron</td><td>8q24.21</td><td>Protective</td><td>&gt; 0.01</td><td>A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)</td></tr><tr style=''><td>CASC8</td><td>rs1562430</td><td>Intron</td><td>8q24.21</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>CASC8&nbsp;</td><td>rs10096351</td><td>Intron&nbsp;</td><td>8q24.21</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CASP10</td><td>rs13010627</td><td>Exon</td><td>2q33.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant</td></tr><tr style=''><td>CASP8</td><td>rs1045485</td><td>Exon</td><td>2q33.1</td><td>Protective</td><td>&gt; 0.01</td><td>A common coding variant in CASP8 is associated with breast cancer risk</td></tr><tr style=''><td>CASP8</td><td>rs1045485</td><td>Exon</td><td>2q33.1</td><td>Protective</td><td>&gt; 0.01</td><td>Commonly Studied Single-Nucleotide Polymorphisms and Breast Cancer: Results From the Breast Cancer Association Consortium</td></tr><tr style=''><td>CASP8</td><td>rs10931936</td><td>Intron</td><td>2q33.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>CASP8</td><td>rs10931936</td><td>Intron</td><td>2q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran</td></tr><tr style=''><td>CASP8</td><td>rs12990906</td><td>Intron</td><td>2q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran</td></tr><tr style=''><td>CASP8</td><td>rs3754934</td><td>Intron</td><td>2q33.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran</td></tr><tr style=''><td>CASP8</td><td>rs3834129</td><td>Intron</td><td>2q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran</td></tr><tr style=''><td>CASP8</td><td>rs7608692</td><td>Intron</td><td>2q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran</td></tr><tr style=''><td>CASP8&nbsp;</td><td>rs3769821</td><td>Intron&nbsp;</td><td>2q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CBFA2T3&nbsp;</td><td>rs61734177</td><td>Exon</td><td>16q24.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>CCDC152</td><td>rs3877899</td><td>3 Prime UTR Variant</td><td>5p12</td><td>Protective</td><td>&gt; 0.01</td><td>Association between Polymorphisms in Glutathione Peroxidase and Selenoprotein P Genes, Glutathione Peroxidase Activity, HRT Use and Breast Cancer Risk</td></tr><tr style=''><td>CCDC170</td><td>rs12662670</td><td>Intron</td><td>6q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>CCDC170</td><td>rs3757318</td><td>Intron</td><td>6q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>CCDC170</td><td>rs3757322</td><td>3 Prime UTR Variant</td><td>6q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170</td></tr><tr style=''><td>CCDC170</td><td>rs3757322</td><td>3 Prime UTR Variant</td><td>6q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>CCDC170</td><td>rs9383935</td><td>3 Prime UTR Variant</td><td>6q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population</td></tr><tr style=''><td>CCDC170&nbsp;</td><td>rs1038304</td><td>Intron&nbsp;</td><td>6q25.1</td><td>Protective</td><td>&gt; 0.01</td><td>Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population</td></tr><tr style=''><td>CCDC33&nbsp;</td><td>rs1484216</td><td>Intron&nbsp;</td><td>15q24.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CCDC88C</td><td>rs941764</td><td>Intron</td><td>14q32.11</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>CCDC88C&nbsp;</td><td>rs933986797</td><td>Intron&nbsp;</td><td>14q32.12</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CCDC91</td><td>rs1871152</td><td>Intron</td><td>12p11.22</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus</td></tr><tr style=''><td>CCND1&nbsp;</td><td>rs9344</td><td>Exon</td><td>11q13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association of CCND1 (c.723G &gt; A, rs9344) variant with elevated risk of breast carcinoma: a retrospective case-control study</td></tr><tr style=''><td>CCNE1</td><td>rs1406</td><td>3 Prime UTR Variant</td><td>19q12 </td><td>Disease</td><td>&gt; 0.01</td><td>Association Between CCNE1 Polymorphisms and the Risk of Breast Cancer in a Sample of Southeast Iranian Population</td></tr><tr style=''><td>CCNE1</td><td>rs997669</td><td>Intron</td><td>19q12 </td><td>Disease</td><td>&gt; 0.01</td><td>Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population</td></tr><tr style=''><td>CDC27</td><td>rs12601027</td><td>Intron</td><td>17q21.32</td><td>Disease</td><td>&gt; 0.01</td><td>Association between polymorphisms in cdc27 and breast cancer in a Chinese population</td></tr><tr style=''><td>CDCA7L</td><td>rs7971</td><td>3 Prime UTR Variant</td><td>7p15.3</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>CDCA7L&nbsp;</td><td>rs7971</td><td>3 Prime UTR Variant</td><td>7p15.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CDH1</td><td>-</td><td>Exon</td><td>16q22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families</td></tr><tr style=''><td>CDH1</td><td>-</td><td>Exon</td><td>16q22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>CDH1</td><td>rs3743674</td><td>Intron</td><td>16q22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of&nbsp;ATM, CDH1&nbsp;and&nbsp;TP53&nbsp;genes polymorphisms with familial breast cancer in patients of Khyber Pakhtunkhwa, Pakistan</td></tr><tr style=''><td>CDK1</td><td>rs1871446</td><td>3 Prime UTR Variant</td><td>10q21.2</td><td>Protective</td><td>&gt; 0.01</td><td>Association Study of Germline Variants in CCNB1 and CDK1 with Breast Cancer Susceptibility, Progression, and Survival among Chinese Han Women</td></tr><tr style=''><td>CDK1</td><td>rs2448343</td><td>Intron</td><td>10q21.2</td><td>Protective</td><td>&gt; 0.01</td><td>Association Study of Germline Variants in CCNB1 and CDK1 with Breast Cancer Susceptibility, Progression, and Survival among Chinese Han Women</td></tr><tr style=''><td>CDKAL1</td><td>rs2223621</td><td>Intron</td><td>6p22.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>CDKAL1&nbsp;</td><td>rs1005745216</td><td>Intron&nbsp;</td><td>6p22.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CDKN1A</td><td>rs1801270</td><td>Exon </td><td>6p21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population</td></tr><tr style=''><td>CDKN1A</td><td>rs1801270</td><td>Exon </td><td>6p21.2</td><td>Protective</td><td>&gt; 0.01</td><td>TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study</td></tr><tr style=''><td>CDKN1A&nbsp;</td><td>rs3829964</td><td>Intron&nbsp;</td><td>6p21.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CDKN1B</td><td>rs34330</td><td>5 Prime UTR Variant</td><td>12p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population</td></tr><tr style=''><td>CDKN2A</td><td>rs3731249</td><td>Exon</td><td>9p21.3</td><td>Disease</td><td>&gt; 0.01</td><td>A common variant of CDKN2A (p16) predisposes to breast cancer</td></tr><tr style=''><td>CDKN2B-AS1</td><td>rs1011970</td><td>Intron</td><td>9p21.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>CDKN2B-AS1</td><td>rs1011970</td><td>Intron</td><td>9p21.3</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>CDYL2</td><td>rs13329835</td><td>Intron</td><td>16q23.2 </td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>CDYL2&nbsp;</td><td>rs12446424</td><td>Intron&nbsp;</td><td>16q23.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CEP131&nbsp;</td><td>rs9319617</td><td>Intron&nbsp;</td><td>17q25.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>CEP131&nbsp;</td><td>rs9896850</td><td>Intron&nbsp;</td><td>17q25.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>CEP131&nbsp;</td><td>rs9913021</td><td>Intron&nbsp;</td><td>17q25.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>CFAP20DC-DT</td><td>rs2886671</td><td>Intron&nbsp;</td><td>3p14.2&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CFLAR</td><td>rs7558475</td><td>Non Coding Transcript Variant</td><td>2q33.1</td><td>Protective</td><td>&gt; 0.01</td><td>Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk</td></tr><tr style=''><td>CHEK2</td><td>-</td><td>CNV</td><td>22q12.1&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>CHEK2</td><td>-</td><td>Exon</td><td>22q12.1 </td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>CHEK2</td><td>-</td><td>Exon</td><td>22q12.1 </td><td>Disease</td><td>-</td><td>Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry</td></tr><tr style=''><td>CHEK2</td><td>-</td><td>Exon</td><td>22q12.1</td><td>Disease</td><td>-</td><td>Evaluating breast cancer predisposition genes in women of African ancestry</td></tr><tr style=''><td>CHEK2</td><td>rs17879961</td><td>Exon</td><td>22q12.1 </td><td>Disease</td><td>&lt; 0.01</td><td>CHEK2 variant I157T may be associated with increased breast cancer risk</td></tr><tr style=''><td>CHEK2</td><td>rs555607708</td><td>Exon</td><td>22q12.1 </td><td>Disease</td><td>&lt; 0.01</td><td>Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations</td></tr><tr style=''><td>CHEK2</td><td>rs555607708</td><td>Exon</td><td>22q12.1 </td><td>Disease</td><td>&lt; 0.01</td><td>CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies</td></tr><tr style=''><td>CHEK2</td><td>rs555607708</td><td>Exon</td><td>22q12.1 </td><td>Disease</td><td>&lt; 0.01</td><td>A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer</td></tr><tr style=''><td>CHEK2</td><td>rs555607708</td><td>Exon</td><td>22q12.1 </td><td>Disease</td><td>&lt; 0.01</td><td>CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls</td></tr><tr style=''><td>CHIC2&nbsp;</td><td>rs368360781</td><td>Exon</td><td>4q12</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>CHST9</td><td>rs1436904</td><td>Intron</td><td>18q11.2</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>CHST9&nbsp;</td><td>rs745983748</td><td>Intron&nbsp;</td><td>18q11.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CLDN10</td><td>rs1325774</td><td>3 Prime UTR Variant</td><td>13q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>CLDN10 single nucleotide polymorphism rs1325774 alters the risk of breast cancer in south chinese women</td></tr><tr style=''><td>CLIP1&nbsp;</td><td>rs34292795</td><td>Exon</td><td>12q24.31</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>CMSS1</td><td>rs9833888</td><td>Intron</td><td>3p12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>CMSS1&nbsp;</td><td>rs35701020</td><td>Intron&nbsp;</td><td>3q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CNTNAP1</td><td>rs72826962</td><td>Intron</td><td>17q21.2</td><td>Disease</td><td>&lt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>CNTRL&nbsp;</td><td>rs17292952</td><td>Exon</td><td>9q33.2</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>COLEC10&nbsp;</td><td>rs3102735</td><td>Intron&nbsp;</td><td>8q24.12&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Risk association of RANKL and OPG gene polymorphism with breast cancer to bone metastasis in Pashtun population of Khyber Pakhtunkhwa, Pakistan</td></tr><tr style=''><td>COMT</td><td>rs4680</td><td>Exon</td><td>22q11.21</td><td>Disease</td><td>&gt; 0.01</td><td>Association between polymorphisms in estrogen metabolism genes and breast cancer development in Chinese women: A prospective case-control study</td></tr><tr style=''><td>COMT</td><td>rs737865</td><td>Intron</td><td>22q11.21</td><td>Protective</td><td>&gt; 0.01</td><td>Breast Cancer Risk Reduction and Membrane-Bound Catechol O-Methyltransferase Genetic Polymorphisms</td></tr><tr style=''><td>COPS2</td><td>rs141308737</td><td>Intron</td><td>15q21.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large‐scale analysis of 14 published GWAS datasets in the DRIVE study</td></tr><tr style=''><td>CREB5</td><td>rs17156577</td><td>Intron</td><td>7p15.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>CTLA4</td><td>rs231775</td><td>Exon</td><td>2q33.2</td><td>Protective</td><td>&gt; 0.01</td><td>Cytotoxic T lymphocyte antigen-4 gene in breast cancer</td></tr><tr style=''><td>CTLA4&nbsp;</td><td>rs231775</td><td>Exon</td><td>2q33.2</td><td>Disease</td><td>&gt; 0.01</td><td>Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis</td></tr><tr style=''><td>CTNNA2</td><td>rs13025833</td><td>Intron</td><td>2p12</td><td>Disease</td><td>&gt; 0.01</td><td>A Pilot Genome-wide Association Study of Breast Cancer Susceptibility Loci in Indonesia </td></tr><tr style=''><td>CTNNB1</td><td>rs4135385</td><td>Intron</td><td>3p22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of Single Nucleotide Polymorphisms in Wnt Signaling Pathway Genes with Breast Cancer in Saudi Patients</td></tr><tr style=''><td>CUX1</td><td>rs71559437</td><td>Intron</td><td>7q22.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>CUX1&nbsp;</td><td>rs71559437</td><td>Intron&nbsp;</td><td>7q22.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CUX1&nbsp;</td><td>rs782176246</td><td>Exon</td><td>7q22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>CUX2</td><td>rs11065822</td><td>Intron</td><td>12q24.11</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>CUX2&nbsp;</td><td>rs11065822</td><td>Intron&nbsp;</td><td>12q24.11&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>CYP17A1</td><td>rs4919687</td><td>Intron</td><td>10q24.32</td><td>Disease</td><td>&gt; 0.01</td><td>CYP17 Genetic Variation and Risk of Breast and Prostate Cancer From the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)</td></tr><tr style=''><td>CYP17A1</td><td>rs743572</td><td>5 Prime UTR Variant</td><td>10q24.32</td><td>Disease</td><td>&gt; 0.01</td><td>Association between CYP17 gene polymorphism and risk of breast cancer in young women</td></tr><tr style=''><td>CYP19A1</td><td>rs10046</td><td>3 Prime UTR Variant</td><td>15q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Analysis of CYP17, CYP19 and CYP1A1 Gene Polymorphisms in Iranian Women With Breast Cancer</td></tr><tr style=''><td>CYP19A1</td><td>rs1008805</td><td>Intron</td><td>15q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk</td></tr><tr style=''><td>CYP1A1</td><td>rs1048943</td><td>Exon</td><td>15q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women</td></tr><tr style=''><td>CYP1A2</td><td>rs762551</td><td>Intron</td><td>15q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women</td></tr><tr style=''><td>CYP1A2</td><td>rs762551</td><td>Intron</td><td>15q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Estrogen Metabolism-Related Genes and Breast Cancer Risk: The Multiethnic Cohort Study</td></tr><tr style=''><td>CYP1A2</td><td>rs762551</td><td>Intron</td><td>15q24.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic polymorphism of estrogen metabolizing enzymes in Siberian women with breast cancer</td></tr><tr style=''><td>CYP1B1</td><td>rs1056836</td><td>Exon</td><td>2p22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Cytochrome P450 CYP1B1 and catechol O -methyltransferase (COMT ) genetic polymorphisms and breast cancer susceptibility in a Turkish population</td></tr><tr style=''><td>CYP1B1</td><td>rs1056836</td><td>Exon</td><td>2p22.2</td><td>Protective</td><td>&gt; 0.01</td><td>Association between polymorphisms in estrogen metabolism genes and breast cancer development in Chinese women: A prospective case-control study</td></tr><tr style=''><td>CYP1B1</td><td>rs1056836</td><td>Exon</td><td>2p22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Evaluation of Breast Cancer Risk in a Multigenic Model Including Low Penetrance Genes Involved in Xenobiotic and Estrogen Metabolisms</td></tr><tr style=''><td>CYP2B7P</td><td>rs3844443</td><td>Intron</td><td>19q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>CYP2C19</td><td>rs4986893</td><td>Exon</td><td>10q23.33</td><td>Disease</td><td>&lt; 0.01</td><td>Association of CYP2C19*3 Gene Polymorphism With Breast Cancer in Chinese Women</td></tr><tr style=''><td>CYP2D6</td><td>rs1065852</td><td>Exon</td><td>22q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Detection of Cytochrome P450 Polymorphisms in Breast Cancer Patients May Impact on Tamoxifen Therapy</td></tr><tr style=''><td>CYP2D6</td><td>rs3892097</td><td>Splice Acceptor Variant</td><td>22q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>CYP2D6 genotypes in Spanish women with breast cancer</td></tr><tr style=''><td>CYP2D6</td><td>rs3892097</td><td>Splice Acceptor Variant</td><td>22q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Detection of Cytochrome P450 Polymorphisms in Breast Cancer Patients May Impact on Tamoxifen Therapy</td></tr><tr style=''><td>CYP3A4</td><td>rs2242480</td><td>Intron</td><td>7q22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Correlations between CYP3A4 polymorphism and susceptibility to breast cancer in Chinese Han population</td></tr><tr style=''><td>CYP3A5</td><td>rs776746</td><td>Splice Acceptor Variant</td><td>2p22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms in estrogen metabolism and breast cancer risk in case–control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians</td></tr><tr style=''><td>DCC&nbsp;</td><td>rs375401214</td><td>Exon</td><td>18q21.2</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>DCLRE1B</td><td>rs11552449</td><td>Exon</td><td>1p13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>DCLRE1B</td><td>rs11552449</td><td>Exon</td><td>1p13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>DENND10&nbsp;</td><td>rs74157632</td><td>Exon</td><td>10q26.11</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>DESI1</td><td>rs2267437</td><td>Intron</td><td>22q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms in Nonhomologous End-Joining Genes Associated with Breast Cancer Risk and Chromosomal Radiosensitivity</td></tr><tr style=''><td>DIRC3</td><td>rs16857609</td><td>Intron</td><td>2q35</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk </td></tr><tr style=''><td>DIRC3</td><td>rs16857609</td><td>Intron</td><td>2q35</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>DIRC3&nbsp;</td><td>rs16857609</td><td>Intron&nbsp;</td><td>2q35&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>DKK3</td><td>rs6485350</td><td>Intron</td><td>11p15.3</td><td>Protective</td><td>&gt; 0.01</td><td>Association of Single Nucleotide Polymorphisms in Wnt Signaling Pathway Genes with Breast Cancer in Saudi Patients</td></tr><tr style=''><td>DKK4</td><td>rs3763511</td><td>Intron</td><td>8p11.21</td><td>Disease</td><td>&gt; 0.01</td><td>Association of Single Nucleotide Polymorphisms in Wnt Signaling Pathway Genes with Breast Cancer in Saudi Patients</td></tr><tr style=''><td>DLEU1</td><td>rs9316500</td><td>Intron</td><td>13q14.3</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>DLEU1&nbsp;</td><td>rs2286657</td><td>Intron&nbsp;</td><td>13q14.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>DLX2-DT</td><td>rs2016394</td><td>Intron</td><td>2q31.1 </td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>DLX2-DT</td><td>rs2016394</td><td>Intron&nbsp;</td><td>2q31.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>DNAH11&nbsp;</td><td>rs7971</td><td>3 Prime UTR Variant</td><td>7p15.3</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>DNAH11&nbsp;</td><td>rs7971</td><td>3 Prime UTR Variant</td><td>7p15.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>DNAJC15</td><td>-</td><td>CNV</td><td>13q14.11</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>DNMT1</td><td>rs16999593</td><td>Exon</td><td>19p13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association of DNMT1 and DNMT3B Polymorphisms With Breast Cancer Risk in Han Chinese Women From South China</td></tr><tr style=''><td>DNMT1</td><td>rs2228612</td><td>Exon</td><td>19p13.2</td><td>Protective</td><td>&gt; 0.01</td><td>DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population</td></tr><tr style=''><td>DNMT3B</td><td>rs2424908</td><td>Intron</td><td>20q11.21</td><td>Protective</td><td>&gt; 0.01</td><td>Association of DNMT1 and DNMT3B Polymorphisms With Breast Cancer Risk in Han Chinese Women From South China</td></tr><tr style=''><td>DOCK1</td><td>rs9418690</td><td>Intron</td><td>10q26.2</td><td>Disease</td><td>&gt; 0.01</td><td>BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts</td></tr><tr style=''><td>DRD3</td><td>rs167770</td><td>Intron</td><td>3q13.31</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case–control study in Thai women</td></tr><tr style=''><td>DROSHA</td><td>rs642321&nbsp;</td><td>3 Prime UTR Variant</td><td>5p13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association of DROSHA rs6877842, rs642321 and rs10719 polymorphisms with increased susceptibility to breast cancer: A case-control study with genotype and haplotype analysis</td></tr><tr style=''><td>E2F1</td><td>-</td><td>CNV</td><td>20q11.22&nbsp;</td><td>Disease</td><td>-</td><td>E2F1 copy number variations in germline and breast cancer: a retrospective study of 222 Italian women</td></tr><tr style=''><td>EBF1</td><td>rs1432679</td><td>Intron</td><td>5q33.3 </td><td>Protective</td><td>&gt; 0.01</td><td>Association of multiple genetic variants with breast cancer susceptibility in the Han Chinese population</td></tr><tr style=''><td>EBF1</td><td>rs1432679</td><td>Intron</td><td>5q33.3 </td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk </td></tr><tr style=''><td>EBF1&nbsp;</td><td>rs1432679</td><td>Intron&nbsp;</td><td>5q33.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>EBF2</td><td>rs13256025</td><td>Intron</td><td>8p21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>EBF2&nbsp;</td><td>rs13256025</td><td>Intron&nbsp;</td><td>8p21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ECE1-AS1</td><td>rs213051</td><td>Intron</td><td>1p36.12</td><td>Protective</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>ECE1&nbsp;</td><td>rs213051</td><td>Intron</td><td>1p36.12</td><td>Protective</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>ECHDC1</td><td>rs6569480</td><td>Intron</td><td>6q22.33</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33</td></tr><tr style=''><td>ECHDC1</td><td>rs7776136</td><td>Intron</td><td>6q22.33</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33</td></tr><tr style=''><td>EHMT1</td><td>rs3125795</td><td>Intron</td><td>9q34.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variants in epigenetic genes and breast cancer risk </td></tr><tr style=''><td>EHMT1</td><td>rs4634736</td><td>Intron</td><td>9q34.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic variants in epigenetic genes and breast cancer risk </td></tr><tr style=''><td>EHMT2</td><td>rs535586</td><td>Exon</td><td>6p21.33</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variants in epigenetic genes and breast cancer risk </td></tr><tr style=''><td>EI24</td><td>rs2155388</td><td>Intron</td><td>3q23</td><td> Disease</td><td>&gt; 0.01</td><td>Associations of ATR and CHEK1 Single Nucleotide Polymorphisms with Breast Cancer</td></tr><tr style=''><td>EIF4E</td><td>rs141689493</td><td>Intron</td><td>4q23</td><td>Disease</td><td>&lt; 0.01</td><td>Association of breast cancer risk and the mTOR pathway in women of African ancestry in ‘The Root’ Consortium</td></tr><tr style=''><td>ELL</td><td>rs1469412</td><td>Intron</td><td>19p13.11</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large‐scale analysis of 14 published GWAS datasets in the DRIVE study</td></tr><tr style=''><td>ELL</td><td>rs4808801</td><td>Intron</td><td>19p13.11</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>ELL&nbsp;</td><td>rs8105994</td><td>Intron&nbsp;</td><td>19p13.11</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ELN-AS1</td><td>rs17855988</td><td>Intron</td><td>7q11.23</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>ELN&nbsp;</td><td>rs17855988</td><td>Exon</td><td>7q11.23</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>EMBP1</td><td>rs11249433</td><td>Intron</td><td>1p11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus</td></tr><tr style=''><td>EMBP1</td><td>rs11249433</td><td>Intron</td><td>1p11.2</td><td>Disease</td><td>&gt; 0.01</td><td>A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)</td></tr><tr style=''><td>EMBP1</td><td>rs11249433</td><td>Intron</td><td>1p11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>EMBP1</td><td>rs11249433</td><td>Intron</td><td>1p11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>EMBP1&nbsp;</td><td>rs11249433</td><td>Intron&nbsp;</td><td>1p11.2&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>EMID1</td><td>rs132390</td><td>Intron</td><td>22q12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>EMID1</td><td>rs132390</td><td>Intron</td><td>22q12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>EMX2OS</td><td>rs2901157</td><td>Intron</td><td>10q26.11</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>EMX2OS</td><td>rs2901157</td><td>Intron&nbsp;</td><td>10q26.11</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>EPCAM</td><td>rs1126497</td><td>Exon</td><td>2p21</td><td>Disease</td><td>&gt; 0.01</td><td>A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population</td></tr><tr style=''><td>EPHX1</td><td>rs1051740</td><td>Exon</td><td>1q42.12</td><td>Protective</td><td>&gt; 0.01</td><td>A Systematic Approach to Analysing Gene-Gene Interactions: Polymorphisms at the Microsomal Epoxide Hydrolase EPHX and Glutathione S-transferase GSTM1, GSTT1, and GSTP1 Loci and Breast Cancer Risk</td></tr><tr style=''><td>EPHX1</td><td>rs1051740</td><td>Exon</td><td>1q42.12</td><td>Disease</td><td>&gt; 0.01</td><td>Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) Polymorphisms in Breast Carcinoma</td></tr><tr style=''><td>ERBB2</td><td>rs1136201</td><td>Exon</td><td>17q12</td><td>Disease</td><td>&gt; 0.01</td><td>Population-Based, Case-Control Study of HER2 Genetic Polymorphism and Breast Cancer Risk</td></tr><tr style=''><td>ERBB2</td><td>rs1136201</td><td>Exon</td><td>17q12</td><td>Disease</td><td>&gt; 0.01</td><td>HER2 polymorphism and breast cancer risk in Portugal</td></tr><tr style=''><td>ERBB2</td><td>rs1136201</td><td>Exon</td><td>17q12</td><td>Disease</td><td>&gt; 0.01</td><td>Association between the Arg72Pro Genotypes in the TP53 Gene and Ile655Val in the HER2 Gene and the Risk of Developing Breast Cancer in the Population of Amapá, Northern Brazil</td></tr><tr style=''><td>ERBB2</td><td>rs1801201</td><td>Exon</td><td>17q12</td><td>Disease</td><td>&lt; 0.01</td><td>The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk</td></tr><tr style=''><td>ERBB3&nbsp;</td><td>rs773123</td><td>Exon</td><td>12q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>ERBB4</td><td>rs13393577</td><td>Intron</td><td>2q34</td><td>Disease</td><td>&gt; 0.01</td><td>A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study</td></tr><tr style=''><td>ERCC1</td><td>rs11615</td><td>Exon</td><td>19q13.32</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms in the ERCC1 and XPF Genes and Risk of Breast Cancer in a Chinese Population</td></tr><tr style=''><td>ERCC1</td><td>rs11615</td><td>Exon</td><td>19q13.32</td><td>Disease</td><td>&gt; 0.01</td><td>Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population</td></tr><tr style=''><td>ERCC2</td><td>rs1799793</td><td>Exon</td><td>19q13.32</td><td>Disease</td><td>&gt; 0.01</td><td>Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study</td></tr><tr style=''><td>ERCC2</td><td>rs1799793</td><td>Exon</td><td>19q13.32</td><td>Disease</td><td>&gt; 0.01</td><td>Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer</td></tr><tr style=''><td>ERCC2</td><td>rs50872</td><td>Intron</td><td>19q13.32</td><td>Disease</td><td>&gt; 0.01</td><td>Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population</td></tr><tr style=''><td>ERCC2&nbsp;</td><td>rs13181</td><td>Exon</td><td>19q13.32</td><td>Disease</td><td>&gt; 0.01</td><td>Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso</td></tr><tr style=''><td>ERCC4</td><td>rs1800067</td><td>Exon</td><td>16p13.12</td><td>Disease</td><td>&gt; 0.01</td><td>Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk</td></tr><tr style=''><td>ERCC4</td><td>rs744154</td><td>Intron</td><td>16p13.12</td><td>Protective</td><td>&gt; 0.01</td><td>ERCC4 Associated with Breast Cancer Risk: A Two-Stage Case-Control Study Using High-throughput Genotyping</td></tr><tr style=''><td>ERCC5</td><td>rs17655</td><td>Exon</td><td>13q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>Synergistic Effects of Polymorphisms in DNA Repair Genes and Endogenous Estrogen Exposure on Female Breast Cancer Risk</td></tr><tr style=''><td>ERCC5&nbsp;</td><td>rs17655</td><td>Exon</td><td>13q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis</td></tr><tr style=''><td>ESR1</td><td>rs2228480</td><td>Exon</td><td>6q25.1-q25.2</td><td>Protective</td><td>&gt; 0.01</td><td>Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population</td></tr><tr style=''><td>ESR1</td><td>rs2747652</td><td>Intron</td><td>6q25.1-q25.2</td><td>Disease</td><td>&gt; 0.01</td><td>Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170</td></tr><tr style=''><td>ESR1</td><td>rs2747652</td><td>Intron</td><td>6q25.1</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>ESR1</td><td>rs3798758</td><td>Intron</td><td>6q25.1-q25.2</td><td>Disease</td><td>&gt; 0.01</td><td>Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population</td></tr><tr style=''><td>ESR1</td><td>rs851984</td><td>Intron</td><td>6q25.1-q25.2</td><td>Disease</td><td>&gt; 0.01</td><td>Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170</td></tr><tr style=''><td>ESR1</td><td>rs9918437</td><td>Intron</td><td>6q25.1-q25.2</td><td>Disease</td><td>&gt; 0.01</td><td>Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170</td></tr><tr style=''><td>ESR1&nbsp;</td><td>rs910416</td><td>Intron&nbsp;</td><td>6q25.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ESR2</td><td>rs2987983</td><td>Intron</td><td>14q23.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India</td></tr><tr style=''><td>ESR2</td><td>rs2987983</td><td>Intron</td><td>14q23.3</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility</td></tr><tr style=''><td>ESRRG</td><td>rs11117758</td><td>Intron</td><td>1q41</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>ESRRG</td><td>rs11117758</td><td>Intron&nbsp;</td><td>1q41</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>EXO1</td><td>rs72755295</td><td>Intron</td><td>1q43 </td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>EXO1&nbsp;</td><td>rs4149991</td><td>Intron&nbsp;</td><td>1q43&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>FAM126B</td><td>rs114962751</td><td>Intron</td><td>2q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>FAM72B</td><td>-</td><td>-</td><td>1p11.2</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>FANCC</td><td>-</td><td>Exon</td><td>9q22.32</td><td>Disease</td><td>&lt; 0.01</td><td>Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility Alleles</td></tr><tr style=''><td>FANCC</td><td>-</td><td>Exon</td><td>9q22.32</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>FANCD2</td><td>rs201811817</td><td>Splice Donor Variant</td><td>3p25.3</td><td>Disease</td><td>&lt; 0.01</td><td>Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility</td></tr><tr style=''><td>FANCM</td><td>-</td><td>Exon</td><td>14q21.2</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>FANCM</td><td>-</td><td>Exon</td><td>14q21.2</td><td>Disease</td><td>&lt; 0.01</td><td>Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer</td></tr><tr style=''><td>FANCM</td><td>-</td><td>Exon</td><td>14q21.2&nbsp;</td><td>Disease</td><td>-</td><td>FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women</td></tr><tr style=''><td>FANCM</td><td>rs144567652</td><td>Exon</td><td>14q21.2</td><td>Disease</td><td>&lt; 0.01</td><td>FANCM Mutation c.5791C&gt;T Is a Risk Factor for Triple-Negative Breast Cancer in the Finnish Population</td></tr><tr style=''><td>FANCM</td><td>rs144567652</td><td>Exon</td><td>14q21.2</td><td>Disease</td><td>&lt; 0.01</td><td>The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer</td></tr><tr style=''><td>FANCM</td><td>rs144567652</td><td>Exon</td><td>14q21.2</td><td>Disease</td><td>&lt; 0.01</td><td>FANCM c.5791C&gt;T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor</td></tr><tr style=''><td>FANCM</td><td>rs147021911</td><td>Exon</td><td>14q21.2</td><td>Disease</td><td>&lt; 0.01</td><td>Exome Sequencing Identifies FANCM as a Susceptibility Gene for Triple-Negative Breast Cancer</td></tr><tr style=''><td>FANCM</td><td>rs368728266</td><td>Exon</td><td>14q21.2</td><td>Disease</td><td>&lt; 0.01</td><td>The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer</td></tr><tr style=''><td>FAS</td><td>rs1800682</td><td>Intron</td><td>10q23.31</td><td>Disease</td><td>&gt; 0.01</td><td>Functional Polymorphisms of FAS and FASL Gene and Risk of Breast Cancer – Pilot Study of 134 Cases</td></tr><tr style=''><td>FAS</td><td>rs2234767</td><td>Exon</td><td>10q23.31</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms of the FAS and FASL genes and risk of breast cancer</td></tr><tr style=''><td>FASLG</td><td>rs5030772</td><td>Intron</td><td>1q24.3</td><td>Disease</td><td>&gt; 0.01</td><td>Functional Polymorphisms of FAS and FASL Gene and Risk of Breast Cancer – Pilot Study of 134 Cases</td></tr><tr style=''><td>FBLN2&nbsp;</td><td>rs556004379</td><td>Exon</td><td>3p25.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>FGFR2</td><td>-</td><td>-</td><td>10q26.13</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>FGFR2</td><td>-</td><td>Exon</td><td>10q26.13</td><td>Disease</td><td>-</td><td>A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31</td></tr><tr style=''><td>FGFR2</td><td>rs1078806</td><td>Intron</td><td>10q26.13</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33</td></tr><tr style=''><td>FGFR2</td><td>rs2981578</td><td>Intron</td><td>10q26.13</td><td>Disease</td><td>&gt; 0.01</td><td>Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1</td></tr><tr style=''><td>FGFR2</td><td>rs2981579</td><td>Intron</td><td>10q26.13</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>FGFR2</td><td>rs2981582</td><td>Intron</td><td>10q26.13</td><td>Disease</td><td>&gt; 0.01</td><td>Low penetrance alleles as risk modifiers in familial and sporadic breast cancer</td></tr><tr style=''><td>FGFR2</td><td>rs2981582</td><td>Intron</td><td>10q26.13</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>FGFR2</td><td>rs2981582</td><td>Intron</td><td>10q26.13</td><td>Disease</td><td>&gt; 0.01</td><td>Evaluation of the Association between&nbsp;FGFR2&nbsp;Gene Polymorphisms and Breast Cancer Risk in the Bangladeshi Population</td></tr><tr style=''><td>FGFR2</td><td>rs35054928</td><td>Intron</td><td>10q26.13</td><td>Disease</td><td>&gt; 0.01</td><td>Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1</td></tr><tr style=''><td>FGFR2</td><td>rs45631563</td><td>Intron</td><td>10q26.13</td><td>Protective</td><td>&gt; 0.01</td><td>Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1</td></tr><tr style=''><td>FGFR2&nbsp;</td><td>rs1219648</td><td>Intron&nbsp;</td><td>10q26.13</td><td>Disease</td><td>&gt; 0.01</td><td>Evaluation of the Association between&nbsp;FGFR2&nbsp;Gene Polymorphisms and Breast Cancer Risk in the Bangladeshi Population</td></tr><tr style=''><td>FGFR2&nbsp;</td><td>rs2981579</td><td>Intron</td><td>10q26.13</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>FGFR2&nbsp;</td><td>rs2981579</td><td>Intron&nbsp;</td><td>10q26.13</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>FGGY</td><td>rs7520470</td><td>Intron</td><td>1p32.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>FILIP1L</td><td>rs9833888</td><td>Intron</td><td>3p12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>FILIP1L&nbsp;</td><td>rs35701020</td><td>Intron&nbsp;</td><td>3q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>FLACC1</td><td>rs1830298</td><td>Intron</td><td>2q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk</td></tr><tr style=''><td>FMNL3</td><td>-</td><td>-</td><td>12q13.12</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>FOXP1</td><td>rs6805189</td><td>Intron</td><td>3p13</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>FOXP1&nbsp;</td><td>rs6805189</td><td>Intron&nbsp;</td><td>3p13&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>FOXP3</td><td>rs3761548</td><td>Intron</td><td>Xp11.23</td><td>Disease</td><td>&gt; 0.01</td><td>Association of two FOXP3 polymorphisms with breast cancer susceptibility in Chinese Han women</td></tr><tr style=''><td>FRZB</td><td>rs7775</td><td>Exon</td><td>2q32.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association of Single Nucleotide Polymorphisms in Wnt Signaling Pathway Genes with Breast Cancer in Saudi Patients</td></tr><tr style=''><td>FTO</td><td>rs11075995</td><td>Intron</td><td>16q12.2 </td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association studies identify four ER negative–specific breast cancer risk loci</td></tr><tr style=''><td>FTO</td><td>rs11075995</td><td>Intron</td><td>16q12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>FTO</td><td>rs11075995</td><td>Intron</td><td>16q12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>FTO</td><td>rs17817449</td><td>Intron</td><td>16q12.2</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>FTO</td><td>rs17817449</td><td>Intron</td><td>16q12.2</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>FTO</td><td>rs9939609</td><td>Intron</td><td>16q12.2 </td><td>Protective</td><td>&gt; 0.01</td><td>Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry</td></tr><tr style=''><td>FTO&nbsp;</td><td>rs62048402</td><td>Intron&nbsp;</td><td>16q12.2&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>GAREM1</td><td>rs117618124</td><td>Intron</td><td>18q12.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>GAREM1&nbsp;</td><td>rs72931898</td><td>Intron&nbsp;</td><td>18q12.1&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>GATA3</td><td>rs570613</td><td>Intron</td><td>10p14</td><td>Protective</td><td>&gt; 0.01</td><td>Common Genetic Variation in GATA-Binding Protein 3 and Differential Susceptibility to Breast Cancer by Estrogen Receptor α Tumor Status</td></tr><tr style=''><td>GATAD2A</td><td>rs2965183</td><td>Intron</td><td>19p13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>GATAD2A&nbsp;</td><td>rs4808961</td><td>Intron&nbsp;</td><td>19p13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>GH1</td><td>rs6173</td><td>5 Prime UTR Variant</td><td>17q23.3</td><td>Protective</td><td>&gt; 0.01</td><td>Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer</td></tr><tr style=''><td>GIPR</td><td>rs71338792</td><td>Intron</td><td>19q13.32</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>GIPR&nbsp;</td><td>rs61373376</td><td>Intron&nbsp;</td><td>19q13.32</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>GLO1</td><td>rs4746</td><td>Exon</td><td>6p21.2</td><td>Disease</td><td>&gt; 0.01</td><td>CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study</td></tr><tr style=''><td>GNAS-AS1</td><td>rs563844600</td><td>Intron</td><td>20q13.32</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>GNAS&nbsp;</td><td>rs563844600</td><td>Exon</td><td>20q13.32</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>GPC1-AS1</td><td>rs2292832&nbsp;</td><td>Intron</td><td>2q37.3</td><td>Disease</td><td>&gt; 0.01</td><td>The association between genetic variation rs2292832 and the processing efficiency of pre-mir-149 affects the risk of breast cancer</td></tr><tr style=''><td>GPC1&nbsp;</td><td>rs2292832&nbsp;</td><td>Intron</td><td>2q37.3</td><td>Disease</td><td>&gt; 0.01</td><td>The association between genetic variation rs2292832 and the processing efficiency of pre-mir-149 affects the risk of breast cancer</td></tr><tr style=''><td>GPR19</td><td>rs34330</td><td>5 Prime UTR Variant</td><td>12p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population</td></tr><tr style=''><td>GPRIN2&nbsp;</td><td>rs4445576</td><td>Exon</td><td>10q11.22</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>GPX1</td><td>rs1050450</td><td>Exon</td><td>3p21.31</td><td>Disease</td><td>&gt; 0.01</td><td>Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study</td></tr><tr style=''><td>GPX1</td><td>rs1050450</td><td>Exon</td><td>3p21.31</td><td>Disease</td><td>&gt; 0.01</td><td>Association between Polymorphisms in Glutathione Peroxidase and Selenoprotein P Genes, Glutathione Peroxidase Activity, HRT Use and Breast Cancer Risk</td></tr><tr style=''><td>GRHL1</td><td>rs113577745</td><td>Intron</td><td>2p25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>GRHL1&nbsp;</td><td>rs539902477</td><td>Intron&nbsp;</td><td>2p25.1</td><td>Disease</td><td>&lt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>GRIA4</td><td>-</td><td>Exon</td><td>11q22.3</td><td>Disease</td><td>-</td><td>A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31</td></tr><tr style=''><td>GRM7</td><td>rs7610073</td><td>Intron</td><td>3p26.1</td><td>Disease</td><td>&gt; 0.01</td><td>A genome-wide association study of breast cancer in women of African ancestry</td></tr><tr style=''><td>GSTM1</td><td>PseudoSNP for CNV - rs366631</td><td>CNV deletion</td><td>1p13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Allelotype Influence at Glutathione S-transferase M1 Locus on Breast Cancer Susceptibility</td></tr><tr style=''><td>GSTM1</td><td>PseudoSNP for CNV - rs366631</td><td>CNV deletion</td><td>1p13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population</td></tr><tr style=''><td>GSTM1</td><td>PseudoSNP for CNV - rs366631</td><td>CNV deletion</td><td>1p13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms in GSTM1, GSTT1, GSTP1, and GSTM3 Genes and Breast Cancer Risk in Northeastern Mexico</td></tr><tr style=''><td>GSTM1</td><td>PseudoSNP for CNV - rs366631</td><td>CNV deletion</td><td>1p13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Glutathione S-transferase M1, T1, and P1 Genotypes and Breast Cancer Risk: A Study in a Portuguese Population</td></tr><tr style=''><td>GSTM1</td><td>PseudoSNP for CNV - rs366631</td><td>CNV deletion</td><td>1p13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival</td></tr><tr style=''><td>GSTM1</td><td>PseudoSNP for CNV - rs366631</td><td>CNV deletion</td><td>1p13.3</td><td>Disease</td><td>&gt; 0.01</td><td>A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer</td></tr><tr style=''><td>GSTM1</td><td>PseudoSNP for CNV - rs366631</td><td>CNV deletion</td><td>1p13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Investigating the Role of Glutathione S- Transferase Genes, Histopathological and Molecular Subtypes, Gene-Gene Interaction and Its Susceptibility to Breast Carcinoma in Ethnic North- Indian Population</td></tr><tr style=''><td>GSTM2&nbsp;</td><td>rs1245957540</td><td>Intron&nbsp;</td><td>1p13.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>GSTO1</td><td>rs4925</td><td>Exon</td><td>10q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of GSTO1 A140D and GSTO2 N142D Gene Variations with Breast Cancer Risk</td></tr><tr style=''><td>GSTO2</td><td>rs156697</td><td>Exon</td><td>10q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of GSTO1 A140D and GSTO2 N142D Gene Variations with Breast Cancer Risk</td></tr><tr style=''><td>GSTP1</td><td>rs1695</td><td>Exon</td><td>11q13.2 </td><td>Disease</td><td>&gt; 0.01</td><td>Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk</td></tr><tr style=''><td>GSTP1</td><td>rs1695</td><td>Exon</td><td>11q13.2 </td><td>Disease</td><td>&gt; 0.01</td><td>The GSTP1 105Val Allele Increases Breast Cancer Risk and Aggressiveness but Enhances Response to Cyclophosphamide Chemotherapy in North China</td></tr><tr style=''><td>GSTP1</td><td>rs1695</td><td>Exon</td><td>11q13.2 </td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women</td></tr><tr style=''><td>GSTP1</td><td>rs1695</td><td>Exon</td><td>11q13.2 </td><td>Disease</td><td>&gt; 0.01</td><td>Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population</td></tr><tr style=''><td>GSTP1</td><td>rs1695</td><td>Exon</td><td>11q13.2 </td><td>Disease</td><td>&gt; 0.01</td><td>Association between polymorphisms in estrogen metabolism genes and breast cancer development in Chinese women: A prospective case-control study</td></tr><tr style=''><td>GSTP1</td><td>rs1695</td><td>Exon</td><td>11q13.2 </td><td>Protective</td><td>&gt; 0.01</td><td>Investigating the Role of Glutathione S- Transferase Genes, Histopathological and Molecular Subtypes, Gene-Gene Interaction and Its Susceptibility to Breast Carcinoma in Ethnic North- Indian Population</td></tr><tr style=''><td>GSTT1</td><td>-</td><td>Gene deletion</td><td>22q11.23</td><td>Disease</td><td>&gt; 0.01</td><td>Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) variants and breast cancer risk in Burkina Faso</td></tr><tr style=''><td>GSTT1</td><td>-</td><td>Gene deletion</td><td>22q11.23</td><td>Disease</td><td>&gt; 0.01</td><td>Glutathione S-transferases (GSTT1 and GSTM1) gene deletions in Tunisians: susceptibility and prognostic implications in breast carcinoma</td></tr><tr style=''><td>GSTT1</td><td>-</td><td>Gene deletion</td><td>22q11.23</td><td>Disease</td><td>&gt; 0.01</td><td>Glutathione S-transferase M1, T1, and P1 Genotypes and Breast Cancer Risk: A Study in a Portuguese Population</td></tr><tr style=''><td>GSTT1</td><td>-</td><td>Gene deletion</td><td>22q11.23</td><td>Disease</td><td>&gt; 0.01</td><td>Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival</td></tr><tr style=''><td>GSTT1</td><td>-</td><td>Gene deletion</td><td>22q11.23</td><td>Disease</td><td>&gt; 0.01</td><td>Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians</td></tr><tr style=''><td>GTF2H4</td><td>rs1264308</td><td>Intron</td><td>6p21.33</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large‐scale analysis of 14 published GWAS datasets in the DRIVE study</td></tr><tr style=''><td>H19</td><td>rs2107425</td><td>Intron</td><td>11p15.5</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>H19&nbsp;</td><td>rs217727</td><td>Non Coding Transcript Variant</td><td>11p15.5</td><td>Disease</td><td>&gt; 0.01</td><td>Association between long non-coding RNA H19 polymorphisms and breast cancer risk: a meta-analysis</td></tr><tr style=''><td>H19&nbsp;</td><td>rs2839698&nbsp;</td><td>Non Coding Transcript Variant</td><td>11p15.5</td><td>Disease</td><td>&gt; 0.01</td><td>Association between long non-coding RNA H19 polymorphisms and breast cancer risk: a meta-analysis</td></tr><tr style=''><td>H19&nbsp;</td><td>rs3741219</td><td>Non Coding Transcript Variant</td><td>11p15.5</td><td>Disease</td><td>&gt; 0.01</td><td>Association between long non-coding RNA H19 polymorphisms and breast cancer risk: a meta-analysis</td></tr><tr style=''><td>H3-3A&nbsp;</td><td>rs749423281</td><td>Exon</td><td>1q42.12&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>HCN1</td><td>rs981782</td><td>Intron</td><td>5p12</td><td>Disease</td><td>&gt; 0.01</td><td>Association of multiple genetic variants with breast cancer susceptibility in the Han Chinese population</td></tr><tr style=''><td>HCN1</td><td>rs981782</td><td>Intron</td><td>5p12</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>HELQ</td><td>rs10718573</td><td>Intron</td><td>4q21.23</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>HIF1A</td><td>rs11549465</td><td>Exon</td><td>14q23.2</td><td>Disease</td><td>&gt; 0.01</td><td>Associations Between Hypoxia-Inducible factor-1alpha (HIF-1alpha) Gene Polymorphisms and Risk of Developing Breast Cancer</td></tr><tr style=''><td>HIF1A</td><td>rs11549465</td><td>Exon</td><td>14q23.2</td><td>Disease</td><td>&gt; 0.01</td><td>SNP 1772 C &gt; T of HIF-1α gene associates with breast cancer risk in a Taiwanese population</td></tr><tr style=''><td>HIF1A</td><td>rs11549467</td><td>Exon</td><td>14q23.2</td><td>Disease</td><td>&lt; 0.01</td><td>Polymorphisms in HIFs and Breast Cancer Sutarsceptibility in Chinese Women: A Case-Control Study</td></tr><tr style=''><td>HIF1A</td><td>rs142179458</td><td>Exon</td><td>14q23.2</td><td>Disease</td><td>&lt; 0.01</td><td>Identification of Novel Breast Cancer Risk Loci</td></tr><tr style=''><td>HIF1A-AS3</td><td>rs11549465</td><td>Intron</td><td>14q23.2</td><td>Disease</td><td>&gt; 0.01</td><td>Associations Between Hypoxia-Inducible factor-1alpha (HIF-1alpha) Gene Polymorphisms and Risk of Developing Breast Cancer</td></tr><tr style=''><td>HIF1A-AS3</td><td>rs11549465</td><td>Intron</td><td>14q23.2</td><td>Disease</td><td>&gt; 0.01</td><td>SNP 1772 C &gt; T of HIF-1α gene associates with breast cancer risk in a Taiwanese population</td></tr><tr style=''><td>HIF1A-AS3</td><td>rs11549467</td><td>Intron</td><td>14q23.2</td><td>Disease</td><td>&lt; 0.01</td><td>Polymorphisms in HIFs and Breast Cancer Sutarsceptibility in Chinese Women: A Case-Control Study</td></tr><tr style=''><td>HIF1A-AS3</td><td>rs142179458</td><td>Intron</td><td>14q23.2</td><td>Disease</td><td>&lt; 0.01</td><td>Identification of Novel Breast Cancer Risk Loci</td></tr><tr style=''><td>HIVEP3</td><td>rs79724016</td><td>Intron</td><td>1p34.2</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>HIVEP3&nbsp;</td><td>rs10749837</td><td>Intron&nbsp;</td><td>1p34.2&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>HLA-A</td><td>rs369261720</td><td>Exon</td><td>6p22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>HLA-A</td><td>rs41548917</td><td>Exon</td><td>6p22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>HLA-A</td><td>rs41562120</td><td>Exon</td><td>6p22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>HLA-A</td><td>rs756231831</td><td>Exon</td><td>6p22.1</td><td>Disease</td><td>-</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>HLA-A&nbsp;</td><td>rs372503438</td><td>Exon</td><td>6p22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>HLA-A&nbsp;</td><td>rs758168864</td><td>Exon</td><td>6p22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>HLA-B</td><td>rs9266183</td><td>Exon</td><td>6p21.33</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>HLA-DRB1</td><td>rs17885222</td><td>Exon</td><td>6p21.32</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>HLA-DRB1</td><td>rs756741350</td><td>Exon</td><td>6p21.32</td><td>Disease</td><td>-</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>HLA-DRB1</td><td>rs769556955</td><td>Exon</td><td>6p21.32</td><td>Disease</td><td>-</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>HLA-G</td><td>rs1063320</td><td>3 Prime UTR Variant</td><td>6p22.1</td><td>Protective</td><td>&gt; 0.01</td><td>3'UTR-HLA-G polymorphisms and circulating sHLA-G are associated with breast cancer: Evidence from a meta-analysis</td></tr><tr style=''><td>HLA-G</td><td>rs371194629</td><td>3 Prime UTR Variant</td><td>6p22.1</td><td>Disease</td><td>&gt; 0.01</td><td>3'UTR-HLA-G polymorphisms and circulating sHLA-G are associated with breast cancer: Evidence from a meta-analysis</td></tr><tr style=''><td>HMMR</td><td>rs10515860</td><td>Intron</td><td>5q34</td><td>Disease</td><td>&gt; 0.01</td><td>Network modeling links breast cancer susceptibility and centrosome dysfunction</td></tr><tr style=''><td>HMMR-AS1</td><td>rs10515860</td><td>Intron</td><td>5q34</td><td>Disease</td><td>&gt; 0.01</td><td>Network modeling links breast cancer susceptibility and centrosome dysfunction</td></tr><tr style=''><td>HNF4G</td><td>rs2943559</td><td>Intron</td><td>8q21.13</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>HOXB13</td><td>rs138213197</td><td>Exon</td><td>17q21.32</td><td>Disease</td><td>&lt; 0.01</td><td>Association of a HOXB13 Variant with Breast Cancer</td></tr><tr style=''><td>HSD11B1</td><td>rs11807619</td><td>Intron</td><td>1q32.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II</td></tr><tr style=''><td>HSD11B1</td><td>rs932335</td><td>Intron</td><td>1q32.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II</td></tr><tr style=''><td>HSD11B1-AS1</td><td>rs11807619</td><td>Intron</td><td>1q32.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II</td></tr><tr style=''><td>HSD11B1-AS1</td><td>rs932335</td><td>Intron</td><td>1q32.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II</td></tr><tr style=''><td>HSD17B1</td><td>rs605059</td><td>Exon</td><td>17q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer</td></tr><tr style=''><td>HSD17B14&nbsp;</td><td>-</td><td>CNV deletion</td><td>19q13.33</td><td>Disease</td><td>&lt; 0.01</td><td>Exome sequencing identified rare recurrent copy number variants and hereditary breast cancer susceptibility</td></tr><tr style=''><td>HSPA1A</td><td>rs1061581</td><td>Exon</td><td>14q23.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Variation in the Tumor Necrosis Factor-Alpha Promoter Region and in the Stress Protein hsp70-2: Susceptibility and Prognostic Implications in Breast Carcinoma</td></tr><tr style=''><td>HSPA4</td><td>rs6596100</td><td>Intron</td><td>5q31.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>HSPA4&nbsp;</td><td>rs571173399</td><td>3 Prime UTR Variant</td><td>5q31.1</td><td>Protective</td><td>&lt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>HUS1</td><td>rs1056663</td><td>Exon</td><td>7p12.3</td><td>Disease</td><td>&gt; 0.01</td><td>Low penetrance alleles as risk modifiers in familial and sporadic breast cancer</td></tr><tr style=''><td>HUS1</td><td>rs2708861</td><td>Intron</td><td>7p12.3</td><td>Disease</td><td>&gt; 0.01</td><td>Low penetrance alleles as risk modifiers in familial and sporadic breast cancer</td></tr><tr style=''><td>ICAM1</td><td>rs5498</td><td>Exon</td><td>19p13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Large-Scale Association Study Identifies ICAM Gene Region as Breast and Prostate Cancer Susceptibility Locus</td></tr><tr style=''><td>ICAM5</td><td>rs1056538</td><td>Exon</td><td>19p13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Large-Scale Association Study Identifies ICAM Gene Region as Breast and Prostate Cancer Susceptibility Locus</td></tr><tr style=''><td>ICAM5</td><td>rs281439</td><td>Non Coding Transcript Variant</td><td>19p13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Large-Scale Association Study Identifies ICAM Gene Region as Breast and Prostate Cancer Susceptibility Locus</td></tr><tr style=''><td>IFNG</td><td>rs2430561</td><td>Intron</td><td>21q22.11</td><td>Disease</td><td>&gt; 0.01</td><td>Tumor Necrosis Factor Alpha and Beta and Interferon Gamma Gene Polymorphisms in Turkish Breast Cancer Patients</td></tr><tr style=''><td>IFNG</td><td>rs2430561</td><td>Intron</td><td>21q22.11</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-α and TNF-β) and gamma interferon (IFN-γ) among Iranian women with breast cancer</td></tr><tr style=''><td>IGF1</td><td>rs1019731</td><td>Intron</td><td>12q23.2</td><td>Protective</td><td>&gt; 0.01</td><td>Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk</td></tr><tr style=''><td>IGF1</td><td>rs12821878</td><td>Intron</td><td>12q23.2</td><td>Protective</td><td>&gt; 0.01</td><td>Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk</td></tr><tr style=''><td>IGF1</td><td>rs1520220</td><td>Intron</td><td>12q23.2</td><td>Disease</td><td>&gt; 0.01</td><td>IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer</td></tr><tr style=''><td>IGF1</td><td>rs2162679</td><td>Intron</td><td>12q23.2</td><td>Protective</td><td>&gt; 0.01</td><td>Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study</td></tr><tr style=''><td>IGF2BP2</td><td>rs4402960</td><td>Intron</td><td>3q27.2 </td><td>Disease</td><td>&gt; 0.01</td><td>Correlation Between IGF2BP2 Gene Polymorphism and the Risk of Breast Cancer in Chinese Han Women</td></tr><tr style=''><td>IGF2BP2&nbsp;</td><td>rs4402960</td><td>Intron&nbsp;</td><td>3q27.2&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Novel Association of IGF2BP2 Gene Variants With Altered Risk of Breast Cancer and as Potential Molecular Biomarker of Triple Negative Breast Cancer</td></tr><tr style=''><td>IGFBP-AS1</td><td>rs4442975</td><td>Intron&nbsp;</td><td>2q35&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>IL18&nbsp;</td><td>rs549908</td><td>Exon</td><td>11q23.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genotypic and haplotype analysis of Interleukin-6 and -18 gene polymorphisms in association with clinicopathological factors in breast cancer</td></tr><tr style=''><td>IL19</td><td>rs1800871</td><td>Intron</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Inflammatory Response Genes and Their Associations With Breast Cancer Risk</td></tr><tr style=''><td>IL19</td><td>rs1800872</td><td>Intron</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of the IL-10 gene rs1800872 (-592 C&gt;A) polymorphism with breast cancer in a Mexican population</td></tr><tr style=''><td>IL19</td><td>rs1800896</td><td>Intron</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women</td></tr><tr style=''><td>IL19</td><td>rs1800896</td><td>Intron</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of interleukin-10 polymorphisms and haplotypes with the risk of breast cancer in northern China</td></tr><tr style=''><td>IL1B</td><td>rs1143627</td><td>5 Prime UTR Variant</td><td>2q14.1</td><td>Disease</td><td>&gt; 0.01</td><td>The Correlation between IL-1β-C31T Gene Polymorphism and Susceptibility to Breast Cancer</td></tr><tr style=''><td>IL1B</td><td>rs1143634</td><td>Exon</td><td>2q14.1</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women</td></tr><tr style=''><td>IL1R1</td><td>rs10490571</td><td>Intron</td><td>2q11.2-q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Interleukin gene polymorphisms in Chinese Han population with breast cancer, a case-control study</td></tr><tr style=''><td>IL1RN</td><td>rs2234663</td><td>Intron&nbsp;</td><td>2q14.1&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Association between interleukin-1 receptor antagonist (IL-1ra) VNTR, gene polymorphism and breast cancer susceptibility in Iranian population: Experimental and web-based analysis</td></tr><tr style=''><td>IL1RN</td><td>rs315919</td><td>Intron</td><td>2q14.1</td><td>Protective</td><td>&gt; 0.01</td><td>IL‐1RN gene polymorphisms are associated with breast cancer risk in a Chinese Han population</td></tr><tr style=''><td>IL1RN</td><td>rs3181052</td><td>Intron</td><td>2q14.1</td><td>Protective</td><td>&gt; 0.01</td><td>IL‐1RN gene polymorphisms are associated with breast cancer risk in a Chinese Han population</td></tr><tr style=''><td>IL1RN</td><td>rs4252019</td><td>Intron</td><td>2q14.1</td><td>Protective</td><td>&gt; 0.01</td><td>IL‐1RN gene polymorphisms are associated with breast cancer risk in a Chinese Han population</td></tr><tr style=''><td>IL1RN</td><td>rs452204</td><td>Intron</td><td>2q14.1</td><td>Protective</td><td>&gt; 0.01</td><td>IL‐1RN gene polymorphisms are associated with breast cancer risk in a Chinese Han population</td></tr><tr style=''><td>IL1RN</td><td>rs928940</td><td>Intron</td><td>2q14.1</td><td>Protective</td><td>&gt; 0.01</td><td>IL‐1RN gene polymorphisms are associated with breast cancer risk in a Chinese Han population</td></tr><tr style=''><td>IL6</td><td>rs1800795</td><td>Intron</td><td>7p15.3</td><td>Protective</td><td>&gt; 0.01</td><td>Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women</td></tr><tr style=''><td>IL6-AS1</td><td>rs1800795</td><td>Intron</td><td>7p15.3</td><td>Protective</td><td>&gt; 0.01</td><td>Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women</td></tr><tr style=''><td>IL6-AS1</td><td>rs1800795</td><td>Intron&nbsp;</td><td>7p15.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genotypic and haplotype analysis of Interleukin-6 and -18 gene polymorphisms in association with clinicopathological factors in breast cancer</td></tr><tr style=''><td>IL6-AS1</td><td>rs1800796</td><td>Non Coding Transcript Variant</td><td>7p15.3&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genotypic and haplotype analysis of Interleukin-6 and -18 gene polymorphisms in association with clinicopathological factors in breast cancer</td></tr><tr style=''><td>IL6-AS1</td><td>rs1800797</td><td>Non Coding Transcript Variant</td><td>7p15.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genotypic and haplotype analysis of Interleukin-6 and -18 gene polymorphisms in association with clinicopathological factors in breast cancer</td></tr><tr style=''><td>INSL6</td><td>rs56118985</td><td>Intron</td><td>9p24.1</td><td>Disease</td><td>&lt; 0.01</td><td>Identification of Novel Breast Cancer Risk Loci</td></tr><tr style=''><td>INSR</td><td>rs1799817</td><td>Exon</td><td>19p13.2</td><td>Protective</td><td>&gt; 0.01</td><td>Nested case-control study of energy regulation candidate gene single nucleotide polymorphisms and breast cancer</td></tr><tr style=''><td>IRF1-AS1</td><td>rs2522057</td><td>Intron&nbsp;</td><td>5q31.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>IRS2</td><td>rs2289046</td><td>3 Prime UTR Variant</td><td>13q34</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II</td></tr><tr style=''><td>ISX&nbsp;</td><td>rs8140287</td><td>Exon</td><td>22q12.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>ITGA2</td><td>rs1801106</td><td>Exon</td><td>5q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk</td></tr><tr style=''><td>ITGB3</td><td>rs5918</td><td>Exon</td><td>17q21.32</td><td>Disease</td><td>&gt; 0.01</td><td>Integrin beta3 Leu33Pro polymorphism and breast cancer risk: a population-based case-control study in Germany</td></tr><tr style=''><td>ITPR1</td><td>rs6762644</td><td>Intron</td><td>3p26.1</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>ITPR1&nbsp;</td><td>rs6762558</td><td>Intron&nbsp;</td><td>3p26.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ITPR2</td><td>rs4964006</td><td>Intron</td><td>12p11.23</td><td>Disease</td><td>&gt; 0.01</td><td>BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts</td></tr><tr style=''><td>ITPR3&nbsp;</td><td>rs2229642</td><td>Exon</td><td>6p21.31</td><td>Disease</td><td>&gt; 0.01</td><td>Inositol 1,4,5-trisphosphate receptor gene variants are related to the risk of breast cancer in a Chinese population</td></tr><tr style=''><td>Intergenic</td><td>-</td><td>Intergenic</td><td>11q13.3</td><td>Disease</td><td>-</td><td>A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31</td></tr><tr style=''><td>Intergenic</td><td>-</td><td>Intergenic</td><td>15q11.2</td><td>Disease</td><td>-</td><td>A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31</td></tr><tr style=''><td>Intergenic</td><td>-</td><td>Intergenic</td><td>16q24.1</td><td>Disease</td><td>-</td><td>A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31</td></tr><tr style=''><td>Intergenic</td><td>rs1027113</td><td>Intergenic</td><td>12p11.22</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs10472076</td><td>Intergenic</td><td>5q11.2 </td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs10474352</td><td>Intergenic</td><td>5q14.3 </td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.2</td></tr><tr style=''><td>Intergenic</td><td>rs10484919</td><td>Intergenic</td><td>6q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population</td></tr><tr style=''><td>Intergenic</td><td>rs10637593</td><td>Intergenic</td><td>2p23.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs10759243</td><td>Intergenic</td><td>9q31.2 </td><td>Disease</td><td>&gt; 0.01</td><td>Association of multiple genetic variants with breast cancer susceptibility in the Han Chinese population</td></tr><tr style=''><td>Intergenic</td><td>rs10759243</td><td>Intergenic</td><td>9q31.2 </td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs10771399</td><td>Intergenic</td><td>12p11.22</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association studies identify four ER negative–specific breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs10771399</td><td>Intergenic</td><td>12p11.22</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis identifies three new breast cancer susceptibility loci</td></tr><tr style=''><td>Intergenic</td><td>rs10771399</td><td>Intergenic</td><td>12p11.22</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs10814138</td><td>Intergenic</td><td>9p13.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>Intergenic</td><td>rs10894076</td><td>Intergenic</td><td>11q24.3&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs10895304</td><td>Intergenic</td><td>11q22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Common MMP-7 Polymorphisms and Breast Cancer Susceptibility: A Multistage Study of Association and Functionality</td></tr><tr style=''><td>Intergenic</td><td>rs10941679</td><td>Intergenic</td><td>5p12</td><td>Disease</td><td>&gt; 0.01</td><td>Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs10941679</td><td>Intergenic</td><td>5p12</td><td>Disease</td><td>&gt; 0.01</td><td>Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through&nbsp;FGF10&nbsp;and&nbsp;MRPS30&nbsp;Regulation</td></tr><tr style=''><td>Intergenic</td><td>rs10941679</td><td>Intergenic</td><td>5p12</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>Intergenic</td><td>rs10941679</td><td>Intergenic</td><td>5p12&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs10995201</td><td>Intergenic</td><td>10q21.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs11155804</td><td>Intergenic</td><td>6q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs11199914</td><td>Intergenic</td><td>10q26.12&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs11242675</td><td>Intergenic</td><td>6p25.3</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk </td></tr><tr style=''><td>Intergenic</td><td>rs11264454</td><td>Intergenic</td><td>1q22</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs113701136</td><td>Intergenic</td><td>19q12</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs113778879</td><td>Intergenic</td><td>5q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs11568820</td><td>Intergenic</td><td>12q13.11&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Associations of vitamin D receptor encoding gene variants with premenopausal breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs11570443</td><td>Intergenic</td><td>17q21.32</td><td>Disease</td><td>&lt; 0.01</td><td>Association between polymorphisms in cdc27 and breast cancer in a Chinese population</td></tr><tr style=''><td>Intergenic</td><td>rs11588271</td><td>Intergenic</td><td>1p32.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs116426014</td><td>Intergenic</td><td>8p23.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs1167362</td><td>Intergenic</td><td>12q24.31</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs11684853</td><td>Intergenic</td><td>2p24.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs11780156</td><td>Intergenic</td><td>8q24.21</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk </td></tr><tr style=''><td>Intergenic</td><td>rs11801299&nbsp;</td><td>Intergenic</td><td>1q12</td><td>Disease</td><td>&gt; 0.01</td><td>Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients</td></tr><tr style=''><td>Intergenic</td><td>rs11814448</td><td>Intergenic</td><td>10p12.31</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs11820646</td><td>Intergenic</td><td>11q24.3</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs11903787</td><td>Intergenic</td><td>2q14.2</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs12118297</td><td>Intergenic</td><td>1p22.3 </td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci</td></tr><tr style=''><td>Intergenic</td><td>rs12184413</td><td>Intergenic</td><td>11q22.2</td><td>Protective</td><td>&gt; 0.01</td><td>Common MMP-7 Polymorphisms and Breast Cancer Susceptibility: A Multistage Study of Association and Functionality</td></tr><tr style=''><td>Intergenic</td><td>rs12250948</td><td>Intergenic</td><td>10q25.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs12335941</td><td>Intergenic</td><td>9p21.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs12422552</td><td>Intergenic</td><td>12p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls</td></tr><tr style=''><td>Intergenic</td><td>rs12422552</td><td>Intergenic</td><td>12p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs12422552</td><td>Intergenic</td><td>12p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs12422933</td><td>Intergenic</td><td>12q24.21</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs12479355</td><td>Intergenic</td><td>2q36.3</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs12479355</td><td>Intergenic</td><td>2q36.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs12519859</td><td>Intergenic</td><td>5p13.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs12710696</td><td>Intergenic</td><td>2p24.2-p24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association studies identify four ER negative–specific breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs12710696</td><td>Intergenic</td><td>2p24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs12710696</td><td>Intergenic</td><td>2p24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs12710696</td><td>Intergenic</td><td>2p24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>Intergenic</td><td>rs12711947</td><td>Intergenic</td><td>2q14.2&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs12763451</td><td>Intergenic</td><td>10p15.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs12870942</td><td>Intergenic</td><td>13q22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs12888245</td><td>Intergenic</td><td>14q11.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>Intergenic</td><td>rs12962334</td><td>Intergenic</td><td>18q11.2&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs13074711</td><td>Intergenic</td><td>3q26.31</td><td>Disease</td><td>&gt; 0.01</td><td>A genome-wide association study of breast cancer in women of African ancestry</td></tr><tr style=''><td>Intergenic</td><td>rs13162653</td><td>Intergenic</td><td>5p15.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs13365225</td><td>Intergenic</td><td>8p11.23</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs140850326</td><td>Intergenic</td><td>1p32.3</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs1429142</td><td>Intergenic</td><td>19q13.41</td><td>Disease</td><td>&gt; 0.01</td><td>Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility</td></tr><tr style=''><td>Intergenic</td><td>rs1550623</td><td>Intergenic</td><td>2q31.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>Intergenic</td><td>rs1550623</td><td>Intergenic</td><td>2q31.1</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk </td></tr><tr style=''><td>Intergenic</td><td>rs17167576</td><td>Intergenic</td><td>7p21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs17181761</td><td>Intergenic</td><td>13q22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs17181761</td><td>Intergenic</td><td>13q22.1&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs17356907</td><td>Intergenic</td><td>12q22 </td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs17356907</td><td>Intergenic</td><td>12q22 </td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk </td></tr><tr style=''><td>Intergenic</td><td>rs17356907</td><td>Intergenic</td><td>12q22&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs17426269</td><td>Intergenic</td><td>1p22.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs17513613</td><td>Intergenic</td><td>19q12&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs17529111</td><td>Intergenic</td><td>6q14.1</td><td>Disease</td><td>&gt; 0.01</td><td>Evaluating Genome-Wide Association Study-Identified Breast Cancer Risk Variants in African-American Women</td></tr><tr style=''><td>Intergenic</td><td>rs17529111</td><td>Intergenic</td><td>6q14.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>Intergenic</td><td>rs1800629</td><td>Intergenic</td><td>6p21.33</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Inflammatory Response Genes and Their Associations With Breast Cancer Risk</td></tr><tr style=''><td>Intergenic</td><td>rs187238</td><td>Intergenic</td><td>11q23.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genotypic and haplotype analysis of Interleukin-6 and -18 gene polymorphisms in association with clinicopathological factors in breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs187238</td><td>Intergenic</td><td>11q23.1</td><td>Disease</td><td>&gt; 0.01</td><td>Associations between single-nucleotide polymorphisms of the interleukin-18 gene and breast cancer in Iraqi women</td></tr><tr style=''><td>Intergenic</td><td>rs188686860</td><td>Intergenic</td><td>2q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs1895449</td><td>Intergenic</td><td>5q14.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs190843378</td><td>Intergenic</td><td>2q35</td><td>Protective</td><td>&gt; 0.01</td><td>Association of breast cancer risk and the mTOR pathway in women of African ancestry in ‘The Root’ Consortium</td></tr><tr style=''><td>Intergenic</td><td>rs1946518</td><td>Intergenic</td><td>11q23.1</td><td>Disease</td><td>&gt; 0.01</td><td>Associations between single-nucleotide polymorphisms of the interleukin-18 gene and breast cancer in Iraqi women</td></tr><tr style=''><td>Intergenic</td><td>rs1972372</td><td>Intergenic</td><td>14q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>Intergenic</td><td>rs2010610</td><td>Intergenic</td><td>2q14.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs202049448</td><td>Intergenic</td><td>12q21.31</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs202049448</td><td>Intergenic</td><td>12q21.31</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs204247</td><td>Intergenic</td><td>6p23</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs2069429</td><td>Intergenic</td><td>5q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association Study of Germline Variants in CCNB1 and CDK1 with Breast Cancer Susceptibility, Progression, and Survival among Chinese Han Women</td></tr><tr style=''><td>Intergenic</td><td>rs206966</td><td>Intergenic</td><td>12q24.31</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs2132572</td><td>Intergenic</td><td>7p12.3</td><td>Disease</td><td>&gt; 0.01</td><td>IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs2181965</td><td>Intergenic</td><td>13q22.1</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs2188648</td><td>Intergenic</td><td>7q21.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs2233406</td><td>Intergenic</td><td>14q13.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Inflammatory Response Genes and Their Associations With Breast Cancer Risk</td></tr><tr style=''><td>Intergenic</td><td>rs2302019</td><td>Intergenic</td><td>7p14.3</td><td>Protective</td><td>&gt; 0.01</td><td>Polymorphisms in genes involved in GH1 release and their association with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs2380205</td><td>Intergenic</td><td>10p15.1</td><td>Disease</td><td>&gt; 0.01</td><td>A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study</td></tr><tr style=''><td>Intergenic</td><td>rs2380205</td><td>Intergenic</td><td>10p15.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>Intergenic</td><td>rs2403907</td><td>Intergenic</td><td>21q21.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs2594714</td><td>Intergenic</td><td>19p13.13</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs2736108</td><td>Intergenic</td><td>5p15.33</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs2823093</td><td>Intergenic</td><td>21q21.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis identifies three new breast cancer susceptibility loci</td></tr><tr style=''><td>Intergenic</td><td>rs2853669</td><td>Intergenic</td><td>5p15.33</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs2854744</td><td>Intergenic</td><td>7p12.3</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms in the IGF-1 and IGFBP3 promoter and the risk of breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs2854744</td><td>Intergenic</td><td>7p12.3</td><td>Disease</td><td>&gt; 0.01</td><td>Impact of the IGFBP3 A-202C polymorphism on susceptibility and clinicopathologic features of breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs2992756</td><td>Intergenic</td><td>1p36.13</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs2992756</td><td>Intergenic</td><td>1p36.13&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs30099</td><td>Intergenic</td><td>5q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>Intergenic</td><td>rs3087243</td><td>Intergenic</td><td>2q33.2</td><td>Disease</td><td>&gt; 0.01</td><td>Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis</td></tr><tr style=''><td>Intergenic</td><td>rs3215401</td><td>Intergenic</td><td>5p15.33</td><td>Protective</td><td>&gt; 0.01</td><td>Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer</td></tr><tr style=''><td>Intergenic</td><td>rs34197572</td><td>Intergenic</td><td>19p13.2</td><td>Disease</td><td>&gt; 0.01</td><td>KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes</td></tr><tr style=''><td>Intergenic</td><td>rs34753522</td><td>Intergenic</td><td>20q12&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs35781392</td><td>Intergenic</td><td>10p14&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs35951924</td><td>Intergenic</td><td>5q11.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs35951924</td><td>Intergenic</td><td>5q11.1&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs361525</td><td>Intergenic</td><td>6p21.33</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF–LTA) and breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs361525</td><td>Intergenic</td><td>6p21.33</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Inflammatory Response Genes and Their Associations With Breast Cancer Risk</td></tr><tr style=''><td>Intergenic</td><td>rs36194942</td><td>Intergenic</td><td>18q12.1 </td><td>Protective</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs3760982</td><td>Intergenic</td><td>19q13.31</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs3809114</td><td>Intergenic</td><td>12q13.3&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs3903072</td><td>Intergenic</td><td>11q13.1</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs3928337</td><td>Intergenic</td><td>14q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>Intergenic</td><td>rs405447</td><td>Intergenic</td><td>6p23&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs4073</td><td>Intergenic</td><td>4q13.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Inflammatory Response Genes and Their Associations With Breast Cancer Risk</td></tr><tr style=''><td>Intergenic</td><td>rs4233486</td><td>Intergenic</td><td>1p34.2</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs4233486</td><td>Intergenic</td><td>1p34.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs4322600</td><td>Intergenic</td><td>14q31.3</td><td>Disease</td><td>&gt; 0.01</td><td>A genome-wide association study of breast cancer in women of African ancestry</td></tr><tr style=''><td>Intergenic</td><td>rs4415084</td><td>Intergenic</td><td>5p12</td><td>Disease</td><td>&gt; 0.01</td><td>Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs4415084</td><td>Intergenic</td><td>5p12</td><td>Disease</td><td>&gt; 0.01</td><td>LncRNA-SNPs in a Brazilian Breast Cancer Cohort: A Case-Control Study</td></tr><tr style=''><td>Intergenic</td><td>rs4496150</td><td>Intergenic</td><td>16q24.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs4516035</td><td>Intergenic</td><td>12q13.11&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Associations of vitamin D receptor encoding gene variants with premenopausal breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs4553808</td><td>Intergenic</td><td>2q33.2</td><td>Disease</td><td>&gt; 0.01</td><td>Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis</td></tr><tr style=''><td>Intergenic</td><td>rs4562056</td><td>Intergenic</td><td>5q35.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs4609972</td><td>Intergenic</td><td>19p13.11</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs4646903</td><td>Intergenic</td><td>15q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>A CYP1A1 Restriction Fragment Length Polymorphism Is Associated with Breast Cancer in African-American Women</td></tr><tr style=''><td>Intergenic</td><td>rs4646903</td><td>Intergenic</td><td>15q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphism of estrogen metabolizing enzymes in Siberian women with breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs4666451</td><td>Intergenic</td><td>2p24.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>Intergenic</td><td>rs4702131</td><td>Intergenic</td><td>5p15.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs4755816</td><td>Intergenic</td><td>11p11.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs4793090</td><td>Intergenic</td><td>17q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs4822992</td><td>Intergenic</td><td>22q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs4849887</td><td>Intergenic</td><td>2q14.2</td><td>Disease</td><td>&gt; 0.01</td><td>Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls</td></tr><tr style=''><td>Intergenic</td><td>rs4849887</td><td>Intergenic</td><td>2q14.2</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs4849887</td><td>Intergenic</td><td>2q14.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>Intergenic</td><td>rs4866496</td><td>Intergenic</td><td>5p15.33</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs514192</td><td>Intergenic</td><td>8q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs527616</td><td>Intergenic</td><td>18q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls</td></tr><tr style=''><td>Intergenic</td><td>rs527616</td><td>Intergenic</td><td>18q11.2</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs527616</td><td>Intergenic</td><td>18q11.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs531874019</td><td>Intergenic</td><td>20q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs544173</td><td>Intergenic</td><td>1p12</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs549494279</td><td>Intergenic</td><td>17q21.31</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs554219</td><td>Intergenic</td><td>11q13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers</td></tr><tr style=''><td>Intergenic</td><td>rs554219</td><td>Intergenic</td><td>11q13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>Intergenic</td><td>rs559989662</td><td>Intergenic</td><td>3p21.31</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs56234354</td><td>Intergenic</td><td>5q35.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs56963355</td><td>Intergenic</td><td>5p15.33</td><td>Protective</td><td>&gt; 0.01</td><td>Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer</td></tr><tr style=''><td>Intergenic</td><td>rs58847541</td><td>Intergenic</td><td>8q24.13</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs58847541</td><td>Intergenic</td><td>8q24.13</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs59954380</td><td>Intergenic</td><td>10q23.33</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs59957907</td><td>Intergenic</td><td>5q11.2&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs60037937</td><td>Intergenic</td><td>9q31.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs6012911</td><td>Intergenic</td><td>20q13.13</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs6024836</td><td>Intergenic</td><td>20q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in AURKA and BRCA1 Are Associated With Breast Cancer Susceptibility in a Chinese Han Population</td></tr><tr style=''><td>Intergenic</td><td>rs60954078</td><td>Intergenic</td><td>6q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs6122906</td><td>Intergenic</td><td>20q13.13</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs614367</td><td>Intergenic</td><td>11q13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>Intergenic</td><td>rs614367</td><td>Intergenic</td><td>11q13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>Intergenic</td><td>rs62078064</td><td>Intergenic</td><td>17q12</td><td>Protective</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>Intergenic</td><td>rs62282635</td><td>Intergenic</td><td>3q26.31</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs62355902</td><td>Intergenic</td><td>5q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating&nbsp;MAP3K1</td></tr><tr style=''><td>Intergenic</td><td>rs6472903</td><td>Intergenic</td><td>8q21.11</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs6472903</td><td>Intergenic</td><td>8q21.11</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>Intergenic</td><td>rs6562760</td><td>Intergenic</td><td>13q22.1</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs6562760</td><td>Intergenic</td><td>13q22.1</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs67397200</td><td>Intergenic</td><td>19p13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus</td></tr><tr style=''><td>Intergenic</td><td>rs67397200</td><td>Intergenic</td><td>19p13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs67958007</td><td>Intergenic</td><td>10p14</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs6796502</td><td>Intergenic</td><td>3p21.31</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs6815814</td><td>Intergenic</td><td>4p14</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs6890591</td><td>Intergenic</td><td>5q35.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs6940159</td><td>Intergenic</td><td>6q27&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs7149721</td><td>Intergenic</td><td>14q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>Intergenic</td><td>rs72658071</td><td>Intergenic</td><td>8q21.13</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs72749841</td><td>Intergenic</td><td>5q11.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs72749841</td><td>Intergenic</td><td>5q11.1&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs72758040&nbsp;</td><td>Intergenic</td><td>5q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Heritable genomic diversity in breast cancer driver genes and associations with risk in a Chilean population</td></tr><tr style=''><td>Intergenic</td><td>rs7297051</td><td>Intergenic</td><td>12p11.22</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus</td></tr><tr style=''><td>Intergenic</td><td>rs7297051</td><td>Intergenic</td><td>12p11.22</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs7297051</td><td>Intergenic</td><td>12p11.22&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs7304105</td><td>Intergenic</td><td>12q15&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs733618</td><td>Intergenic</td><td>2q33.2</td><td>Disease</td><td>&gt; 0.01</td><td>Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis</td></tr><tr style=''><td>Intergenic</td><td>rs74392007</td><td>Intergenic</td><td>6q22.31</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs745570</td><td>Intergenic</td><td>17q25.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs7463114</td><td>Intergenic</td><td>8p12&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs74943274</td><td>Intergenic</td><td>2q33</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs75224640</td><td>Intergenic</td><td>13q14.2</td><td>Disease</td><td>&lt; 0.01</td><td>Association of breast cancer risk and the mTOR pathway in women of African ancestry in ‘The Root’ Consortium</td></tr><tr style=''><td>Intergenic</td><td>rs7529522</td><td>Intergenic</td><td>1p12</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs75772194</td><td>Intergenic</td><td>8p12&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs75915166</td><td>Intergenic</td><td>11q13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers</td></tr><tr style=''><td>Intergenic</td><td>rs75915166</td><td>Intergenic</td><td>11q13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>Intergenic</td><td>rs763354</td><td>Intergenic</td><td>6q13</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Variations in miR-30 Family Member Regulatory Regions Are Associated with Breast Cancer Risk in a Chinese Population</td></tr><tr style=''><td>Intergenic</td><td>rs76535198</td><td>Intergenic</td><td>16q22.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs7697216</td><td>Intergenic</td><td>4q34.1&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs7710996</td><td>Intergenic</td><td>5p12&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs7716600&nbsp;</td><td>Intergenic</td><td>5p12</td><td>Disease</td><td>&gt; 0.01</td><td>LncRNA-SNPs in a Brazilian Breast Cancer Cohort: A Case-Control Study</td></tr><tr style=''><td>Intergenic</td><td>rs77528541</td><td>Intergenic</td><td>4q28.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs77528541</td><td>Intergenic</td><td>4q28.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs77554484</td><td>Intergenic</td><td>15q26.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs7799039</td><td>Intergenic</td><td>7q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma</td></tr><tr style=''><td>Intergenic</td><td>rs78540526</td><td>Intergenic</td><td>11q13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs7935378</td><td>Intergenic</td><td>11q22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Common MMP-7 Polymorphisms and Breast Cancer Susceptibility: A Multistage Study of Association and Functionality</td></tr><tr style=''><td>Intergenic</td><td>rs79858006</td><td>Intergenic</td><td>18q12.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs8002929</td><td>Intergenic</td><td>13q22.1</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs8035987</td><td>Intergenic</td><td>15q24.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs805510</td><td>Intergenic</td><td>12p11.22</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus</td></tr><tr style=''><td>Intergenic</td><td>rs8082452</td><td>Intergenic</td><td>17q25.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs8176636</td><td>Intergenic</td><td>9q34.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>Intergenic</td><td>rs833061</td><td>Intergenic</td><td>6p21.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of polymorphisms of angiogenesis genes with breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs889312</td><td>Intergenic</td><td>5q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>Intergenic</td><td>rs889312</td><td>Intergenic</td><td>5q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>Intergenic</td><td>rs889312</td><td>Intergenic</td><td>5q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>Intergenic</td><td>rs9257408</td><td>Intergenic</td><td>6p22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs9284657</td><td>Intergenic</td><td>4q21.23</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs9341894</td><td>Intergenic</td><td>6q14.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs9397437</td><td>Intergenic</td><td>6q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Breast cancer risk variants at 6q25 display different phenotype associations and regulate&nbsp;ESR1,&nbsp;RMND1&nbsp;and&nbsp;CCDC170</td></tr><tr style=''><td>Intergenic</td><td>rs9420318</td><td>Intergenic</td><td>10q26.12&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs9573140</td><td>Intergenic</td><td>13q22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>Intergenic</td><td>rs9693444</td><td>Intergenic</td><td>8p12 </td><td>Protective</td><td>&gt; 0.01</td><td>Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls</td></tr><tr style=''><td>Intergenic</td><td>rs9693444</td><td>Intergenic</td><td>8p12 </td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>Intergenic</td><td>rs9712235</td><td>Intergenic</td><td>2p14&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>Intergenic</td><td>rs9790879</td><td>Intergenic</td><td>5p12</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>Intergenic</td><td>rs9862599</td><td>Intergenic</td><td>3q13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population</td></tr><tr style=''><td>Intergenic</td><td>rs9868094</td><td>Intergenic</td><td>3p24.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>JAK2</td><td>rs56118985</td><td>Exon</td><td>9p24.1</td><td>Disease</td><td>&lt; 0.01</td><td>Identification of Novel Breast Cancer Risk Loci</td></tr><tr style=''><td>KANSL1</td><td>rs2532263</td><td>Intron</td><td>17q21.31</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>KCNJ6&nbsp;</td><td>rs11910276</td><td>Intron&nbsp;</td><td>21q22.13</td><td>Protective</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>KCNJ6&nbsp;</td><td>rs2409939</td><td>Intron&nbsp;</td><td>21q22.13</td><td>Protective</td><td>&gt; 0.01</td><td>Genome‑wide analysis of genetic predisposition to common polygenic cancers</td></tr><tr style=''><td>KCNN4</td><td>-</td><td>-</td><td>19q13.31</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>KCNN4&nbsp;</td><td>rs56681946</td><td>Intron&nbsp;</td><td>19q13.31</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>KIAA1217</td><td>rs11014002</td><td>Intron</td><td>10p12.2</td><td>Protective</td><td>&gt; 0.01</td><td>Association Study of hsa-mir-603 rs11014002 Polymorphism and Risk of Breast Cancer in a Sample of Iranian Population</td></tr><tr style=''><td>KLC1</td><td>rs1799796</td><td>Intron</td><td>14q32.33</td><td>Protective</td><td>&gt; 0.01</td><td>Variants in DNA double-strand break repair genes and breast cancer susceptibility</td></tr><tr style=''><td>KLC1</td><td>rs861539</td><td>Intron</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Variants in DNA double-strand break repair genes and breast cancer susceptibility</td></tr><tr style=''><td>KLC1</td><td>rs861539</td><td>Intron</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Correlation between selected XRCC2, XRCC3 and RAD51 gene polymorphisms and primary breast cancer in women in Pakistan</td></tr><tr style=''><td>KLC1</td><td>rs861539</td><td>Intron</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Variations of DNA Repair Genes in Breast Cancer</td></tr><tr style=''><td>KLC1&nbsp;</td><td>rs861539</td><td>Intron</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Homologous recombination DNA repair gene RAD51, XRCC2 &amp; XRCC3 polymorphisms and breast cancer risk in South Indian women</td></tr><tr style=''><td>KLC1&nbsp;</td><td>rs861539</td><td>Intron</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Relationship between polymorphisms in homologous recombination repair genes RAD51 G172T、XRCC2 &amp; XRCC3 and risk of breast cancer: A meta-analysis</td></tr><tr style=''><td>KLC1&nbsp;</td><td>rs861539</td><td>Intron&nbsp;</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis</td></tr><tr style=''><td>KLC1&nbsp;</td><td>rs861539</td><td>Intron&nbsp;</td><td>14q32.33</td><td>Protective</td><td>&gt; 0.01</td><td>Association of&nbsp;RAD51,&nbsp;XRCC1,&nbsp;XRCC2, and&nbsp;XRCC3&nbsp;Polymorphisms with Risk of Breast Cancer</td></tr><tr style=''><td>KMT2C&nbsp;</td><td>rs200662726</td><td>Exon</td><td>7q36.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>KMT2C&nbsp;</td><td>rs772146328</td><td>Exon</td><td>7q36.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>KRAS&nbsp;</td><td>rs9266</td><td>3 Prime UTR Variant</td><td>12p12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association between KRAS gene polymorphisms and genetic susceptibility to breast cancer in a Chinese population</td></tr><tr style=''><td>L3MBTL3</td><td>rs6569648</td><td>Intron</td><td>6q23.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>L3MBTL3</td><td>rs6569648</td><td>Intron</td><td>6q23.1</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>L3MBTL3&nbsp;</td><td>rs6569648</td><td>Intron&nbsp;</td><td>6q23.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LDLRAD4&nbsp;</td><td>rs4797754</td><td>Intron&nbsp;</td><td>18p11.21</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LEPR</td><td>rs1137101</td><td>Exon</td><td>1p31.3</td><td>Disease</td><td>&gt; 0.01</td><td>Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma</td></tr><tr style=''><td>LEPR</td><td>rs1137101</td><td>Exon</td><td>1p31.3</td><td>Disease</td><td>&gt; 0.01</td><td>Associations among Lipids, Leptin, and Leptin Receptor Gene Gin223Arg Polymorphisms and Breast Cancer in China</td></tr><tr style=''><td>LEPR</td><td>rs1137101</td><td>Exon</td><td>1p31.3</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphic Markers Associated with Genes Responsible for Lipid and Carbohydrate Metabolism Disorders and Insulin Resistance in Cancer Patients</td></tr><tr style=''><td>LEPR</td><td>rs1137101</td><td>Exon</td><td>1p31.3</td><td>Disease</td><td>&gt; 0.01</td><td>Effect of leptin receptor Q223R polymorphism on breast cancer risk</td></tr><tr style=''><td>LEPR</td><td>rs1137101</td><td>Exon</td><td>1p31.3</td><td>Protective</td><td>&gt; 0.01</td><td>Single-Nucleotide Polymorphisms in LEP and LEPR Associated With Breast Cancer Risk: Results From a Multicenter Case-Control Study in Chinese Females</td></tr><tr style=''><td>LEPR&nbsp;</td><td>rs1137100</td><td>Exon</td><td>1p31.3</td><td>Protective/Disease</td><td>&gt; 0.01</td><td>Correlation of Q223R and K109R polymorphisms in leptin receptor gene with susceptibility of breast cancer: A systematic review and meta-analysis</td></tr><tr style=''><td>LEPR&nbsp;</td><td>rs1137101</td><td>Exon</td><td>1p31.3</td><td>Protective/Disease</td><td>&gt; 0.01</td><td>Correlation of Q223R and K109R polymorphisms in leptin receptor gene with susceptibility of breast cancer: A systematic review and meta-analysis</td></tr><tr style=''><td>LEPR&nbsp;</td><td>rs4655555</td><td>Intron&nbsp;</td><td>1p31.3</td><td>Protective</td><td>&gt; 0.01</td><td>Single-Nucleotide Polymorphisms in LEP and LEPR Associated With Breast Cancer Risk: Results From a Multicenter Case-Control Study in Chinese Females</td></tr><tr style=''><td>LGR6</td><td>rs17489300</td><td>Intron</td><td>1q32.1</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>LGR6</td><td>rs6678914</td><td>Intron</td><td>1q32.1 </td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association studies identify four ER negative–specific breast cancer risk loci</td></tr><tr style=''><td>LGR6</td><td>rs6678914</td><td>Intron</td><td>1q32.1</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>LGR6</td><td>rs6678914</td><td>Intron</td><td>1q32.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>LGR6&nbsp;</td><td>rs12129456</td><td>Intron&nbsp;</td><td>1q32.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LINC-PINT</td><td>rs2048672</td><td>Intron</td><td>7q32.3 </td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>LINC-PINT</td><td>rs4593472</td><td>Intron</td><td>7q32.3 </td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>LINC-PINT</td><td>rs68056147</td><td>Intron&nbsp;</td><td>7q32.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LINC00536</td><td>rs13267382</td><td>Intron</td><td>8q23.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>LINC00536&nbsp;</td><td>rs13267382</td><td>Intron&nbsp;</td><td>8q23.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LINC00673</td><td>rs11652463</td><td>Intron</td><td>17q24.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>LINC00673&nbsp;</td><td>rs4793442</td><td>Intron&nbsp;</td><td>17q24.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LINC00886</td><td>rs11281251</td><td>Intron</td><td>3q25.31</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>LINC00886&nbsp;</td><td>rs5853769</td><td>Intron&nbsp;</td><td>3q25.31</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LINC01282 </td><td>rs12689301</td><td>Intron</td><td>23p11.4</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>LINC01483</td><td>rs9302903</td><td>Intron</td><td>17q24.3</td><td>Protective</td><td>&gt; 0.01</td><td>Common genetic variation and novel loci associated with volumetric mammographic density</td></tr><tr style=''><td>LINC01488</td><td>rs537626</td><td>Non Coding Transcript Variant</td><td>11q13.3</td><td>Disease</td><td>&gt; 0.01</td><td>A Genome-wide Association Study of Early-onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age</td></tr><tr style=''><td>LINC01612</td><td>rs10030422</td><td>Intron</td><td>4q33</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>LINC02068</td><td>rs58058861</td><td>Intron</td><td>3q26.31</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>LINC02288</td><td>rs75004998</td><td>Intron</td><td>14q24.3</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>LINC02288&nbsp;</td><td>rs2216310</td><td>Intron&nbsp;</td><td>14q24.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LINC02456</td><td>rs1520220</td><td>Intron</td><td>12q23.2</td><td>Disease</td><td>&gt; 0.01</td><td>IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer</td></tr><tr style=''><td>LINC02456&nbsp;</td><td>rs855596</td><td>Intron&nbsp;</td><td>12q23.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LMX1B</td><td>rs10760444</td><td>Intron</td><td>9q33.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>LMX1B&nbsp;</td><td>rs10760444</td><td>Intron&nbsp;</td><td>9q33.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC100128494</td><td>rs3750913</td><td>Non Coding Transcript Variant</td><td>11q13.4</td><td>Disease</td><td>&gt; 0.01</td><td>Association of the NuMA region on chromosome 11q13 with breast cancer susceptibility</td></tr><tr style=''><td>LOC100287329</td><td>rs909253</td><td>Intron</td><td>6p21.33</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms of tumour necrosis factors A and B in breast cancer</td></tr><tr style=''><td>LOC100507346&nbsp;</td><td>rs2066829</td><td>Non Coding Transcript Variant</td><td>9q22.32&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Inherited rare and common variants in PTCH1 and PTCH2 contributing to the predisposition to reproductive cancers</td></tr><tr style=''><td>LOC101927871&nbsp;</td><td>rs2151842</td><td>Intron&nbsp;</td><td>1p22.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC101928278</td><td>rs13387042</td><td>Intron</td><td>2q35</td><td>Protective</td><td>&gt; 0.01</td><td>A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)</td></tr><tr style=''><td>LOC101928278</td><td>rs13387042</td><td>Intron</td><td>2q35</td><td>Disease</td><td>&gt; 0.01</td><td>Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer</td></tr><tr style=''><td>LOC101928278</td><td>rs13387042</td><td>Intron</td><td>2q35</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>LOC101928278</td><td>rs13387042</td><td>Intron</td><td>2q35</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>LOC101928278</td><td>rs34005590</td><td>Intron</td><td>2q35</td><td>Protective</td><td>&gt; 0.01</td><td>An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression</td></tr><tr style=''><td>LOC101928278</td><td>rs4442975</td><td>Intron</td><td>2q35</td><td>Protective</td><td>&gt; 0.01</td><td>Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation</td></tr><tr style=''><td>LOC101929512</td><td>rs7309</td><td>Intron</td><td>2q24.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study</td></tr><tr style=''><td>LOC101929626</td><td>rs1707302</td><td>Intron</td><td>1p34.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>LOC101929626&nbsp;</td><td>rs1707302</td><td>Intron&nbsp;</td><td>1p34.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC102724851</td><td>rs71557345</td><td>Intron</td><td>6p22.2</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>LOC102724851&nbsp;</td><td>rs71557345</td><td>Non Coding Transcript Variant</td><td>6p22.2&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC105369501</td><td>rs10891556</td><td>Intron</td><td>11q23.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case–control study in Thai women</td></tr><tr style=''><td>LOC105369828&nbsp;</td><td>rs61754227</td><td>Non Coding Transcript Variant</td><td>12q15&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>LOC105369944</td><td>rs855596</td><td>Intron</td><td>12q23.2</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>LOC105370003</td><td>rs1292011</td><td>Intron</td><td>12q24.21 </td><td>Protective</td><td>&gt; 0.01</td><td>Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls</td></tr><tr style=''><td>LOC105370003</td><td>rs1292011</td><td>Intron</td><td>12q24.21 </td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis identifies three new breast cancer susceptibility loci</td></tr><tr style=''><td>LOC105370003&nbsp;</td><td>rs1292011</td><td>Intron&nbsp;</td><td>12q24.21</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC105371082&nbsp;</td><td>rs33989964&nbsp;</td><td>Intron&nbsp;</td><td>16p13.13</td><td>Disease</td><td>&gt; 0.01</td><td>The importance of SOCS1 - 1478 CA/del polymorphism and expression in breast cancer: a case-control study in the north of Iran</td></tr><tr style=''><td>LOC105371274</td><td>rs28539243</td><td>Intron</td><td>16q12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>LOC105371274&nbsp;</td><td>rs16953806</td><td>Intron&nbsp;</td><td>16q12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC105371393</td><td>rs4496150</td><td>Intron</td><td>16q24.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>LOC105373071&nbsp;</td><td>rs77848624</td><td>Non Coding Transcript Variant</td><td>22q13.31</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC105373874</td><td>rs13387042</td><td>Non Coding Transcript Variant</td><td>2q35</td><td>Protective</td><td>&gt; 0.01</td><td>A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)</td></tr><tr style=''><td>LOC105373874</td><td>rs13387042</td><td>Non Coding Transcript Variant</td><td>2q35</td><td>Disease</td><td>&gt; 0.01</td><td>Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer</td></tr><tr style=''><td>LOC105373874</td><td>rs13387042</td><td>Non Coding Transcript Variant</td><td>2q35</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>LOC105373874</td><td>rs13387042</td><td>Non Coding Transcript Variant</td><td>2q35</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>LOC105374610</td><td>rs17045754</td><td>Non Coding Transcript Variant</td><td>2p16.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic variants in the acylphosphatase 2 gene and the risk of breast cancer in a Han Chinese population</td></tr><tr style=''><td>LOC105375404&nbsp;</td><td>rs17268829</td><td>Intron</td><td>7q21.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>LOC105375508&nbsp;</td><td>rs972283&nbsp;</td><td>Intron</td><td>7q32.2</td><td>Disease</td><td>&gt; 0.01</td><td>Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients</td></tr><tr style=''><td>LOC105375739</td><td>rs17350191</td><td>Intron</td><td>8q24.13</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>LOC105375739&nbsp;</td><td>rs13279803</td><td>Intron&nbsp;</td><td>8q24.13</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC105376214</td><td>rs10816625</td><td>Intron</td><td>9q31.2</td><td>Disease</td><td>&gt; 0.01</td><td>Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2</td></tr><tr style=''><td>LOC105376214</td><td>rs13294895</td><td>Intron</td><td>9q31.2</td><td>Disease</td><td>&gt; 0.01</td><td>Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2</td></tr><tr style=''><td>LOC105376214</td><td>rs676256&nbsp;</td><td>Intron</td><td>9q31.2</td><td>Protective</td><td>&gt; 0.01</td><td>Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2</td></tr><tr style=''><td>LOC105376214</td><td>rs865686</td><td>Intron</td><td>9q31.2</td><td>Protective</td><td>&gt; 0.01</td><td>Novel Breast Cancer Susceptibility Locus at 9q31.2: Results of a Genome-Wide Association Study</td></tr><tr style=''><td>LOC105376214</td><td>rs865686</td><td>Intron</td><td>9q31.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>LOC105376214&nbsp;</td><td>rs7862747</td><td>Intron&nbsp;</td><td>9q31.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC105377110</td><td>rs2886671</td><td>Intron</td><td>3p14.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>LOC105377110</td><td>rs9831300</td><td>Intron</td><td>3p14.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>LOC105377621</td><td>rs28362491</td><td>Intron</td><td>4q24</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Inflammatory Response Genes and Their Associations With Breast Cancer Risk</td></tr><tr style=''><td>LOC105377641</td><td>rs1375631</td><td>Intron</td><td>3p24.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>LOC105377871</td><td>rs17530068</td><td>Intron</td><td>6q14.1</td><td>Disease</td><td>&gt; 0.01</td><td>A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11</td></tr><tr style=''><td>LOC105379003</td><td>rs7727166</td><td>Non Coding Transcript Variant</td><td>5q12.3</td><td>Disease</td><td>&gt; 0.01</td><td>A genome-wide association study of breast cancer in women of African ancestry</td></tr><tr style=''><td>LOC107984214</td><td>rs7072776</td><td>Intron</td><td>10p12.31</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>LOC107984270</td><td>rs2089176</td><td>Intron</td><td>10q25.3</td><td>Protective</td><td>&gt; 0.01</td><td>Common genetic variation and novel loci associated with volumetric mammographic density</td></tr><tr style=''><td>LOC107984284</td><td>rs3813867</td><td>Non Coding Transcript Variant</td><td>10q26.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association of CYP2E1, STK15 and XRCC1 Polymorphisms with Risk of Breast Cancer in Malaysian Women</td></tr><tr style=''><td>LOC107984567&nbsp;</td><td>rs2286657</td><td>Intron&nbsp;</td><td>13q14.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC107985393</td><td>rs3746444</td><td>Intron</td><td>20q11.22</td><td>Disease</td><td>&gt; 0.01</td><td>Common Genetic Variants in pre-microRNAs Were Associated With Increased Risk of Breast Cancer in Chinese Women</td></tr><tr style=''><td>LOC107985515</td><td>rs16992204</td><td>Intron</td><td>21q22.12</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci</td></tr><tr style=''><td>LOC107985515&nbsp;</td><td>rs12482521</td><td>Intron&nbsp;</td><td>21q22.12</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC107985532</td><td>rs384262</td><td>Intron</td><td>22q11.21</td><td>Disease</td><td>&gt; 0.01</td><td>Association Study of miR-100, miR-124-1, miR-218-2, miR-301b, miR-605, and miR-4293 Polymorphisms and the Risk of Breast Cancer in a Sample of Iranian Population</td></tr><tr style=''><td>LOC107985535</td><td>rs28512361</td><td>Intron</td><td>22q13.31</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>LOC107985535&nbsp;</td><td>rs77848624</td><td>Intron&nbsp;</td><td>22q13.31</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC107986528&nbsp;</td><td>rs1038304</td><td>Intron&nbsp;</td><td>6q25.1</td><td>Protective</td><td>&gt; 0.01</td><td>Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population</td></tr><tr style=''><td>LOC107986620</td><td>rs7768862</td><td>Intron</td><td>6q14.3</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>LOC107986620&nbsp;</td><td>rs9444166</td><td>Intron&nbsp;</td><td>6q14.3&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC107986820</td><td>rs10953105</td><td>Intron</td><td>7q21.3</td><td>Disease</td><td>&gt; 0.01</td><td>BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts</td></tr><tr style=''><td>LOC107986854</td><td>rs11977670</td><td>Intron</td><td>7q34</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>LOC107986854&nbsp;</td><td>rs11977670</td><td>Intron&nbsp;</td><td>7q34&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC107986930</td><td>rs144145984</td><td>Intron</td><td>8p21.2</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>LOC107986930&nbsp;</td><td>rs310291</td><td>Non Coding Transcript Variant</td><td>8p21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC107986961</td><td>rs514192</td><td>Intron</td><td>8q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>LOC107987209&nbsp;</td><td>rs4983544</td><td>Non Coding Transcript Variant</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC112268294</td><td>rs1065852</td><td>Intron</td><td>22q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Detection of Cytochrome P450 Polymorphisms in Breast Cancer Patients May Impact on Tamoxifen Therapy</td></tr><tr style=''><td>LOC124900631&nbsp;</td><td>rs4445576</td><td>Exon</td><td>10q11.22</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>LOC124900701&nbsp;</td><td>rs12506630</td><td>Intron&nbsp;</td><td>4q12&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC124900868&nbsp;</td><td>rs62331150</td><td>Intron&nbsp;</td><td>4q24&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC124901298</td><td>rs369261720</td><td>Non Coding Transcript Variant</td><td>6p22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>LOC124901298&nbsp;</td><td>rs372503438</td><td>Intron</td><td>6p22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>LOC124901298&nbsp;</td><td>rs41548917</td><td>Intron</td><td>6p22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>LOC124901298&nbsp;</td><td>rs41562120</td><td>Intron</td><td>6p22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>LOC124901298&nbsp;</td><td>rs758168864</td><td>Intron</td><td>6p22.1</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>LOC124901435&nbsp;</td><td>rs2046210</td><td>Non Coding Transcript Variant</td><td>6q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Estrogen receptor alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in pashtun population of Khyber Pakhtunkhwa</td></tr><tr style=''><td>LOC124901435&nbsp;</td><td>rs2046210</td><td>Non Coding Transcript Variant</td><td>6q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population</td></tr><tr style=''><td>LOC124902020&nbsp;</td><td>rs1121948</td><td>Non Coding Transcript Variant</td><td>8q24.21&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC124903335&nbsp;</td><td>rs10483813</td><td>Non Coding Transcript Variant</td><td>14q24.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC124905970&nbsp;</td><td>rs539902477</td><td>Intron&nbsp;</td><td>2p25.1</td><td>Disease</td><td>&lt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC124909400&nbsp;</td><td>rs35701020</td><td>Non Coding Transcript Variant</td><td>3q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LOC339902</td><td>rs9831300</td><td>Intron</td><td>3p14.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>LRTOMT</td><td>rs3018301</td><td>Intron</td><td>11q13.4</td><td>Disease</td><td>&gt; 0.01</td><td>Association of the NuMA region on chromosome 11q13 with breast cancer susceptibility</td></tr><tr style=''><td>LRTOMT</td><td>rs673478</td><td>Intron</td><td>11q13.4</td><td>Disease</td><td>&gt; 0.01</td><td>Association of the NuMA region on chromosome 11q13 with breast cancer susceptibility</td></tr><tr style=''><td>LSP1</td><td>-</td><td>-</td><td>11p15.5</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>LSP1</td><td>rs3817198</td><td>Intron</td><td>11p15.5 </td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>LSP1</td><td>rs3817198</td><td>Intron</td><td>11p15.5 </td><td>Disease</td><td>&gt; 0.01</td><td>The correlation of leukocyte-specific protein 1 (LSP1) rs3817198(T&gt;C) polymorphism with breast cancer: A meta-analysis</td></tr><tr style=''><td>LSP1</td><td>rs4980383</td><td>Intron</td><td>11p15.5</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>LSP1</td><td>rs569550</td><td>Intron</td><td>11p15.5 </td><td>Disease</td><td>&gt; 0.01</td><td>Correlation between LSP1 polymorphisms and the susceptibility to breast cancer</td></tr><tr style=''><td>LSP1</td><td>rs592373</td><td>Intron</td><td>11p15.5 </td><td>Disease</td><td>&gt; 0.01</td><td>Correlation between LSP1 polymorphisms and the susceptibility to breast cancer</td></tr><tr style=''><td>LSP1&nbsp;</td><td>rs588321</td><td>Intron&nbsp;</td><td>11p15.5&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>LTA</td><td>rs909253</td><td>Intron</td><td>6p21.33</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms of tumour necrosis factors A and B in breast cancer</td></tr><tr style=''><td>LYPD5</td><td>-</td><td>-</td><td>19q13.31</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>LZTS1</td><td>rs903999</td><td>Intron</td><td>8p21.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>MAD1L1</td><td>-</td><td>CNV</td><td>7p22.3&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>MAF&nbsp;</td><td>rs1030258012</td><td>Exon</td><td>16q23.2</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>MAP3K1</td><td>-</td><td>-</td><td>5q11.2</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>MAPK3</td><td>rs7698</td><td>Non Coding Transcript Variant</td><td>16p11.2</td><td>Protective</td><td>&gt; 0.01</td><td>MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: The Breast Cancer Health Disparities Study</td></tr><tr style=''><td>MCC</td><td>rs11283943</td><td>Intron</td><td>5q22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association of APC and MCC polymorphisms with increased breast cancer risk in an Indian population </td></tr><tr style=''><td>MCM8</td><td>rs16991615</td><td>Exon</td><td>20p12.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>MCM8&nbsp;</td><td>rs16991615</td><td>Exon</td><td>20p12.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>MCPH1</td><td>rs747489687</td><td>Exon</td><td>8p23.1</td><td>Disease</td><td>&lt; 0.01</td><td>Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating With Hereditary Breast Cancer Susceptibility</td></tr><tr style=''><td>MCPH1&nbsp;</td><td>rs1823375</td><td>Intron&nbsp;</td><td>8p23.1</td><td>Protective</td><td>&gt; 0.01</td><td>The impact of Angiopoietin-2 genetic polymorphisms on susceptibility for malignant breast neoplasms</td></tr><tr style=''><td>MDM2</td><td>rs2279744</td><td>Intron</td><td>12q15</td><td>Disease</td><td>&gt; 0.01</td><td>Significant Association of the MDM2 T309G Polymorphism with Breast Cancer Risk in a Turkish Population</td></tr><tr style=''><td>MDM2</td><td>rs2279744</td><td>Intron</td><td>12q15</td><td>Disease</td><td>&gt; 0.01</td><td>Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer</td></tr><tr style=''><td>MDM2</td><td>rs2279744</td><td>Intron</td><td>12q15</td><td>Disease</td><td>&gt; 0.01</td><td>Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer</td></tr><tr style=''><td>MDM2</td><td>rs2279744</td><td>Intron</td><td>12q15</td><td>Disease</td><td>&gt; 0.01</td><td>A single‐nucleotide polymorphism in the TP53 and MDM‐2 gene modifies breast cancer risk in an ethnic Arab population</td></tr><tr style=''><td>MDM2</td><td>rs937283</td><td>5 Prime UTR Variant</td><td>12q15</td><td>Disease</td><td>&gt; 0.01</td><td>The Study of MDM2 rs937283 Variant and Cancer Susceptibility in a Central Chinese Population</td></tr><tr style=''><td>MDM4</td><td>rs4245739</td><td>Non Coding Transcript Variant</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association studies identify four ER negative–specific breast cancer risk loci</td></tr><tr style=''><td>MDM4</td><td>rs4245739</td><td>Non Coding Transcript Variant</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>MDM4</td><td>rs4245739</td><td>Non Coding Transcript Variant</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>MDM4&nbsp;</td><td>rs2169137</td><td>Intron&nbsp;</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>MEAK7</td><td>-</td><td>CNV</td><td>16q24.1&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>MEN1</td><td>-</td><td>Exon</td><td>11q13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Breast-Cancer Predisposition in Multiple Endocrine Neoplasia Type 1</td></tr><tr style=''><td>MGA&nbsp;</td><td>rs61736074</td><td>Exon</td><td>15q15</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>MGMT</td><td>rs2296675</td><td>Intron</td><td>10q26.3</td><td>Disease</td><td>&gt; 0.01</td><td>DNA repair gene variants in relation to overall cancer risk: a population-based study</td></tr><tr style=''><td>MIER3</td><td>-</td><td>-</td><td>5q11.2&nbsp;</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>MIR149&nbsp;</td><td>rs2292832&nbsp;</td><td>Non Coding Transcript Variant</td><td>2q37.3</td><td>Disease</td><td>&gt; 0.01</td><td>The association between genetic variation rs2292832 and the processing efficiency of pre-mir-149 affects the risk of breast cancer</td></tr><tr style=''><td>MIR155HG&nbsp;</td><td>rs190708267</td><td>Non Coding Transcript Variant</td><td>21q21.3</td><td>Disease</td><td>&lt; 0.01</td><td>A Single Variant in Pri-miRNA-155 Associated with Susceptibility to Hereditary Breast Cancer Promotes Aggressiveness in Breast Cancer Cells</td></tr><tr style=''><td>MIR196A2</td><td>rs11614913</td><td>Non Coding Transcript Variant</td><td>12q13.13</td><td>Disease</td><td>&gt; 0.01</td><td>Common Genetic Variants in pre-microRNAs Were Associated With Increased Risk of Breast Cancer in Chinese Women</td></tr><tr style=''><td>MIR196A2</td><td>rs11614913</td><td>Non Coding Transcript Variant</td><td>12q13.13</td><td>Disease</td><td>&gt; 0.01</td><td>Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients</td></tr><tr style=''><td>MIR23AHG&nbsp;</td><td>rs1531212</td><td>Non Coding Transcript Variant</td><td>19p13.12</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>MIR23AHG&nbsp;</td><td>rs895819&nbsp;</td><td>Non Coding Transcript Variant</td><td>19p13.12</td><td>Disease</td><td>&gt; 0.01</td><td>Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients</td></tr><tr style=''><td>MIR27A&nbsp;</td><td>rs895819&nbsp;</td><td>Non Coding Transcript Variant</td><td>19p13.12</td><td>Disease</td><td>&gt; 0.01</td><td>Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients</td></tr><tr style=''><td>MIR4713HG</td><td>rs10046</td><td>Intron</td><td>15q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Analysis of CYP17, CYP19 and CYP1A1 Gene Polymorphisms in Iranian Women With Breast Cancer</td></tr><tr style=''><td>MIR4713HG</td><td>rs1008805</td><td>Intron</td><td>15q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk</td></tr><tr style=''><td>MIR499A</td><td>rs3746444</td><td>Non Coding Transcript Variant</td><td>20q11.22</td><td>Disease</td><td>&gt; 0.01</td><td>Common Genetic Variants in pre-microRNAs Were Associated With Increased Risk of Breast Cancer in Chinese Women</td></tr><tr style=''><td>MIR499B</td><td>rs3746444</td><td>Non Coding Transcript Variant</td><td>20q11.22</td><td>Disease</td><td>&gt; 0.01</td><td>Common Genetic Variants in pre-microRNAs Were Associated With Increased Risk of Breast Cancer in Chinese Women</td></tr><tr style=''><td>MIR520F</td><td>rs75598818</td><td>Non Coding Transcript Variant</td><td>19q13.42</td><td>Protective</td><td>&gt; 0.01</td><td>Association of a Potential Functional mir-520f rs75598818 G&gt;A Polymorphism With Breast Cancer</td></tr><tr style=''><td>MIR603</td><td>rs11014002</td><td>Non Coding Transcript Variant</td><td>10p12.2</td><td>Protective</td><td>&gt; 0.01</td><td>Association Study of hsa-mir-603 rs11014002 Polymorphism and Risk of Breast Cancer in a Sample of Iranian Population</td></tr><tr style=''><td>MIR608</td><td>rs4919510</td><td>Non Coding Transcript Variant</td><td>10q24.31</td><td>Protective</td><td>&gt; 0.01</td><td>miR-608 rs4919510 C&gt;G Polymorphism Decreased the Risk of Breast Cancer in an Iranian Subpopulation</td></tr><tr style=''><td>MLH1</td><td>rs1799977</td><td>Exon</td><td>3p22.2</td><td>Protective</td><td>&gt; 0.01</td><td>Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk</td></tr><tr style=''><td>MLH3</td><td>rs175080</td><td>Exon</td><td>14q24.3</td><td>Protective</td><td>&gt; 0.01</td><td>Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study</td></tr><tr style=''><td>MLLT10</td><td>rs1243182</td><td>Intron</td><td>10p12.31</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>MLLT10&nbsp;</td><td>rs7098100</td><td>Intron&nbsp;</td><td>10p12.31</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>MLLT1&nbsp;</td><td>rs11880101</td><td>Exon</td><td>19p13.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>MMP1</td><td>rs5854</td><td>3 Prime UTR Variant</td><td>11q22.2</td><td>Protective</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study</td></tr><tr style=''><td>MMP1</td><td>rs7125062</td><td>Intron</td><td>11q22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study</td></tr><tr style=''><td>MMP1</td><td>rs996999</td><td>Intron</td><td>11q22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study</td></tr><tr style=''><td>MMP2</td><td>rs11541998</td><td>Exon</td><td>16q12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study</td></tr><tr style=''><td>MMP2</td><td>rs243845</td><td>Intron</td><td>16q12.2</td><td>Protective</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study</td></tr><tr style=''><td>MMP3</td><td>rs650108</td><td>Intron</td><td>11q22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study</td></tr><tr style=''><td>MMP9</td><td>rs17576</td><td>Exon</td><td>20q13.12</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study</td></tr><tr style=''><td>MMP9</td><td>rs17576</td><td>Exon</td><td>20q13.12</td><td>Protective</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Gene Polymorphisms Are Associated with Breast Cancer in the Caucasian Women of Russia</td></tr><tr style=''><td>MMP9</td><td>rs2250889</td><td>Exon</td><td>20q13.12</td><td>Protective</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Gene Polymorphisms Are Associated with Breast Cancer in the Caucasian Women of Russia</td></tr><tr style=''><td>MMP9</td><td>rs3787268</td><td>Intron</td><td>20q13.12</td><td>Disease</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study</td></tr><tr style=''><td>MRE11</td><td>-</td><td>Exon</td><td>11q21</td><td>Disease</td><td>&lt; 0.01</td><td>Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study</td></tr><tr style=''><td>MRPL23</td><td>rs2107425</td><td>Intron</td><td>11p15.5</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>MRPL23&nbsp;</td><td>rs217727</td><td>Intron&nbsp;</td><td>11p15.5</td><td>Disease</td><td>&gt; 0.01</td><td>Association between long non-coding RNA H19 polymorphisms and breast cancer risk: a meta-analysis</td></tr><tr style=''><td>MRPL23&nbsp;</td><td>rs2839698&nbsp;</td><td>Intron&nbsp;</td><td>11p15.5</td><td>Disease</td><td>&gt; 0.01</td><td>Association between long non-coding RNA H19 polymorphisms and breast cancer risk: a meta-analysis</td></tr><tr style=''><td>MRPL23&nbsp;</td><td>rs3741219</td><td>Intron&nbsp;</td><td>11p15.5</td><td>Disease</td><td>&gt; 0.01</td><td>Association between long non-coding RNA H19 polymorphisms and breast cancer risk: a meta-analysis</td></tr><tr style=''><td>MRPS18C</td><td>rs11099601</td><td>3 Prime UTR Variant</td><td>4q21.23</td><td>Disease</td><td>&gt; 0.01</td><td>Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21</td></tr><tr style=''><td>MRTFA</td><td>rs6001930</td><td>Intron</td><td>22q13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer</td></tr><tr style=''><td>MRTFA</td><td>rs6001930</td><td>Intron</td><td>22q13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk </td></tr><tr style=''><td>MRTFA&nbsp;</td><td>rs1246457062</td><td>Intron&nbsp;</td><td>22q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>MSH2</td><td>-</td><td>Exon</td><td>2p21-p16.3</td><td>Disease</td><td>&lt; 0.01</td><td>Association between the Lynch syndrome gene MSH2 and breast cancer susceptibility in a Canadian familial cancer registry</td></tr><tr style=''><td>MSH6</td><td>-</td><td>Exon</td><td>2p16.3</td><td>Disease</td><td>&lt; 0.01</td><td>MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer</td></tr><tr style=''><td>MSH6</td><td>-</td><td>Exon</td><td>2p16.3</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>MSH6</td><td>-</td><td>Exon</td><td>2p16.3</td><td>Protective</td><td>-</td><td>Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry</td></tr><tr style=''><td>MSTO1&nbsp;</td><td>rs12091730</td><td>Intron&nbsp;</td><td>1q22</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>MTCL1</td><td>rs2111836</td><td>Intron</td><td>18p11.2</td><td>Disease</td><td>&gt; 0.01</td><td>A Pilot Genome-wide Association Study of Breast Cancer Susceptibility Loci in Indonesia </td></tr><tr style=''><td>MTCL1</td><td>rs8087976</td><td>Intron</td><td>18p11.2</td><td>Disease</td><td>&gt; 0.01</td><td>A Pilot Genome-wide Association Study of Breast Cancer Susceptibility Loci in Indonesia </td></tr><tr style=''><td>MTHFR</td><td>rs1801133</td><td>Exon</td><td>1p36.22</td><td>Disease</td><td>&gt; 0.01</td><td>Association of MTHFR, MTRR and MTR polymorphisms with breast cancer risk: a study in Chinese females</td></tr><tr style=''><td>MTHFR</td><td>rs1801133</td><td>Exon</td><td>1p36.22</td><td>Disease</td><td>&gt; 0.01</td><td>Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer</td></tr><tr style=''><td>MTHFR</td><td>rs1801133</td><td>Exon</td><td>1p36.22</td><td>Disease</td><td>&gt; 0.01</td><td>One-Carbon Metabolism, MTHFR Polymorphisms, and Risk of Breast Cancer</td></tr><tr style=''><td>MTHFR</td><td>rs1801133</td><td>Exon</td><td>1p36.22</td><td>Disease</td><td>&gt; 0.01</td><td>Methylenetetrahydrofolate Reductase C677T polymorphism and breast cancer risk in Moroccan women</td></tr><tr style=''><td>MTHFR</td><td>rs1801133</td><td>Exon</td><td>1p36.22</td><td>Disease</td><td>&gt; 0.01</td><td>Association between dietary intake of folate and MTHFR and MTR genotype with risk of breast cancer</td></tr><tr style=''><td>MTHFR</td><td>rs1801133</td><td>Exon</td><td>1p36.22</td><td>Disease</td><td>&gt; 0.01</td><td>Evaluation of the Contribution of Methylenetetrahydrofolate Reductase Genotypes to Taiwan Breast Cancer</td></tr><tr style=''><td>MTHFR</td><td>rs1801133</td><td>Exon</td><td>1p36.22</td><td>Disease</td><td>&gt; 0.01</td><td>Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancer risk and interaction with folate, vitamin B6, and vitamin B 12 intakes</td></tr><tr style=''><td>MTHFR</td><td>rs1801133</td><td>Exon</td><td>1p36.22</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms in the MTHFR gene are associated with breast cancer risk and prognosis in a Chinese population</td></tr><tr style=''><td>MTHFR&nbsp;</td><td>rs1801133</td><td>Exon</td><td>1p36.22</td><td>Disease</td><td>&gt; 0.01</td><td>Association of&nbsp;MTHFR&nbsp;677C&gt;T polymorphism with breast cancer risk: A case-control study and meta-analysis</td></tr><tr style=''><td>MTMR11&nbsp;</td><td>rs11205303</td><td>Exon</td><td>1q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>MTR</td><td>rs1050993</td><td>3 Prime UTR Variant</td><td>1q43</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case–control study in Thai women </td></tr><tr style=''><td>MTR</td><td>rs1770449</td><td>Intron</td><td>1q43</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case–control study in Thai women </td></tr><tr style=''><td>MTR</td><td>rs1805087</td><td>Exon</td><td>1q43</td><td>Protective</td><td>&gt; 0.01</td><td>Role of polymorphism of methyltetrahydrofolate-homocysteine methyltransferase (MTR) A2756G and breast cancer risk</td></tr><tr style=''><td>MTR</td><td>rs1805087</td><td>Exon</td><td>1q43</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic polymorphisms in the one‐carbon metabolism pathway and breast cancer risk: A population‐based case–control study and meta‐analyses</td></tr><tr style=''><td>MTR</td><td>rs1805087</td><td>Exon</td><td>1q43</td><td>Disease</td><td>&gt; 0.01</td><td>Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent</td></tr><tr style=''><td>MTRR</td><td>rs162049</td><td>Intron</td><td>5p15.31</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case–control study in Thai women</td></tr><tr style=''><td>MTRR</td><td>rs1801394</td><td>Exon</td><td>5p15.31</td><td>Disease</td><td>&gt; 0.01</td><td>Association of MTHFR, MTRR and MTR polymorphisms with breast cancer risk: a study in Chinese females</td></tr><tr style=''><td>MUC4&nbsp;</td><td>rs868560707</td><td>Exon</td><td>3q29</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>MUS81</td><td>rs61754785</td><td>Exon</td><td>11q13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Germline Mutation in&nbsp;MUS81&nbsp;Resulting in Impaired Protein Stability is Associated with Familial Breast and Thyroid Cancer</td></tr><tr style=''><td>MUTYH</td><td>-</td><td>Exon</td><td>1p34.1</td><td>Disease</td><td>&lt; 0.01</td><td>Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP)</td></tr><tr style=''><td>MUTYH</td><td>-</td><td>Exon</td><td>1p34.1</td><td>Disease</td><td>&lt; 0.01</td><td>Expanded Extracolonic Tumor Spectrum in MUTYH -Associated Polyposis</td></tr><tr style=''><td>MUTYH</td><td>rs34612342</td><td>Exon</td><td>1p34.1</td><td>Disease</td><td>&lt; 0.01</td><td>Contribution of MUTYH Variants to Male Breast Cancer Risk: Results From a Multicenter Study in Italy</td></tr><tr style=''><td>MUTYH</td><td>rs36053993</td><td>Exon</td><td>1p34.1</td><td>Disease</td><td>&lt; 0.01</td><td>MutYH mutation carriers have increased breast cancer risk</td></tr><tr style=''><td>MYC</td><td>rs4645959</td><td>Exon</td><td>8q24.21</td><td>Disease</td><td>&gt; 0.01</td><td>c-MYC Asn11Ser is associated with increased risk for familial breast cancer</td></tr><tr style=''><td>MYH7B</td><td>rs3746444</td><td>Intron</td><td>20q11.22</td><td>Disease</td><td>&gt; 0.01</td><td>Common Genetic Variants in pre-microRNAs Were Associated With Increased Risk of Breast Cancer in Chinese Women</td></tr><tr style=''><td>MYO5A&nbsp;</td><td>rs61731219</td><td>Exon</td><td>15q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>NAT2</td><td>rs1799930</td><td>Exon</td><td>8p22</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case–control study in Thai women</td></tr><tr style=''><td>NBEA</td><td>-</td><td>Exon</td><td>13q13.3&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>NBN</td><td>rs1187082186</td><td>Exon</td><td>8q21.3</td><td>Disease</td><td>&lt; 0.01</td><td>Germline 657del5 mutation in the NBS1 gene in breast cancer patients</td></tr><tr style=''><td>NBN</td><td>rs1187082186</td><td>Exon</td><td>8q21.3</td><td>Disease</td><td>&lt; 0.01</td><td>Germline Mutations 657del5 of the NBS1 Gene Contribute Significantly to the Incidence of Breast Cancer in Central Poland</td></tr><tr style=''><td>NCOA1</td><td>rs200648189</td><td>Intron</td><td>2p23.3 </td><td>Protective</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>NCOA3</td><td>rs2076546</td><td>Exon</td><td>20q13.12</td><td>Protective</td><td>&gt; 0.01</td><td>Association of NCOA3 Polymorphisms with Breast Cancer Risk</td></tr><tr style=''><td>NCOA3</td><td>rs2230782</td><td>Exon</td><td>20q13.12</td><td>Protective</td><td>&gt; 0.01</td><td>Association of NCOA3 Polymorphisms with Breast Cancer Risk</td></tr><tr style=''><td>NDUFB3</td><td>rs116739540</td><td>Intron</td><td>2q33.2</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>NEK10&nbsp;</td><td>rs552647</td><td>Intron&nbsp;</td><td>3p24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>NF1</td><td>-</td><td>Exon</td><td>17q11.2</td><td>Disease</td><td>&lt; 0.01</td><td>Increased risk of breast cancer in women with NF1</td></tr><tr style=''><td>NF1</td><td>-</td><td>Exon</td><td>17q11.2</td><td>Disease</td><td>&lt; 0.01</td><td>Age-specific risk of breast cancer in women with neurofibromatosis type 1</td></tr><tr style=''><td>NF1</td><td>-</td><td>Exon</td><td>17q11.2</td><td>Disease</td><td>&lt; 0.01</td><td>A prospective study of neurofibromatosis type 1 cancer incidence in the UK</td></tr><tr style=''><td>NF1</td><td>-</td><td>Exon</td><td>17q11.2</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>NF1</td><td>-</td><td>Exon</td><td>17q11.2&nbsp;</td><td>Disease</td><td>-</td><td>Evaluating breast cancer predisposition genes in women of African ancestry</td></tr><tr style=''><td>NFIA</td><td>rs12727993</td><td>Intron</td><td>1p31.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>NFIX</td><td>rs78269692</td><td>Intron</td><td>19p13.13</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>NFIX&nbsp;</td><td>rs78269692</td><td>Intron&nbsp;</td><td>19p13.13&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>NLGN4X</td><td>-</td><td>CNV</td><td>Xp22.31&nbsp;</td><td>Protective</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>NOS3</td><td>rs1799983</td><td>Exon</td><td>7q36.1</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer</td></tr><tr style=''><td>NOTCH3</td><td>rs200504060</td><td>Exon</td><td>19p13.12</td><td>Disease</td><td>&lt; 0.01</td><td>Identification of Novel Breast Cancer Risk Loci</td></tr><tr style=''><td>NPHP1</td><td>-</td><td>CNV</td><td>2q13&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>NQO1</td><td>rs1800566</td><td>Exon</td><td>16q22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Breast cancer: role of polymorphisms in biotransformation enzymes</td></tr><tr style=''><td>NQO2</td><td>rs2071002</td><td>5 Prime UTR Variant</td><td>6p25.2</td><td>Protective</td><td>&gt; 0.01</td><td>Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53</td></tr><tr style=''><td>NR2F6</td><td>rs891205</td><td>Intron</td><td>19p13.12</td><td>Disease</td><td>&gt; 0.01</td><td>Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus</td></tr><tr style=''><td>NREP</td><td>rs6882649</td><td>Intron</td><td>5q22.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>NREP&nbsp;</td><td>rs6594555</td><td>Intron&nbsp;</td><td>5q22.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>NRG1&nbsp;</td><td>rs113317778</td><td>Exon</td><td>8p12</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>NTRK1&nbsp;</td><td>rs6336</td><td>Exon</td><td>1q23.1</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>NTRK1&nbsp;</td><td>rs6339</td><td>Exon</td><td>1q23.1</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>NUMA1</td><td>rs3750913</td><td>Exon</td><td>11q13.4</td><td>Disease</td><td>&gt; 0.01</td><td>Association of the NuMA region on chromosome 11q13 with breast cancer susceptibility</td></tr><tr style=''><td>NUP214&nbsp;</td><td>rs61756081</td><td>Exon</td><td>9q34.13</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>OGG1</td><td>rs1052133</td><td>Exon</td><td>3p25.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphism of hOGG1 ser326cys and its association with breast cancer in Jammu and Kashmir</td></tr><tr style=''><td>OGG1</td><td>rs1052133</td><td>Exon</td><td>3p25.3</td><td>Disease</td><td>&gt; 0.01</td><td>The hOGG1 Ser326Cys Gene Polymorphism and Breast Cancer Risk in Saudi Population</td></tr><tr style=''><td>OR2A1-AS1</td><td>rs62485509</td><td>Intron&nbsp;</td><td>7q35&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>OR4C11</td><td>-</td><td>CNV</td><td>11q11&nbsp;</td><td>Disease</td><td>-</td><td>Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry</td></tr><tr style=''><td>OR4P4</td><td>-</td><td>CNV</td><td>11q11&nbsp;</td><td>Disease</td><td>-</td><td>Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry</td></tr><tr style=''><td>ORC2</td><td>rs17383256</td><td>Intron</td><td>2q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>OTUD7B</td><td>rs12048493</td><td>Intron</td><td>1q21.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>P3R3URF-PIK3R3</td><td>rs1707302</td><td>Intron</td><td>1p34.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>P3R3URF-PIK3R3</td><td>rs1707302</td><td>Intron&nbsp;</td><td>1p34.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PALB2</td><td>-</td><td>Exon</td><td>16p12.2</td><td>Disease</td><td>&lt; 0.01</td><td>PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene</td></tr><tr style=''><td>PALB2</td><td>-</td><td>Exon</td><td>16p12.2</td><td>Disease</td><td>&lt; 0.01</td><td>Breast-Cancer Risk in Families with Mutations in PALB2</td></tr><tr style=''><td>PALB2</td><td>-</td><td>Exon</td><td>16p12.2</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>PALB2</td><td>-</td><td>Exon</td><td>16p12.2</td><td>Disease</td><td>&lt; 0.01</td><td>Male breast cancer risk associated with pathogenic variants in genes other than&nbsp;BRCA1/2: an Italian case-control study</td></tr><tr style=''><td>PALB2</td><td>-</td><td>Exon</td><td>16p12.2</td><td>Disease</td><td>-</td><td>Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry</td></tr><tr style=''><td>PALB2</td><td>-</td><td>Exon</td><td>16p12.2</td><td>Disease</td><td>-</td><td>Evaluating breast cancer predisposition genes in women of African ancestry</td></tr><tr style=''><td>PALB2</td><td>rs180177102</td><td>Exon</td><td>16p12.2</td><td>Disease</td><td>&lt; 0.01</td><td>A Recurrent Mutation in PALB2 in Finnish Cancer Families</td></tr><tr style=''><td>PARP1</td><td>rs1136410</td><td>Exon</td><td>1q42.12</td><td>Protective</td><td>&gt; 0.01</td><td>Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk</td></tr><tr style=''><td>PAX9</td><td>rs2236007</td><td>Intron</td><td>14q13.3</td><td>Protective</td><td>&gt; 0.01</td><td>Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls</td></tr><tr style=''><td>PAX9</td><td>rs2236007</td><td>Intron</td><td>14q13.3</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>PAX9&nbsp;</td><td>rs12881240</td><td>Exon</td><td>14q13.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PCDHGB2</td><td>-</td><td>CNV</td><td>5q31&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>PCM1&nbsp;</td><td>rs1302934371</td><td>Intron&nbsp;</td><td>8p22&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PCNT</td><td>rs35418111</td><td>Intron</td><td>21q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>PCNT</td><td>rs9808759</td><td>Intron</td><td>21q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>PCNT&nbsp;</td><td>rs35418111</td><td>Intron&nbsp;</td><td>21q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PCSK7</td><td>rs36028244</td><td>Intron&nbsp;</td><td>11q23.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PDCD6-AHRR</td><td>rs62641919</td><td>Intron</td><td>5p15.33</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>PDCD6-AHRR</td><td>rs62641919</td><td>Intron&nbsp;</td><td>5p15.33&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PDE4D</td><td>rs1353747</td><td>Intron</td><td>5q11.2 </td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>PDE7B</td><td>rs11154838</td><td>Intron</td><td>6q23.3 </td><td>Disease</td><td>&gt; 0.01</td><td>BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts</td></tr><tr style=''><td>PDGFRB&nbsp;</td><td>rs41287110</td><td>Exon</td><td>5q32&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>PEX14</td><td>rs10864459</td><td>Intron</td><td>1p36.22</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>PEX14</td><td>rs616488</td><td>Intron</td><td>1p36.22</td><td>Protective</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>PEX14</td><td>rs616488</td><td>Intron</td><td>1p36.22</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association studies identify four ER negative–specific breast cancer risk loci</td></tr><tr style=''><td>PEX14&nbsp;</td><td>rs2506885</td><td>Intron</td><td>1p36.22</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PEX14&nbsp;</td><td>rs616488</td><td>Intron&nbsp;</td><td>1p36.22</td><td>Disease</td><td>&gt; 0.01</td><td>Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population</td></tr><tr style=''><td>PGR</td><td>rs1042838</td><td>Exon</td><td>11q22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Commonly Studied Single-Nucleotide Polymorphisms and Breast Cancer: Results From the Breast Cancer Association Consortium</td></tr><tr style=''><td>PHF20&nbsp;</td><td>rs112208395</td><td>Intron&nbsp;</td><td>20q11.22</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PHLDA3</td><td>rs35383942</td><td>Exon</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>PHLDA3&nbsp;</td><td>rs35383942</td><td>Exon</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PIDD1</td><td>rs6597981</td><td>Intron</td><td>11p15.5</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>PIDD1&nbsp;</td><td>rs6597981</td><td>Intron&nbsp;</td><td>11p15.5&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PIK3CA&nbsp;</td><td>rs121913281&nbsp;</td><td>Exon </td><td>3q26.32</td><td>Disease</td><td>&gt; 0.01</td><td>Potential Impact of PI3K-AKT Signaling Pathway Genes, KLF-14, MDM4, miRNAs 27a, miRNA-196a Genetic Alterations in the Predisposition and Progression of Breast Cancer Patients</td></tr><tr style=''><td>PIK3R3</td><td>rs1707302</td><td>Intron</td><td>1p34.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>PIK3R3&nbsp;</td><td>rs1707302</td><td>Intron&nbsp;</td><td>1p34.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PIP4K2A</td><td>rs541079479</td><td>Intron</td><td>10p12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>PIP4K2A&nbsp;</td><td>rs541079479</td><td>Intron&nbsp;</td><td>10p12.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PLA2G6</td><td>rs738321</td><td>Intron</td><td>22q13.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>PLA2G6&nbsp;</td><td>rs738323</td><td>Intron&nbsp;</td><td>22q13.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PMF1</td><td>rs2758598</td><td>Intron</td><td>1q22</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>PMF1-BGLAP</td><td>rs2758598</td><td>Intron</td><td>1q22</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>PMS2</td><td>-</td><td>Exon</td><td>7p22.1</td><td>Disease</td><td>&lt; 0.01</td><td>MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer</td></tr><tr style=''><td>PMS2P5&nbsp;</td><td>rs111422494</td><td>Intron&nbsp;</td><td>7q11.23&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PNPLA4</td><td>-</td><td>CNV</td><td>Xp22.31&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>POGLUT3</td><td>rs11374964</td><td>3 Prime UTR Variant</td><td>11q22.3 </td><td>Protective</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>POGLUT3</td><td>rs74911261</td><td>Exon</td><td>11q22.3 </td><td>Protective</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>POLG</td><td>rs145289229</td><td>Exon</td><td>15q26.1</td><td>Disease</td><td>&lt; 0.01</td><td>Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer</td></tr><tr style=''><td>POLR3C&nbsp;</td><td>rs143384623</td><td>Intron&nbsp;</td><td>1q21.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PON1</td><td>rs854560</td><td>Exon</td><td>7q21.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association of Polymorphisms in the Paraoxonase 1 Gene with Breast Cancer Incidence in the CPS-II Nutrition Cohort</td></tr><tr style=''><td>PON1</td><td>rs854560</td><td>Exon</td><td>7q21.3</td><td>Disease</td><td>&gt; 0.01</td><td>CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study</td></tr><tr style=''><td>PON1</td><td>rs854560</td><td>Exon</td><td>7q21.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms of Paraoxonase 1 (PON1) Gene: Association Between L55M or Q192R with Breast Cancer Risk and Clinico-Pathological Parameters</td></tr><tr style=''><td>PON1</td><td>rs854560</td><td>Exon</td><td>7q21.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association of L55M and Q192R Polymorphisms in Paraoxonase 1 (PON1) Gene With Breast Cancer Risk and Their Clinical Significance</td></tr><tr style=''><td>PON1</td><td>rs854560</td><td>Exon</td><td>7q21.3</td><td>Disease</td><td>&gt; 0.01</td><td>A common genetic variation in paraoxonase 1 and risk of breast cancer: a literature review, meta-analysis, and&nbsp;in silico&nbsp;analysis</td></tr><tr style=''><td>POR</td><td>rs10262966</td><td>Exon</td><td>7q11.23</td><td>Disease</td><td>&gt; 0.01</td><td>A Variant in the Cytochrome p450 Oxidoreductase Gene Is Associated With Breast Cancer Risk in African Americans</td></tr><tr style=''><td>PPA2</td><td>rs77928427</td><td>Intron</td><td>4q24</td><td>Disease</td><td>&gt; 0.01</td><td>Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk</td></tr><tr style=''><td>PPARA</td><td>rs1800206</td><td>Exon</td><td>22q13.31</td><td>Disease</td><td>&gt; 0.01</td><td>Impact of Interaction Between PPAR Alpha and PPAR Gamma on Breast Cancer Risk in the Chinese Han Population</td></tr><tr style=''><td>PPARA</td><td>rs4253760</td><td>Intron</td><td>22q13.31</td><td>Disease</td><td>&gt; 0.01</td><td>Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: a Long Island ancillary study</td></tr><tr style=''><td>PPARG</td><td>rs1805192</td><td>Exon</td><td>3p25.2</td><td>Disease</td><td>&gt; 0.01</td><td>Impact of Interaction Between PPAR Alpha and PPAR Gamma on Breast Cancer Risk in the Chinese Han Population</td></tr><tr style=''><td>PPARGC1A</td><td>rs3736265</td><td>Exon</td><td>4p15.2</td><td>Disease</td><td>&gt; 0.01</td><td>Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer</td></tr><tr style=''><td>PPARGC1B</td><td>rs7732671</td><td>Exon</td><td>5q32</td><td>Disease</td><td>&gt; 0.01</td><td>Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer</td></tr><tr style=''><td>PPIL3 </td><td>rs115635831</td><td>Intron</td><td>2q33</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>PPM1D</td><td>-</td><td>Exon</td><td>17q23.2</td><td>Disease</td><td>&lt; 0.01</td><td>Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer</td></tr><tr style=''><td>PPM1K-DT</td><td>rs10022462</td><td>Intron</td><td>4q22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>PPM1K-DT</td><td>rs10022462</td><td>Intron&nbsp;</td><td>4q22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PPP3CA</td><td>rs17030831</td><td>Intron</td><td>4q23</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>PRC1</td><td>rs2290203</td><td>Intron</td><td>15q26.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1</td></tr><tr style=''><td>PRC1</td><td>rs8042680</td><td>Intron</td><td>15q26.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry</td></tr><tr style=''><td>PRC1-AS1</td><td>rs2290203</td><td>Intron</td><td>15q26.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1</td></tr><tr style=''><td>PRC1-AS1</td><td>rs8042680</td><td>Intron</td><td>15q26.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry</td></tr><tr style=''><td>PRDM2</td><td>rs2235515</td><td>Intron</td><td>1p36.21</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic variants in epigenetic genes and breast cancer risk </td></tr><tr style=''><td>PRKG1&nbsp;</td><td>rs1937680</td><td>Intron&nbsp;</td><td>10q11.23</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>PSMG4</td><td>rs9391988</td><td>3 Prime UTR Variant</td><td>6p25.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>PTCH1&nbsp;</td><td>rs2066829</td><td>Intron&nbsp;</td><td>9q22.32&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Inherited rare and common variants in PTCH1 and PTCH2 contributing to the predisposition to reproductive cancers</td></tr><tr style=''><td>PTCH1&nbsp;</td><td>rs2236405</td><td>Exon</td><td>9q22.32&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Inherited rare and common variants in PTCH1 and PTCH2 contributing to the predisposition to reproductive cancers</td></tr><tr style=''><td>PTCH1&nbsp;</td><td>rs2277184</td><td>Intron&nbsp;</td><td>9q22.32&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Inherited rare and common variants in PTCH1 and PTCH2 contributing to the predisposition to reproductive cancers</td></tr><tr style=''><td>PTCH1&nbsp;</td><td>rs357564</td><td>Exon</td><td>9q22.32&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Inherited rare and common variants in PTCH1 and PTCH2 contributing to the predisposition to reproductive cancers</td></tr><tr style=''><td>PTCH2&nbsp;</td><td>rs11211040</td><td>Intron&nbsp;</td><td>1p34.1</td><td>Protective</td><td>&gt; 0.01</td><td>Inherited rare and common variants in PTCH1 and PTCH2 contributing to the predisposition to reproductive cancers</td></tr><tr style=''><td>PTCH2&nbsp;</td><td>rs11573590</td><td>Exon</td><td>1p34.1</td><td>Protective</td><td>&gt; 0.01</td><td>Inherited rare and common variants in PTCH1 and PTCH2 contributing to the predisposition to reproductive cancers</td></tr><tr style=''><td>PTCH2&nbsp;</td><td>rs3795720</td><td>Intron&nbsp;</td><td>1p34.1</td><td>Protective</td><td>&gt; 0.01</td><td>Inherited rare and common variants in PTCH1 and PTCH2 contributing to the predisposition to reproductive cancers</td></tr><tr style=''><td>PTEN</td><td>-</td><td>Exon</td><td>10q23.31</td><td>Disease</td><td>&lt; 0.01</td><td>Inherited Mutations in PTEN That Are Associated with Breast Cancer, Cowden Disease, and Juvenile Polyposis</td></tr><tr style=''><td>PTEN</td><td>-</td><td>Exon</td><td>10q23.31</td><td>Disease</td><td>&lt; 0.01</td><td>High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome</td></tr><tr style=''><td>PTEN</td><td>-</td><td>Exon</td><td>10q23.31</td><td>Disease</td><td>&lt; 0.01</td><td> Lifetime Cancer Risks in Individuals with Germline PTEN Mutations</td></tr><tr style=''><td>PTEN</td><td>-</td><td>Exon</td><td>10q23.31</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>PTEN</td><td>-</td><td>Exon</td><td>10q23.31</td><td>Disease</td><td>-</td><td>Evaluating breast cancer predisposition genes in women of African ancestry</td></tr><tr style=''><td>PTGS1</td><td>rs10306194</td><td>3 Prime UTR Variant</td><td>9q33.2</td><td>Disease</td><td>&gt; 0.01</td><td>Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non‐Hispanic white women: The breast cancer health disparities study</td></tr><tr style=''><td>PTPN9</td><td>rs8027365</td><td>Intron</td><td>15q24.2</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>PTPRB&nbsp;</td><td>rs61754227</td><td>Exon</td><td>12q15&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>RABEP1</td><td>rs61735455</td><td>Exon</td><td>17p13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>RAD50</td><td>rs751781524</td><td>Exon</td><td>5q31.1</td><td>Disease</td><td>&lt; 0.01</td><td>RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability</td></tr><tr style=''><td>RAD51</td><td>rs1801320</td><td>Intron</td><td>15q15.1</td><td>Disease</td><td>&gt; 0.01</td><td>Correlation between selected XRCC2, XRCC3 and RAD51 gene polymorphisms and primary breast cancer in women in Pakistan</td></tr><tr style=''><td>RAD51B</td><td>-</td><td>Exon</td><td>14q24.1</td><td>Disease</td><td>&lt; 0.01</td><td>Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination</td></tr><tr style=''><td>RAD51B</td><td>rs10483813</td><td>Intron</td><td>14q24.1</td><td>Protective</td><td>&gt; 0.01</td><td>Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium</td></tr><tr style=''><td>RAD51B</td><td>rs1314913</td><td>Intron</td><td>14q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>RAD51B in Familial Breast Cancer</td></tr><tr style=''><td>RAD51B</td><td>rs2588809</td><td>Intron</td><td>14q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>RAD51B in Familial Breast Cancer</td></tr><tr style=''><td>RAD51B</td><td>rs2588809</td><td>Intron</td><td>14q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk </td></tr><tr style=''><td>RAD51B</td><td>rs2588809</td><td>Intron</td><td>14q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>RAD51B</td><td>rs8009944</td><td>Intron</td><td>14q24.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>RAD51B</td><td>rs999737</td><td>Intron</td><td>14q24.1</td><td>Protective</td><td>&gt; 0.01</td><td>Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium</td></tr><tr style=''><td>RAD51B</td><td>rs999737</td><td>Intron</td><td>14q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>RAD51B in Familial Breast Cancer</td></tr><tr style=''><td>RAD51B</td><td>rs999737</td><td>Intron</td><td>14q24.1</td><td>Protective</td><td>&gt; 0.01</td><td>A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)</td></tr><tr style=''><td>RAD51B&nbsp;</td><td>rs10483813</td><td>Intron&nbsp;</td><td>14q24.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>RAD51B&nbsp;</td><td>rs1744947</td><td>Intron&nbsp;</td><td>14q24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>RAD51C</td><td>-</td><td>Exon</td><td>17q22</td><td>Disease</td><td>&lt; 0.01</td><td>Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene</td></tr><tr style=''><td>RAD51C</td><td>-</td><td>Exon</td><td>17q22</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>RAD51C</td><td>-</td><td>Exon</td><td>17q22&nbsp;</td><td>Disease</td><td>-</td><td>Evaluating breast cancer predisposition genes in women of African ancestry</td></tr><tr style=''><td>RAD51D</td><td>-</td><td>Exon</td><td>17q12</td><td>Disease</td><td>&lt; 0.01</td><td>Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing</td></tr><tr style=''><td>RAD51D</td><td>-</td><td>Exon</td><td>17q12</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>RAD51D</td><td>-</td><td>Exon</td><td>17q12</td><td>Disease</td><td>-</td><td>Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry</td></tr><tr style=''><td>RAD51D</td><td>-</td><td>Exon</td><td>17q12&nbsp;</td><td>Disease</td><td>-</td><td>Evaluating breast cancer predisposition genes in women of African ancestry</td></tr><tr style=''><td>RAD51D</td><td>rs28363284</td><td>Exon</td><td>17q12</td><td>Disease</td><td>&lt; 0.01</td><td>The variant E233G of the RAD51D gene could be a low‐penetrance allele in high‐risk breast cancer families without BRCA1/2 mutations</td></tr><tr style=''><td>RAD51D</td><td>rs753862052</td><td>Exon</td><td>17q12</td><td>Disease</td><td>&lt; 0.01</td><td>Associations between RAD51D germline mutations and breast cancer risk and survival in BRCA1/2-negative breast cancers</td></tr><tr style=''><td>RAD51L3-RFFL</td><td>rs28363284</td><td>Non Coding Transcript Variant</td><td>17q12</td><td>Disease</td><td>&lt; 0.01</td><td>The variant E233G of the RAD51D gene could be a low‐penetrance allele in high‐risk breast cancer families without BRCA1/2 mutations</td></tr><tr style=''><td>RAD51L3-RFFL</td><td>rs753862052</td><td>Intron</td><td>17q12</td><td>Disease</td><td>&lt; 0.01</td><td>Associations between RAD51D germline mutations and breast cancer risk and survival in BRCA1/2-negative breast cancers</td></tr><tr style=''><td>RAD51&nbsp;</td><td>rs1801320</td><td>Intron&nbsp;</td><td>15q15.1</td><td>Disease</td><td>&gt; 0.01</td><td>Homologous recombination DNA repair gene RAD51, XRCC2 &amp; XRCC3 polymorphisms and breast cancer risk in South Indian women</td></tr><tr style=''><td>RAD51&nbsp;</td><td>rs1801320</td><td>Intron&nbsp;</td><td>15q15.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association of&nbsp;RAD51,&nbsp;XRCC1,&nbsp;XRCC2, and&nbsp;XRCC3&nbsp;Polymorphisms with Risk of Breast Cancer</td></tr><tr style=''><td>RAD51&nbsp;</td><td>rs1801321</td><td>Intron&nbsp;</td><td>15q15.1&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Relationship between polymorphisms in homologous recombination repair genes RAD51 G172T、XRCC2 &amp; XRCC3 and risk of breast cancer: A meta-analysis</td></tr><tr style=''><td>RAD52&nbsp;</td><td>-</td><td>CNV deletion</td><td>12p13.33</td><td>Disease</td><td>&lt; 0.01</td><td>Exome sequencing identified rare recurrent copy number variants and hereditary breast cancer susceptibility</td></tr><tr style=''><td>RALY</td><td>rs2284378</td><td>Intron</td><td>20q11</td><td>Disease</td><td>&gt; 0.01</td><td>A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11</td></tr><tr style=''><td>RALY</td><td>rs2284378</td><td>Intron</td><td>20q11.21</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>RASSF1&nbsp;</td><td>rs2073498</td><td>Exon</td><td>3p21.31&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Exome sequencing identifies RASSF1 and KLK3 germline variants in an Iranian multiple-case breast cancer family</td></tr><tr style=''><td>RBBP8</td><td>rs1467584861</td><td>Exon</td><td>18q11.2</td><td>Disease</td><td>&lt; 0.01</td><td>Germline RBBP8 variants associated with early-onset breast cancer compromise replication fork stability</td></tr><tr style=''><td>RBFOX1</td><td>rs17823421</td><td>Intron</td><td>16p13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>RCC2&nbsp;</td><td>rs6586541</td><td>Intron</td><td>1p36.13</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>RECQL</td><td>-</td><td>Exon</td><td>12p12.1</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>RECQL</td><td>rs376839517</td><td>Exon</td><td>12p12.1</td><td>Disease</td><td>&lt; 0.01</td><td>Germline RECQL mutations are associated with breast cancer susceptibility </td></tr><tr style=''><td>RECQL</td><td>rs777214281</td><td>Exon</td><td>12p12.1</td><td>Disease</td><td>&lt; 0.01</td><td>Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer</td></tr><tr style=''><td>RECQL5&nbsp;</td><td>-</td><td>Exon</td><td>17q25&nbsp;</td><td>Disease</td><td>-</td><td>A Large Case-Control Study Performed in Spanish Population Suggests That&nbsp;RECQL5&nbsp;Is the Only RECQ Helicase Involved in Breast Cancer Susceptibility</td></tr><tr style=''><td>RIN3</td><td>rs11627032</td><td>Intron</td><td>14q32.12</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>RIN3&nbsp;</td><td>rs78440108</td><td>Intron&nbsp;</td><td>14q32.12</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>RINT1</td><td>rs143184349</td><td>Exon</td><td>7q22.3</td><td>Disease</td><td>&lt; 0.01</td><td>Rare mutations in RINT1 predispose carriers to breast and Lynch Syndrome-spectrum cancers</td></tr><tr style=''><td>RINT1</td><td>rs150793856</td><td>Exon</td><td>7q22.3</td><td>Disease</td><td>&lt; 0.01</td><td>Rare mutations in RINT1 predispose carriers to breast and Lynch Syndrome-spectrum cancers</td></tr><tr style=''><td>RNF115</td><td>rs12405132</td><td>Intron</td><td>1q21.1 </td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>RNF146</td><td>rs2180341</td><td>Intron</td><td>6q22.33</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33</td></tr><tr style=''><td>RNF146</td><td>rs6569479</td><td>Intron</td><td>6q22.33</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33</td></tr><tr style=''><td>RNF19A</td><td>rs2849506</td><td>Intron</td><td>8q22.2</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>RNF19A&nbsp;</td><td>rs2849506</td><td>Intron&nbsp;</td><td>8q22.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>RNF213</td><td>rs62077764</td><td>Exon</td><td>17q25.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>RNF213-AS1</td><td>rs61745599</td><td>Intron</td><td>17q25.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>RNF213-AS1</td><td>rs62077764</td><td>Intron</td><td>17q25.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>RNF213&nbsp;</td><td>rs61745599</td><td>Exon</td><td>17q25.3&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>RNF43&nbsp;</td><td>rs142097313</td><td>Exon</td><td>17q22</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>RNF43&nbsp;</td><td>rs2680701</td><td>Exon</td><td>17q22</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>RNF43&nbsp;</td><td>rs34523089</td><td>Exon</td><td>17q22</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>ROPN1L</td><td>rs1092913</td><td>Intron</td><td>19q13.41</td><td>Disease</td><td>&gt; 0.01</td><td>Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility</td></tr><tr style=''><td>ROS1&nbsp;</td><td>rs2229079</td><td>Exon</td><td>6q22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>RP11.363G10.2</td><td>-</td><td>CNV</td><td>Xp11.22</td><td>Protective</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>RPL23AP53</td><td>rs66823261</td><td>Intron</td><td>8p23.3</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>RPS6KA2</td><td>-</td><td>CNV</td><td>6q27</td><td>Protective</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>RPS6KA3</td><td>rs114874970</td><td>Intron</td><td>Xp22.12</td><td>Disease</td><td>&gt; 0.01</td><td>Association of breast cancer risk and the mTOR pathway in women of African ancestry in ‘The Root’ Consortium</td></tr><tr style=''><td>RSU1</td><td>-</td><td>CNV</td><td>10p13&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>SCFD2</td><td>rs11947923</td><td>Intron</td><td>4q12</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>SCFD2&nbsp;</td><td>rs12506630</td><td>Intron&nbsp;</td><td>4q12&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>SDC4&nbsp;</td><td>rs1981429&nbsp;</td><td>Intron&nbsp;</td><td>20q13.12</td><td>Disease</td><td>&gt; 0.01</td><td>SDC4-rs1981429 and ATM-rs228590 may provide early biomarkers of breast cancer risk</td></tr><tr style=''><td>SELENOP</td><td>rs3877899</td><td>Exon</td><td>5p12</td><td>Protective</td><td>&gt; 0.01</td><td>Association between Polymorphisms in Glutathione Peroxidase and Selenoprotein P Genes, Glutathione Peroxidase Activity, HRT Use and Breast Cancer Risk</td></tr><tr style=''><td>SEMA4G</td><td>rs4919510</td><td>Intron</td><td>10q24.31</td><td>Protective</td><td>&gt; 0.01</td><td>miR-608 rs4919510 C&gt;G Polymorphism Decreased the Risk of Breast Cancer in an Iranian Subpopulation</td></tr><tr style=''><td>SERPINA3</td><td>rs199710314</td><td>Splice Acceptor Variant</td><td>14q32.13</td><td>Disease</td><td>&lt; 0.01</td><td>Exome sequencing identifies a recurrent variant in&nbsp;SERPINA3&nbsp;associating with hereditary susceptibility to breast cancer</td></tr><tr style=''><td>SETBP1</td><td>rs11875595</td><td>Intron</td><td>18q12.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>SETBP1</td><td>rs6507583</td><td>Intron</td><td>18q12.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>SETBP1</td><td>rs6507583</td><td>Intron</td><td>18q12.3</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>SETBP1&nbsp;</td><td>rs9954058</td><td>Intron&nbsp;</td><td>18q12.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>SHBG</td><td>rs6257</td><td>Intron</td><td>17p13.1</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of common variants in the SHBG gene affecting sex hormone-binding globulin levels and breast cancer risk in postmenopausal women</td></tr><tr style=''><td>SHC1</td><td>rs8191979</td><td>Exon</td><td>1q21.3</td><td>Protective</td><td>&gt; 0.01</td><td>The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer</td></tr><tr style=''><td>SHMT1</td><td>rs1979277</td><td>Exon</td><td>17p11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent</td></tr><tr style=''><td>SHMT1</td><td>rs1979277</td><td>Exon</td><td>17p11.2</td><td>Protective</td><td>&gt; 0.01</td><td>Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan</td></tr><tr style=''><td>SIAH2</td><td>rs60538652</td><td>Intron</td><td>3q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts</td></tr><tr style=''><td>SIAH2</td><td>rs6788895</td><td>Intron</td><td>3q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese</td></tr><tr style=''><td>SIAH2&nbsp;</td><td>rs73006998</td><td>Intron&nbsp;</td><td>3q25.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>SIPA1</td><td>rs3741378</td><td>Exon</td><td>11q13.1</td><td>Disease</td><td>&gt; 0.01</td><td>The Relationship between the Mutation rs3741378 of SIPA1 Gene and Breast Cancer in Vietnamese Women</td></tr><tr style=''><td>SIRT3</td><td>-</td><td>Intron</td><td>11p15.5&nbsp;</td><td>Disease</td><td>-</td><td>VNTR Polymorphism in the Intron 5 of SIRT3 and Susceptibility to Breast Cancer</td></tr><tr style=''><td>SLC12A5-AS1</td><td>rs2250889</td><td>Non Coding Transcript Variant</td><td>20q13.12</td><td>Protective</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Gene Polymorphisms Are Associated with Breast Cancer in the Caucasian Women of Russia</td></tr><tr style=''><td>SLC14A2</td><td>rs17743054</td><td>Intron</td><td>18q12.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>SLC14A2&nbsp;</td><td>rs9952980</td><td>Intron&nbsp;</td><td>18q12.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>SLC19A1</td><td>rs1051266</td><td>Exon</td><td>4p14</td><td>Protective</td><td>&gt; 0.01</td><td>Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent</td></tr><tr style=''><td>SLC22A23</td><td>rs9391988</td><td>Intron</td><td>6p25.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>SLC36A4</td><td>rs1508608</td><td>Intron</td><td>11q21</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>SLC39A11</td><td>rs4969001</td><td>Intron</td><td>17q25.1</td><td>Disease</td><td>&gt; 0.01</td><td>BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts</td></tr><tr style=''><td>SLC4A7</td><td>rs4973768</td><td>Non Coding Transcript Variant</td><td>3p24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2</td></tr><tr style=''><td>SLC4A7</td><td>rs4973768</td><td>Non Coding Transcript Variant</td><td>3p24.1</td><td>Disease</td><td>&gt; 0.01</td><td>The SLC4A7 variant rs4973768 is associated with breast cancer risk: evidence from a case-control study and a meta-analysis</td></tr><tr style=''><td>SLC4A7</td><td>rs4973768</td><td>Non Coding Transcript Variant</td><td>3p24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>SLC4A7</td><td>rs4973768</td><td>Non Coding Transcript Variant</td><td>3p24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Update on the relationship between the&nbsp;SLC4A7&nbsp;variant rs4973768 and breast cancer risk: a systematic review and meta-analysis</td></tr><tr style=''><td>SLC6A4</td><td>rs140701</td><td>Intron</td><td>17q11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case–control study in Thai women</td></tr><tr style=''><td>SLC8A1&nbsp;</td><td>rs727477</td><td>Intron&nbsp;</td><td>2p22.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>SLIT3</td><td>rs11134527</td><td>Intron</td><td>5q35.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association Study of miR-100, miR-124-1, miR-218-2, miR-301b, miR-605, and miR-4293 Polymorphisms and the Risk of Breast Cancer in a Sample of Iranian Population</td></tr><tr style=''><td>SMARCA2</td><td>-</td><td>Exon</td><td>9p24.3</td><td>Disease</td><td>-</td><td>A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31</td></tr><tr style=''><td>SMC2</td><td>rs10820600</td><td>Non Coding Transcript Variant</td><td>9q31.1</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>SMC2</td><td>rs4742903</td><td>Intron</td><td>9q31.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>SMC2&nbsp;</td><td>rs10820600</td><td>Intron&nbsp;</td><td>9q31.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>SNX32&nbsp;</td><td>rs548082010</td><td>Intron&nbsp;</td><td>11q13.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>SOD1&nbsp;</td><td>rs1041740</td><td>Intron&nbsp;</td><td>21q22.11</td><td>Disease</td><td>&gt; 0.01</td><td>SOD1 gene variants rs4817415, rs2070424, and rs1041740 and their association with breast cancer risk</td></tr><tr style=''><td>SOD1&nbsp;</td><td>rs2070424</td><td>Intron&nbsp;</td><td>21q22.11</td><td>Disease</td><td>&gt; 0.01</td><td>SOD1 gene variants rs4817415, rs2070424, and rs1041740 and their association with breast cancer risk</td></tr><tr style=''><td>SOD2</td><td>rs4880</td><td>Exon</td><td>6q25.3</td><td>Protective</td><td>&gt; 0.01</td><td>Oxidative stress-related enzyme gene polymorphisms and susceptibility to breast cancer in non-smoking, non-alcohol-consuming Taiwanese women: a case-control study</td></tr><tr style=''><td>SOD2</td><td>rs5746136</td><td>Intron&nbsp;</td><td>6q25.3</td><td>Protective</td><td>&gt; 0.01</td><td>Association of SOD2 rs2758339, rs5746136 and rs2842980 polymorphisms with increased risk of breast cancer: a haplotype-based case-control study</td></tr><tr style=''><td>SPDYE12&nbsp;</td><td>rs111422494</td><td>Intron&nbsp;</td><td>7q11.23&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>SRD5A2</td><td>rs523349</td><td>Exon</td><td>2p23.1</td><td>Disease</td><td>&gt; 0.01</td><td>SRD5A2 gene polymorphisms affect the risk of breast cancer</td></tr><tr style=''><td>SRGAP2C</td><td>-</td><td>-</td><td>1p11.2</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>SSBP2</td><td>rs6887937</td><td>Intron</td><td>5q14.1</td><td>Disease</td><td>&gt; 0.01</td><td>A Pilot Genome-wide Association Study of Breast Cancer Susceptibility Loci in Indonesia </td></tr><tr style=''><td>SST</td><td>rs4988513</td><td>Intron</td><td>3q27.3</td><td>Protective</td><td>&gt; 0.01</td><td>Polymorphisms in genes involved in GH1 release and their association with breast cancer risk</td></tr><tr style=''><td>SST</td><td>rs4988513</td><td>Intron</td><td>3q27.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Variation in the Growth Hormone Synthesis Pathway in Relation to Circulating Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Breast Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition Study</td></tr><tr style=''><td>SSTR2</td><td>rs1466113</td><td>Intron</td><td>17q25.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Variation in the Growth Hormone Synthesis Pathway in Relation to Circulating Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Breast Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition Study</td></tr><tr style=''><td>STAU2</td><td>rs6991116</td><td>Intron</td><td>8q21.11</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>STK11</td><td>-</td><td>Exon</td><td>19p13.3</td><td>Disease</td><td>&lt; 0.01</td><td>Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome</td></tr><tr style=''><td>STRADB</td><td>rs16837635</td><td>Intron</td><td>2q33.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association of breast cancer risk and the mTOR pathway in women of African ancestry in ‘The Root’ Consortium</td></tr><tr style=''><td>STT3A-AS1</td><td>rs2155388</td><td>Intron</td><td>3q23</td><td> Disease</td><td>&gt; 0.01</td><td>Associations of ATR and CHEK1 Single Nucleotide Polymorphisms with Breast Cancer</td></tr><tr style=''><td>STXBP4</td><td>rs1156287</td><td>Exon</td><td>17q22 </td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>STXBP4</td><td>rs2787486</td><td>Intron</td><td>17q22</td><td>Protective</td><td>&gt; 0.01</td><td>Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)</td></tr><tr style=''><td>STXBP4</td><td>rs6504950</td><td>Intron</td><td>17q22 </td><td>Protective</td><td>&gt; 0.01</td><td>Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2</td></tr><tr style=''><td>STXBP4&nbsp;</td><td>rs244373</td><td>Intron&nbsp;</td><td>17q22&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>SUB1</td><td>rs2012709</td><td>Intron</td><td>5p13.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>SULT1A1</td><td>rs1042028</td><td>Exon</td><td>16p11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Sulfotransferase 1A1 Polymorphism, Endogenous Estrogen Exposure, Well-done Meat Intake, and Breast Cancer Risk</td></tr><tr style=''><td>SULT1A1</td><td>rs1042028</td><td>Exon</td><td>16p11.2</td><td>Disease</td><td>&gt; 0.01</td><td>CYP17 and SULT1A1 Gene Polymorphisms in Indian Breast Cancer</td></tr><tr style=''><td>SULT1A1</td><td>rs1042028</td><td>Exon</td><td>16p11.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphism of estrogen metabolizing enzymes in Siberian women with breast cancer</td></tr><tr style=''><td>SULT1E1</td><td>rs3775778</td><td>Intron</td><td>4q13.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer</td></tr><tr style=''><td>SUPT3H</td><td>-</td><td>CNV</td><td>6p21.1&nbsp;</td><td>Protective</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>TAB2</td><td>rs9485372</td><td>Intron</td><td>6q25.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-Wide Association Study in East Asians Identifies Novel Susceptibility Loci for Breast Cancer</td></tr><tr style=''><td>TAB2&nbsp;</td><td>rs574009266</td><td>Intron&nbsp;</td><td>6q25.1&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>TANK</td><td>rs7309</td><td>3 Prime UTR Variant</td><td>2q24.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study</td></tr><tr style=''><td>TBX1</td><td>rs34331122</td><td>Intron</td><td>22q11.21</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>TBX1&nbsp;</td><td>rs34331122</td><td>Intron&nbsp;</td><td>22q11.21</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>TBX3</td><td>rs1061657</td><td>3 Prime UTR Variant</td><td>12q24.21</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>TBX3&nbsp;</td><td>rs12366395&nbsp;</td><td>5 Prime UTR Variant</td><td>12q24.21</td><td>Disease</td><td>&gt; 0.01</td><td>Heritable genomic diversity in breast cancer driver genes and associations with risk in a Chilean population</td></tr><tr style=''><td>TCF7L2</td><td>rs12255372</td><td>Intron</td><td>10q25.2</td><td>Disease</td><td>&gt; 0.01</td><td>Transcription Factor 7-like 2 (TCF7L2) Variant Is Associated With Familial Breast Cancer Risk: A Case-Control Study</td></tr><tr style=''><td>TCF7L2</td><td>rs12255372</td><td>Intron</td><td>10q25.2</td><td>Protective</td><td>&gt; 0.01</td><td>Association of Single Nucleotide Polymorphisms in Wnt Signaling Pathway Genes With Breast Cancer in Saudi Patients</td></tr><tr style=''><td>TCF7L2</td><td>rs12255372</td><td>Intron</td><td>10q25.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genotypes and Haplotypes in the&nbsp;AXIN2&nbsp;and&nbsp;TCF7L2&nbsp;Genes are Associated With Susceptibility and With Clinicopathological Characteristics in Breast Cancer Patients</td></tr><tr style=''><td>TCF7L2</td><td>rs6585202</td><td>Intron</td><td>10q25.2&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>TCF7L2</td><td>rs7903146</td><td>Intron</td><td>10q25.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry</td></tr><tr style=''><td>TCF7L2</td><td>rs7903146</td><td>Intron</td><td>10q25.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genotypes and Haplotypes in the&nbsp;AXIN2&nbsp;and&nbsp;TCF7L2&nbsp;Genes are Associated With Susceptibility and With Clinicopathological Characteristics in Breast Cancer Patients</td></tr><tr style=''><td>TCF7L2</td><td>rs7904519</td><td>Intron</td><td>10q25.2</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>TEC</td><td>rs11944638</td><td>Intron</td><td>4p11</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants</td></tr><tr style=''><td>TEC&nbsp;</td><td>rs11944638</td><td>Intron&nbsp;</td><td>4p11&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>TEFM</td><td>rs10612648</td><td>Intron</td><td>17q11.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</td></tr><tr style=''><td>TERT</td><td>rs10069690</td><td>Intron</td><td>5p15.33</td><td>Disease</td><td>&gt; 0.01</td><td>A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer</td></tr><tr style=''><td>TERT</td><td>rs10069690</td><td>Intron</td><td>5p15.33</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>TERT</td><td>rs10069690</td><td>Intron</td><td>5p15.33</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>TERT</td><td>rs2242652</td><td>Intron</td><td>5p15.33</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>TERT</td><td>rs7726159</td><td>Intron</td><td>5p15.33</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>TERT</td><td>rs7726159</td><td>Intron</td><td>5p15.33</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>TERT</td><td>rs7734992</td><td>Intron</td><td>5p15.33</td><td>Disease</td><td>&gt; 0.01</td><td>Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer</td></tr><tr style=''><td>TET2</td><td>rs17253672</td><td>Exon</td><td>4q24&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>TET2</td><td>rs9790517</td><td>Intron</td><td>4q24</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk</td></tr><tr style=''><td>TET2</td><td>rs9790517</td><td>Intron</td><td>4q24</td><td>Disease</td><td>&gt; 0.01</td><td>Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk</td></tr><tr style=''><td>TET2-AS1</td><td>rs17253672</td><td>Intron&nbsp;</td><td>4q24&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>TET2&nbsp;</td><td>rs62331150</td><td>Intron&nbsp;</td><td>4q24&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>TEX10</td><td>rs10124893</td><td>Intron</td><td>9q31.1</td><td>Disease</td><td>&gt; 0.01</td><td>A Pilot Genome-wide Association Study of Breast Cancer Susceptibility Loci in Indonesia </td></tr><tr style=''><td>TEX15</td><td>rs760604179</td><td>Exon</td><td>8p12</td><td>Disease</td><td>&lt; 0.01</td><td>Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility</td></tr><tr style=''><td>TGFB1</td><td>rs1800470</td><td>Exon</td><td>19q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>A common coding variant in CASP8 is associated with breast cancer risk</td></tr><tr style=''><td>TGFB1</td><td>rs1800470</td><td>Exon</td><td>19q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Commonly Studied Single-Nucleotide Polymorphisms and Breast Cancer: Results From the Breast Cancer Association Consortium</td></tr><tr style=''><td>TGFB1</td><td>rs1800470</td><td>Exon</td><td>19q13.2</td><td>Protective</td><td>&gt; 0.01</td><td>Association Study of Transforming Growth Factor Beta 1 + 29 T/C exon 1 Polymorphism in Breast Cancer Patients from North Indian Population</td></tr><tr style=''><td>TGFBR1</td><td>rs11466445</td><td>Exon</td><td>9q22.33</td><td>Disease</td><td>&gt; 0.01</td><td>Transforming Growth Factor beta Receptor 1 Polyalanine Polymorphism and Exon 5 Mutation Analysis in Breast and Ovarian Cancer</td></tr><tr style=''><td>TGFBR2</td><td>rs12493607</td><td>Intron</td><td>3p24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Large-scale genotyping identifies 41 new loci associated with breast cancer risk </td></tr><tr style=''><td>TGFBR2</td><td>rs12493607</td><td>Intron&nbsp;</td><td>3p24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population</td></tr><tr style=''><td>TGFBR2&nbsp;</td><td>rs12493607</td><td>Intron&nbsp;</td><td>3p24.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>TGIF2LX</td><td>-</td><td>Exon</td><td>Xq21.31</td><td>Disease</td><td>-</td><td>A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31</td></tr><tr style=''><td>TINF2&nbsp;</td><td>rs201677741</td><td>Exon</td><td>14q12&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Truncating TINF2 p.Tyr312Ter variant and inherited breast cancer susceptibility</td></tr><tr style=''><td>TLN2&nbsp;</td><td>rs956006</td><td>Intron&nbsp;</td><td>15q22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>TLR1&nbsp;</td><td>rs5743618</td><td>Exon</td><td>4p14&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>TLR6</td><td>rs5743810</td><td>Exon</td><td>4p14</td><td>Protective</td><td>&gt; 0.01</td><td>Novel sequence variants in the TLR6 gene associated with advanced breast cancer risk in the Saudi Arabian population</td></tr><tr style=''><td>TLR9</td><td>rs352140</td><td>Exon</td><td>3p21.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study</td></tr><tr style=''><td>TNFSF11&nbsp;</td><td>rs9533156</td><td>Intron&nbsp;</td><td>13q14&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Risk association of RANKL and OPG gene polymorphism with breast cancer to bone metastasis in Pashtun population of Khyber Pakhtunkhwa, Pakistan</td></tr><tr style=''><td>TNFSF4</td><td>rs3861950</td><td>Intron</td><td>1q25.1 </td><td>Disease</td><td>&gt; 0.01</td><td>A genome-wide association study of breast cancer in women of African ancestry</td></tr><tr style=''><td>TNNT3</td><td>-</td><td>-</td><td>11p15.5</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>TNNT3</td><td>rs909116</td><td>Intron</td><td>11p15.5 </td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>TNPO1-DT&nbsp;</td><td>rs3010266</td><td>Intron&nbsp;</td><td>5q13.2&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>TOGARAM2&nbsp;</td><td>rs56158184</td><td>Intron&nbsp;</td><td>2p23.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>TOX3</td><td>-</td><td>Exon</td><td>16q12.1</td><td>Disease</td><td>-</td><td>A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31</td></tr><tr style=''><td>TOX3</td><td>rs12443621</td><td>Intron</td><td>16q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>TOX3</td><td>rs8051542</td><td>Intron</td><td>16q12.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies novel breast cancer susceptibility loci</td></tr><tr style=''><td>TP53</td><td>-</td><td>Exon</td><td>17p13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer</td></tr><tr style=''><td>TP53</td><td>-</td><td>Exon</td><td>17p13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Germline p53 Mutations in a Cohort with Childhood Sarcoma: Sex Differences in Cancer Risk</td></tr><tr style=''><td>TP53</td><td>-</td><td>Exon</td><td>17p13.1</td><td>Disease</td><td>&lt; 0.01</td><td>Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women</td></tr><tr style=''><td>TP53</td><td>-</td><td>Exon</td><td>17p13.1</td><td>Disease</td><td>-</td><td>Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry</td></tr><tr style=''><td>TP53</td><td>-</td><td>Exon</td><td>17p13.1&nbsp;</td><td>Disease</td><td>-</td><td>Evaluating breast cancer predisposition genes in women of African ancestry</td></tr><tr style=''><td>TP53</td><td>rs1042522</td><td>Exon</td><td>17p13.1</td><td>Protective</td><td>&gt; 0.01</td><td>Impact of p53 arg72pro SNP on Breast Cancer Risk in North Indian Population</td></tr><tr style=''><td>TP53</td><td>rs1042522</td><td>Exon</td><td>17p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan</td></tr><tr style=''><td>TP53</td><td>rs1042522</td><td>Exon</td><td>17p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Association between the Arg72Pro Genotypes in the TP53 Gene and Ile655Val in the HER2 Gene and the Risk of Developing Breast Cancer in the Population of Amapá, Northern Brazil</td></tr><tr style=''><td>TP53</td><td>rs17878362</td><td>Intron</td><td>17p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years</td></tr><tr style=''><td>TP53&nbsp;</td><td>rs121912664</td><td>Exon</td><td>17p13.1&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Detection of germline variants in Brazilian breast cancer patients using multigene panel testing</td></tr><tr style=''><td>TPTE2</td><td>-</td><td>Exon</td><td>13q12.11</td><td>Disease</td><td>&lt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>TRDN</td><td>-</td><td>CNV</td><td>6q22.31</td><td>Protective</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>TRIM46</td><td>rs4971059</td><td>Intron</td><td>1q22</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>TRIM6</td><td>-</td><td>CNV</td><td>11p15.4&nbsp;</td><td>Protective</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>TRPS1</td><td>rs13277568</td><td>Intron</td><td>8q23.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses</td></tr><tr style=''><td>TRPS1&nbsp;</td><td>rs13277568</td><td>Intron</td><td>8q23.3</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>TSPAN16</td><td>rs322144</td><td>Intron</td><td>19p13.2</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>TSPYL6</td><td>rs843706</td><td>3 Prime UTR Variant</td><td>2p16.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association between single nucleotide polymorphisms in the TSPYL6 gene and breast cancer susceptibility in the Han Chinese population</td></tr><tr style=''><td>TXNRD2</td><td>rs2020917</td><td>Intron</td><td>22q11.21</td><td>Protective</td><td>&gt; 0.01</td><td>Breast Cancer Risk Reduction and Membrane-Bound Catechol O-Methyltransferase Genetic Polymorphisms</td></tr><tr style=''><td>TXNRD2</td><td>rs2075507</td><td>Intron</td><td>22q11.21</td><td>Protective</td><td>&gt; 0.01</td><td>The Investigation of Functional Genetic Variation in COMT Gene Promoter (rs2020917 &amp; rs2075507) in Iranian Patients with Breast Cancer</td></tr><tr style=''><td>TopBP1</td><td>rs55633281</td><td>Exon</td><td>3q22.1</td><td>Disease</td><td>&gt; 0.01</td><td>Identification of a Common Polymorphism in the TopBP1 Gene Associated With Hereditary Susceptibility to Breast and Ovarian Cancer</td></tr><tr style=''><td>UGT1A</td><td>rs3064744</td><td>Exon</td><td>2q37.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans</td></tr><tr style=''><td>UGT1A10</td><td>rs3064744</td><td>Intron</td><td>2q37.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans</td></tr><tr style=''><td>UGT1A3</td><td>rs3064744</td><td>Intron</td><td>2q37.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans</td></tr><tr style=''><td>UGT1A4</td><td>rs3064744</td><td>Intron</td><td>2q37.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans</td></tr><tr style=''><td>UGT1A5</td><td>rs3064744</td><td>Intron</td><td>2q37.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans</td></tr><tr style=''><td>UGT1A6</td><td>rs3064744</td><td>Intron</td><td>2q37.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans</td></tr><tr style=''><td>UGT1A7</td><td>rs3064744</td><td>Intron</td><td>2q37.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans</td></tr><tr style=''><td>UGT1A8</td><td>rs3064744</td><td>Intron</td><td>2q37.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans</td></tr><tr style=''><td>UGT1A9</td><td>rs3064744</td><td>Intron</td><td>2q37.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans</td></tr><tr style=''><td>UNC13C </td><td>rs12908083</td><td>Intron</td><td>15q21.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>USHBP1 </td><td>rs7246243</td><td>Intron</td><td>19p13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus</td></tr><tr style=''><td>USP18</td><td>-</td><td>CNV</td><td>22q11.2&nbsp;</td><td>Protective</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>USP31</td><td>-</td><td>CNV</td><td>16p12.2</td><td>Protective</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>VDR</td><td>rs1544410</td><td>Intron</td><td>12q13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Vitamin D receptor genotype and breast cancer in Latinas (United States)</td></tr><tr style=''><td>VDR</td><td>rs2228570</td><td>Initiator Codon Variant</td><td>12q13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Vitamin D Receptor Polymorphisms and Breast Cancer Risk: Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium</td></tr><tr style=''><td>VDR</td><td>rs2228570</td><td>Initiator Codon Variant</td><td>12q13.11</td><td>Disease</td><td>&gt; 0.01</td><td>FokI polymorphism of Vitamin D receptor gene and deficiency of serum Vitamin D increases the risk of breast cancer in North Indian women</td></tr><tr style=''><td>VDR</td><td>rs7975232</td><td>Intron</td><td>12q13.11</td><td>Disease</td><td>&gt; 0.01</td><td>Association of a vitamin D receptor polymorphism with sporadic breast cancer development</td></tr><tr style=''><td>VDR&nbsp;</td><td>rs731236&nbsp;</td><td>Exon</td><td>12q13.11&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Lower vitamin D levels and VDR variants are risk factors for breast cancer: an updated meta-analysis</td></tr><tr style=''><td>VDR&nbsp;</td><td>rs7975232</td><td>Intron&nbsp;</td><td>12q13.11&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Associations of vitamin D receptor encoding gene variants with premenopausal breast cancer risk</td></tr><tr style=''><td>VGLL3</td><td>rs13066793</td><td>Intron</td><td>3p12.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>VGLL3&nbsp;</td><td>rs13066793</td><td>Intron&nbsp;</td><td>3p12.1&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>VPS53</td><td>-</td><td>CNV</td><td>17p13.3&nbsp;</td><td>Protective</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>WDR43</td><td>rs4577244</td><td>Intron</td><td>2p23.2</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>WDR43</td><td>rs4577244</td><td>Intron</td><td>2p23.2</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</td></tr><tr style=''><td>WDR43</td><td>rs67073037</td><td>Intron</td><td>2p23.2</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>WDR43</td><td>rs6734079</td><td>Intron</td><td>2p23.2</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>WRAP53</td><td>rs2287499</td><td>Exon</td><td>17p13.1</td><td>Disease</td><td>&gt; 0.01</td><td>Common Genetic Variation in TP53 and Its Flanking Genes, WDR79 and ATP1B2, and Susceptibility to Breast Cancer</td></tr><tr style=''><td>WRN</td><td>rs1346044</td><td>Exon</td><td>8p12</td><td>Disease</td><td>&gt; 0.01</td><td>Association of the rs1346044 Polymorphism of the Werner Syndrome Gene RECQL2 with Increased Risk and Premature Onset of Breast Cancer</td></tr><tr style=''><td>WTAPP1</td><td>rs1144393</td><td>Intron</td><td>11q22.2</td><td>Protective</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study</td></tr><tr style=''><td>WTAPP1</td><td>rs1799750</td><td>Intron</td><td>11q22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer</td></tr><tr style=''><td>WTAPP1</td><td>rs5854</td><td>Intron</td><td>11q22.2</td><td>Protective</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study</td></tr><tr style=''><td>WTAPP1</td><td>rs7125062</td><td>Intron</td><td>11q22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study</td></tr><tr style=''><td>WTAPP1</td><td>rs996999</td><td>Intron</td><td>11q22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study</td></tr><tr style=''><td>XPA</td><td>rs1800975</td><td>Non Coding Transcript Variant</td><td>9q22.33</td><td>Protective</td><td>&gt; 0.01</td><td>Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population</td></tr><tr style=''><td>XPC</td><td>rs2228000</td><td>Exon</td><td>3p25.1</td><td>Disease</td><td>&gt; 0.01</td><td>Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population</td></tr><tr style=''><td>XPC</td><td>rs2228001</td><td>Exon</td><td>3p25.1</td><td>Protective</td><td>&gt; 0.01</td><td>Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population</td></tr><tr style=''><td>XRCC1</td><td>rs1799782</td><td>Exon</td><td>19q13.31</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Base-Excision Repair Pathway Genes and Risk of Breast Cancer</td></tr><tr style=''><td>XRCC1</td><td>rs25487</td><td>Exon</td><td>19q13.31</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Polymorphisms in Base-Excision Repair Pathway Genes and Risk of Breast Cancer</td></tr><tr style=''><td>XRCC1</td><td>rs25487</td><td>Exon</td><td>19q13.31</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Variations of DNA Repair Genes in Breast Cancer</td></tr><tr style=''><td>XRCC1</td><td>rs25487</td><td>Exon</td><td>19q13.31</td><td>Disease</td><td>&gt; 0.01</td><td>The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis</td></tr><tr style=''><td>XRCC1</td><td>rs25489</td><td>Exon</td><td>19q13.31</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus</td></tr><tr style=''><td>XRCC2</td><td>-</td><td>Exon</td><td>7q36.1</td><td> Disease</td><td>&lt; 0.01</td><td>Rare mutations in XRCC2 increase the risk of breast cancer</td></tr><tr style=''><td>XRCC2</td><td>rs3218536</td><td>Exon</td><td>7q36.1</td><td>Protective</td><td>&gt; 0.01</td><td>Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses</td></tr><tr style=''><td>XRCC2</td><td>rs3218536</td><td>Exon</td><td>7q36.1</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus</td></tr><tr style=''><td>XRCC2</td><td>rs3218536</td><td>Exon</td><td>7q36.1</td><td>Protective</td><td>&gt; 0.01</td><td>Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk</td></tr><tr style=''><td>XRCC2</td><td>rs3218536</td><td>Exon</td><td>7q36.1</td><td> Disease</td><td>&gt; 0.01</td><td>Correlation between Selected XRCC2, XRCC3 and RAD51 Gene Polymorphisms and Primary Breast Cancer in Women in Pakistan</td></tr><tr style=''><td>XRCC3</td><td>rs1799796</td><td>Intron</td><td>14q32.33</td><td>Protective</td><td>&gt; 0.01</td><td>Variants in DNA double-strand break repair genes and breast cancer susceptibility</td></tr><tr style=''><td>XRCC3</td><td>rs861539</td><td>Exon</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Variants in DNA double-strand break repair genes and breast cancer susceptibility</td></tr><tr style=''><td>XRCC3</td><td>rs861539</td><td>Exon</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Correlation between selected XRCC2, XRCC3 and RAD51 gene polymorphisms and primary breast cancer in women in Pakistan</td></tr><tr style=''><td>XRCC3</td><td>rs861539</td><td>Exon</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Variations of DNA Repair Genes in Breast Cancer</td></tr><tr style=''><td>XRCC3&nbsp;</td><td>rs861539</td><td>Exon</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Homologous recombination DNA repair gene RAD51, XRCC2 &amp; XRCC3 polymorphisms and breast cancer risk in South Indian women</td></tr><tr style=''><td>XRCC3&nbsp;</td><td>rs861539</td><td>Exon</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>Relationship between polymorphisms in homologous recombination repair genes RAD51 G172T、XRCC2 &amp; XRCC3 and risk of breast cancer: A meta-analysis</td></tr><tr style=''><td>XRCC3&nbsp;</td><td>rs861539</td><td>Exon</td><td>14q32.33</td><td>Disease</td><td>&gt; 0.01</td><td>The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis</td></tr><tr style=''><td>XRCC3&nbsp;</td><td>rs861539</td><td>Exon</td><td>14q32.33</td><td>Protective</td><td>&gt; 0.01</td><td>Association of&nbsp;RAD51,&nbsp;XRCC1,&nbsp;XRCC2, and&nbsp;XRCC3&nbsp;Polymorphisms with Risk of Breast Cancer</td></tr><tr style=''><td>XRCC5</td><td>rs3835</td><td>Intron</td><td>2q35</td><td>Disease</td><td>&gt; 0.01</td><td>Polymorphisms in Nonhomologous End-Joining Genes Associated with Breast Cancer Risk and Chromosomal Radiosensitivity</td></tr><tr style=''><td>XRCC6</td><td>rs73161324</td><td>Intron</td><td>22q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>XRCC6&nbsp;</td><td>rs73161324</td><td>Intron&nbsp;</td><td>22q13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ZBED6&nbsp;</td><td>rs59867004</td><td>Intron&nbsp;</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ZBTB38</td><td>rs34207738</td><td>Intron</td><td>3q23</td><td>Disease</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>ZBTB38&nbsp;</td><td>rs6440006</td><td>Intron&nbsp;</td><td>3q23&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ZC3H11A</td><td>rs4951011</td><td>Intron</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1</td></tr><tr style=''><td>ZC3H11A&nbsp;</td><td>rs59867004</td><td>Intron&nbsp;</td><td>1q32.1</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ZFPM2</td><td>rs12546444</td><td>Intron</td><td>8q23.1</td><td>Protective</td><td>&gt; 0.01</td><td>Association analysis identifies 65 new breast cancer risk loci</td></tr><tr style=''><td>ZFPM2&nbsp;</td><td>rs12546444</td><td>Intron&nbsp;</td><td>8q23&nbsp;</td><td>Protective</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ZMIZ1</td><td>rs704010</td><td>Intron</td><td>10q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>Association of multiple genetic variants with breast cancer susceptibility in the Han Chinese population</td></tr><tr style=''><td>ZMIZ1</td><td>rs704010</td><td>Intron</td><td>10q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic susceptibility loci for subtypes of breast cancer in an African American population</td></tr><tr style=''><td>ZMIZ1</td><td>rs704010</td><td>Intron</td><td>10q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>ZMIZ1</td><td>rs704010</td><td>Intron</td><td>10q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>ZMIZ1</td><td>rs704010</td><td>Intron&nbsp;</td><td>10q22.3</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr><tr style=''><td>ZNF320</td><td>-</td><td>CNV</td><td>19q13.41&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>ZNF365</td><td>rs10995190</td><td>Intron</td><td>10q21.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies five new breast cancer susceptibility loci</td></tr><tr style=''><td>ZNF365</td><td>rs10995190</td><td>Intron</td><td>10q21.2</td><td>Protective</td><td>&gt; 0.01</td><td>Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer</td></tr><tr style=''><td>ZNF365</td><td>rs10995190</td><td>Intron</td><td>10q21.2</td><td>Protective</td><td>&gt; 0.01</td><td>Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast</td></tr><tr style=''><td>ZNF365</td><td>rs10995201&nbsp;</td><td>Intron</td><td>10q21.2</td><td>Protective</td><td>&gt; 0.01</td><td>Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression</td></tr><tr style=''><td>ZNF404</td><td>-</td><td>-</td><td>19q13.31</td><td>Disease</td><td>-</td><td>Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry</td></tr><tr style=''><td>ZNF439</td><td>-</td><td>CNV</td><td>19p13.2&nbsp;</td><td>Disease</td><td>&lt; 0.01</td><td>Rare germline copy number variants (CNVs) and breast cancer risk</td></tr><tr style=''><td>ZNF479&nbsp;</td><td>rs200382632</td><td>Exon</td><td>7p11.2&nbsp;</td><td>Disease</td><td>&gt; 0.01</td><td>Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility</td></tr><tr style=''><td>ZNF577</td><td>rs10411161</td><td>Intron</td><td>19q13.41</td><td>Disease</td><td>&gt; 0.01</td><td>Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility</td></tr><tr style=''><td>ZNF577</td><td>rs11878583</td><td>Intron</td><td>19q13.41</td><td>Disease</td><td>&gt; 0.01</td><td>Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility</td></tr><tr style=''><td>ZNF577</td><td>rs3848562</td><td>Intron</td><td>19q13.41</td><td>Disease</td><td>&gt; 0.01</td><td>Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility</td></tr><tr style=''><td>ZNF805</td><td>rs7248000</td><td>Intron</td><td>19q13.43</td><td>Protective</td><td>&gt; 0.01</td><td>Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium</td></tr><tr style=''><td>ZSCAN25</td><td>rs776746</td><td>Intron</td><td>2p22.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genetic polymorphisms in estrogen metabolism and breast cancer risk in case–control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians</td></tr><tr style=''><td>ZZEF1&nbsp;</td><td>rs2123844</td><td>Intron&nbsp;</td><td>17p13.2</td><td>Disease</td><td>&gt; 0.01</td><td>Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics</td></tr></table></body></html>